BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151-171. [PMID: 30266282 DOI: 10.1016/j.jhep.2018.09.014] [Cited by in Crossref: 615] [Cited by in F6Publishing: 559] [Article Influence: 153.8] [Reference Citation Analysis]
Number Citing Articles
1 Selicean S, Wang C, Guixé-Muntet S, Stefanescu H, Kawada N, Gracia-Sancho J. Regression of portal hypertension: underlying mechanisms and therapeutic strategies. Hepatol Int 2021;15:36-50. [PMID: 33544313 DOI: 10.1007/s12072-021-10135-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li X, Liu R. Long non-coding RNA H19 in the liver-gut axis: A diagnostic marker and therapeutic target for liver diseases. Experimental and Molecular Pathology 2020;115:104472. [DOI: 10.1016/j.yexmp.2020.104472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Donkor S, Larbie C, Komlaga G, Emikpe BO. Evaluation of the Acute Hepatoprotective Potential of Hydroethanolic Extract of Duranta erecta L. Parts. J Toxicol 2020;2020:8815719. [PMID: 33505464 DOI: 10.1155/2020/8815719] [Reference Citation Analysis]
4 Zahedi M, Yousefi M, Abounoori M, Malekan M, Tajik F, Heydari K, Mortazavi P, Ghahramani S, Ghazaeian M, Sheydaee F, Nasirzadeh A, Alizadeh-Navaei R. The Interrelationship between Liver Function Test and the Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Iran J Med Sci 2021;46:237-55. [PMID: 34305236 DOI: 10.30476/ijms.2021.87555.1793] [Reference Citation Analysis]
5 GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:245-266. [PMID: 31981519 DOI: 10.1016/s2468-1253(19)30349-8] [Cited by in Crossref: 167] [Cited by in F6Publishing: 75] [Article Influence: 83.5] [Reference Citation Analysis]
6 Xu L, Yang C, Ma J, Zhang X, Wang Q, Xiong X. NAMPT-mediated NAD+ biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice. Hum Exp Toxicol 2021;40:S666-75. [PMID: 34752167 DOI: 10.1177/09603271211052991] [Reference Citation Analysis]
7 Owen A, Newsome PN. Mesenchymal Stromal Cells, a New Player in Reducing Complications From Liver Transplantation? Front Immunol 2020;11:1306. [PMID: 32636850 DOI: 10.3389/fimmu.2020.01306] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Decharatanachart P, Chaiteerakij R, Tiyarattanachai T, Treeprasertsuk S. Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis. BMC Gastroenterol 2021;21:10. [PMID: 33407169 DOI: 10.1186/s12876-020-01585-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Adam EH, Möhlmann M, Herrmann E, Schneider S, Zacharowski K, Zeuzem S, Weber CF, Weiler N. Assessment of hemostatic profile in patients with mild to advanced liver cirrhosis. World J Gastroenterol 2020; 26(17): 2097-2110 [PMID: 32536777 DOI: 10.3748/wjg.v26.i17.2097] [Reference Citation Analysis]
10 Ezhilarasan D. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis. J Cell Physiol 2021. [PMID: 34514599 DOI: 10.1002/jcp.30582] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Buchy P, Badur S. Who and when to vaccinate against influenza. International Journal of Infectious Diseases 2020;93:375-87. [DOI: 10.1016/j.ijid.2020.02.040] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
12 Chhimwal J, Sharma S, Kulurkar P, Patial V. Crocin attenuates CCl4-induced liver fibrosis via PPAR-γ mediated modulation of inflammation and fibrogenesis in rats. Hum Exp Toxicol 2020;39:1639-49. [PMID: 32633567 DOI: 10.1177/0960327120937048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Wahyuningsih SPA, Mwendolwa AA, Winarni D, Anggreini RW, Mamuaya BKK. Protective Effect of Red Okra (Abelmoschus esculentus (L.) Moench) Pods against Sodium Nitrite-Induced Liver Injury in Mice. Vet Med Int 2021;2021:6647800. [PMID: 34221340 DOI: 10.1155/2021/6647800] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Qu H, Gao X, Wang ZY, Yi JJ. Comparative study on hepatoprotection of pine nut (Pinus koraiensis Sieb. et Zucc.) polysaccharide against different types of chemical-induced liver injury models in vivo. Int J Biol Macromol 2020;155:1050-9. [PMID: 31712149 DOI: 10.1016/j.ijbiomac.2019.11.069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Yeoman AD. Novel Approaches to Detect Significant Liver Disease in the General Population. Clin Liver Dis (Hoboken) 2021;18:99-103. [PMID: 34584677 DOI: 10.1002/cld.1097] [Reference Citation Analysis]
16 Vaz J, Strömberg U, Eriksson B, Buchebner D, Midlöv P. Socioeconomic and marital status among liver cirrhosis patients and associations with mortality: a population-based cohort study in Sweden. BMC Public Health 2020;20:1820. [PMID: 33256682 DOI: 10.1186/s12889-020-09783-2] [Reference Citation Analysis]
17 Petrillo S, Manco M, Altruda F, Fagoonee S, Tolosano E. Liver Sinusoidal Endothelial Cells at the Crossroad of Iron Overload and Liver Fibrosis. Antioxid Redox Signal 2021;35:474-86. [PMID: 32689808 DOI: 10.1089/ars.2020.8168] [Reference Citation Analysis]
18 Huang X, Lee F, Teng Y, Lingam CB, Chen Z, Sun M, Song Z, Balachander GM, Leo HL, Guo Q, Shah I, Yu H. Sequential drug delivery for liver diseases. Adv Drug Deliv Rev 2019;149-150:72-84. [PMID: 31734169 DOI: 10.1016/j.addr.2019.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Bengtsson B, Askling J, Ludvigsson JF, Hagström H. Validity of administrative codes associated with cirrhosis in Sweden. Scandinavian Journal of Gastroenterology 2020;55:1205-10. [DOI: 10.1080/00365521.2020.1820566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
20 Yang DZ, Alhadab A, Parivar K, Wang DD, Elmeliegy M. Analysis of US Food and Drug Administration Oncology Approvals on the Characterization of Hepatic Impairment Effect and Dosing Recommendations. Clin Pharmacol Ther 2021. [PMID: 34870845 DOI: 10.1002/cpt.2505] [Reference Citation Analysis]
21 Xu D, Tian Y, Xia Q, Ke B. The cGAS-STING Pathway: Novel Perspectives in Liver Diseases. Front Immunol 2021;12:682736. [PMID: 33995425 DOI: 10.3389/fimmu.2021.682736] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Yuan S, Dong M, Zhang H, Jiang X, Yan C, Ye R, Zhou H, Chen L, Lian H, Jin W. Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGFβR1. Int J Biol Macromol 2022;194:556-62. [PMID: 34822828 DOI: 10.1016/j.ijbiomac.2021.11.098] [Reference Citation Analysis]
23 Reza HA, Okabe R, Takebe T. Organoid transplant approaches for the liver. Transpl Int 2021;34:2031-45. [PMID: 34614263 DOI: 10.1111/tri.14128] [Reference Citation Analysis]
24 Grimm D, Wehland M, Corydon TJ, Richter P, Prasad B, Bauer J, Egli M, Kopp S, Lebert M, Krüger M. The effects of microgravity on differentiation and cell growth in stem cells and cancer stem cells. Stem Cells Transl Med 2020;9:882-94. [PMID: 32352658 DOI: 10.1002/sctm.20-0084] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
25 Zhang Y, Chen L, Chen H. Associations between polymorphisms in IL-10 gene and the risk of viral hepatitis: a meta-analysis. Gut Pathog 2020;12:36. [PMID: 32742307 DOI: 10.1186/s13099-020-00372-7] [Reference Citation Analysis]
26 Oyelade T, Alqahtani J, Canciani G. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2020;5. [PMID: 32429038 DOI: 10.3390/tropicalmed5020080] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
27 Gabbia D, Carpi S, Sarcognato S, Cannella L, Colognesi M, Scaffidi M, Polini B, Digiacomo M, Esposito Salsano J, Manera C, Macchia M, Nieri P, Carrara M, Russo FP, Guido M, De Martin S. The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver. Front Nutr 2021;8:715183. [PMID: 34671630 DOI: 10.3389/fnut.2021.715183] [Reference Citation Analysis]
28 Pu J, Li W, Wang A, Zhang Y, Qin Z, Xu Z, Wang J, Lu Y, Tang Q, Wei H. Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages. Cell Death Dis 2021;12:1103. [PMID: 34815380 DOI: 10.1038/s41419-021-04309-z] [Reference Citation Analysis]
29 Shah MD, Venmathi Maran BA, Shaleh SRM, Zuldin WH, Gnanaraj C, Yong YS. Therapeutic Potential and Nutraceutical Profiling of North Bornean Seaweeds: A Review. Marine Drugs 2022;20:101. [DOI: 10.3390/md20020101] [Reference Citation Analysis]
30 Pinheiro D, Dias I, Freire T, Thole AA, Stumbo AC, Cortez EAC, de Carvalho L, de Carvalho SN. Effects of mesenchymal stem cells conditioned medium treatment in mice with cholestatic liver fibrosis. Life Sci 2021;281:119768. [PMID: 34186042 DOI: 10.1016/j.lfs.2021.119768] [Reference Citation Analysis]
31 da Silva Meirelles L, Marson RF, Solari MIG, Nardi NB. Are Liver Pericytes Just Precursors of Myofibroblasts in Hepatic Diseases? Insights from the Crosstalk between Perivascular and Inflammatory Cells in Liver Injury and Repair. Cells 2020;9:E188. [PMID: 31940814 DOI: 10.3390/cells9010188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
32 Ha K, Fujita M, Karlić R, Yang S, Xue R, Zhang C, Bai F, Zhang N, Hoshida Y, Polak P, Nakagawa H, Kim HG, Lee H. Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancer. Heliyon 2020;6:e03350. [PMID: 32083210 DOI: 10.1016/j.heliyon.2020.e03350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Tu S, Jiang Y, Cheng H, Yuan X, He Y, Peng Y, Peng X, Peng Z, Tao L, Yang H. Fluorofenidone protects liver against inflammation and fibrosis by blocking the activation of NF-κB pathway. FASEB J 2021;35:e21497. [PMID: 34152015 DOI: 10.1096/fj.202002402R] [Reference Citation Analysis]
34 Beier JI, Arteel GE. Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns. Acta Pharmaceutica Sinica B 2021;11:3768-78. [DOI: 10.1016/j.apsb.2021.09.005] [Reference Citation Analysis]
35 Zhu Z, Zhou W, Yang Y, Wang K, Li F, Dang Y. Quantitative Profiling of Oxylipin Reveals the Mechanism of Pien-Tze-Huang on Alcoholic Liver Disease. Evid Based Complement Alternat Med 2021;2021:9931542. [PMID: 34158817 DOI: 10.1155/2021/9931542] [Reference Citation Analysis]
36 O'Brien A, Karvellas CJ. Acute-on-chronic liver failure: The challenge of PREDICTing who and when. J Hepatol 2020;73:755-6. [PMID: 32800351 DOI: 10.1016/j.jhep.2020.07.029] [Reference Citation Analysis]
37 Cao J, Qiu W, Yu Y, Li N, Wu H, Chen Z. The association between serum albumin and depression in chronic liver disease may differ by liver histology. BMC Psychiatry 2022;22:5. [PMID: 34983435 DOI: 10.1186/s12888-021-03647-8] [Reference Citation Analysis]
38 Malnick S, Maor Y. The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome. Visc Med 2020;36:198-205. [PMID: 32775350 DOI: 10.1159/000507233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Zheng M, Fang W, Yu M, Ding R, Zeng H, Huang Y, Mi Y, Duan C. IL-6 and IL-10 gene polymorphisms and cirrhosis of liver risk from a comprehensive analysis. BMC Endocr Disord 2021;21:242. [PMID: 34886817 DOI: 10.1186/s12902-021-00906-3] [Reference Citation Analysis]
40 Chandarana H, Shanbhogue K. Noninvasive Staging of Liver Fibrosis with Dual-Energy CT: Close but No Cigar. Radiology 2021;298:609-10. [PMID: 33404360 DOI: 10.1148/radiol.2021204315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Tai Y, Zhao C, Gao J, Lan T, Tong H. Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis. PeerJ 2021;9:e11910. [PMID: 34434654 DOI: 10.7717/peerj.11910] [Reference Citation Analysis]
42 Papatheodoridi M, Mazza G, Pinzani M. Regenerative hepatology: In the quest for a modern prometheus? Dig Liver Dis 2020;52:1106-14. [PMID: 32868215 DOI: 10.1016/j.dld.2020.08.001] [Reference Citation Analysis]
43 Han B, Kim SM, Nam GE, Kim SH, Park SJ, Park YK, Baik HW. A Randomized, Double-Blind, Placebo-Controlled, Multi-Centered Clinical Study to Evaluate the Efficacy and Safety of Artemisia annua L. Extract for Improvement of Liver Function. Clin Nutr Res 2020;9:258-70. [PMID: 33204666 DOI: 10.7762/cnr.2020.9.4.258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Lago-Hernandez C, Nguyen NH, Khera R, Loomba R, Asrani SK, Singh S. Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases. Mayo Clin Proc 2021:S0025-6196(21)00255-X. [PMID: 34120754 DOI: 10.1016/j.mayocp.2021.02.026] [Reference Citation Analysis]
45 Chen J, Rong X, Liu X, Zheng D, Rong X, Chen F, Zhao P, Liu F, Ruan J. FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma. Cancer Cell Int 2020;20:196. [PMID: 32508532 DOI: 10.1186/s12935-020-01265-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev 2021;178:113834. [PMID: 34492233 DOI: 10.1016/j.addr.2021.113834] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Cheng ML, Nakib D, Perciani CT, MacParland SA. The immune niche of the liver. Clin Sci (Lond) 2021;135:2445-66. [PMID: 34709406 DOI: 10.1042/CS20190654] [Reference Citation Analysis]
48 Xue YR, Yao S, Liu Q, Peng ZL, Deng QQ, Liu B, Ma ZH, Wang L, Zhou H, Ye Y, Pan GY. Dihydro-stilbene gigantol relieves CCl4-induced hepatic oxidative stress and inflammation in mice via inhibiting C5b-9 formation in the liver. Acta Pharmacol Sin 2020;41:1433-45. [PMID: 32404983 DOI: 10.1038/s41401-020-0406-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Dwivedi DK, Jena GB. Simultaneous Modulation of NLRP3 Inflammasome and Nrf2/ARE Pathway Rescues Thioacetamide-Induced Hepatic Damage in Mice: Role of Oxidative Stress and Inflammation. Inflammation 2021. [PMID: 34664134 DOI: 10.1007/s10753-021-01571-3] [Reference Citation Analysis]
50 Weng T, Yan D, Shi D, Zhu M, Liu Y, Wu Z, Tang T, Zhu L, Zhang H, Yao H, Li L. The MSP-RON pathway regulates liver fibrosis through transforming growth factor beta-dependent epithelial-mesenchymal transition. Liver Int 2021;41:1956-68. [PMID: 33786995 DOI: 10.1111/liv.14892] [Reference Citation Analysis]
51 Moroni F, Dwyer BJ, Graham C, Pass C, Bailey L, Ritchie L, Mitchell D, Glover A, Laurie A, Doig S, Hargreaves E, Fraser AR, Turner ML, Campbell JDM, McGowan NWA, Barry J, Moore JK, Hayes PC, Leeming DJ, Nielsen MJ, Musa K, Fallowfield JA, Forbes SJ. Safety profile of autologous macrophage therapy for liver cirrhosis. Nat Med 2019;25:1560-5. [PMID: 31591593 DOI: 10.1038/s41591-019-0599-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
52 Wang P, Nie F, Dong T, Wang G, Wang L, Fan X. Study on correlation between two-dimensional ultrasound, contrast-enhanced ultrasound and microvascular invasion in hepatocellular carcinoma. Clin Hemorheol Microcirc 2021. [PMID: 34057142 DOI: 10.3233/CH-211190] [Reference Citation Analysis]
53 Dewi IP, Kwintana RB, Ulinnuha JU, Rachman F, Christianty FM, Holidah D. Hepatoprotective effect of ethanolic extract of sugarcane (Saccharum officinarum Linn.) leaves. J Basic Clin Physiol Pharmacol 2021;32:533-40. [PMID: 34214375 DOI: 10.1515/jbcpp-2020-0432] [Reference Citation Analysis]
54 Gijbels E, Pieters A, De Muynck K, Vinken M, Devisscher L. Rodent models of cholestatic liver disease: A practical guide for translational research. Liver Int 2021;41:656-82. [PMID: 33486884 DOI: 10.1111/liv.14800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
55 Galicia-Moreno M, Lucano-Landeros S, Monroy-Ramirez HC, Silva-Gomez J, Gutierrez-Cuevas J, Santos A, Armendariz-Borunda J. Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects. Antioxidants (Basel) 2020;9:E980. [PMID: 33066023 DOI: 10.3390/antiox9100980] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
56 Bashir MR, Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Chernyak V, Goldstein A, Grajo JR, Hindman NM, Kamaya A, McNamara MM, Porter KK, Solnes LB, Srivastava PK, Zaheer A, Carucci LR; Expert Panel on Gastrointestinal Imaging. ACR Appropriateness Criteria® Chronic Liver Disease. J Am Coll Radiol 2020;17:S70-80. [PMID: 32370979 DOI: 10.1016/j.jacr.2020.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Meyer F, Bannert K, Wiese M, Esau S, Sautter LF, Ehlers L, Aghdassi AA, Metges CC, Garbe LA, Jaster R, Lerch MM, Lamprecht G, Valentini L. Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis. Int J Mol Sci 2020;21:E5357. [PMID: 32731496 DOI: 10.3390/ijms21155357] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
58 Mihai F, Trifan A, Stanciu C, Singeap AM, Cucuteanu B, Lupascu Ursulescu C, Pop C, Girleanu I, Cuciureanu T, Negru D, Cojocariu C. Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment. Medicina (Kaunas) 2020;56:E171. [PMID: 32290305 DOI: 10.3390/medicina56040171] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Gleeson MW. Interplay of Liver Disease and Gut Microbiota in the Development of Colorectal Neoplasia. Curr Treat Options Gastro 2019;17:378-93. [DOI: 10.1007/s11938-019-00241-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Cernigliaro V, Peluso R, Zedda B, Silengo L, Tolosano E, Pellicano R, Altruda F, Fagoonee S. Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases. Cells 2020;9:E386. [PMID: 32046114 DOI: 10.3390/cells9020386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
61 Chen Y, Yang YC, Zhu BL, Wu CC, Lin RF, Zhang X. Association between periodontal disease, tooth loss and liver diseases risk. J Clin Periodontol 2020;47:1053-63. [PMID: 32621350 DOI: 10.1111/jcpe.13341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
62 De Muynck K, Vanderborght B, Van Vlierberghe H, Devisscher L. The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 2021;10:2959. [PMID: 34831182 DOI: 10.3390/cells10112959] [Reference Citation Analysis]
63 Macías-Pérez JR, Vázquez-López BJ, Muñoz-Ortega MH, Aldaba-Muruato LR, Martínez-Hernández SL, Sánchez-Alemán E, Ventura-Juárez J. Curcumin and α/β-Adrenergic Antagonists Cotreatment Reverse Liver Cirrhosis in Hamsters: Participation of Nrf-2 and NF-κB. J Immunol Res 2019;2019:3019794. [PMID: 31183386 DOI: 10.1155/2019/3019794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
64 Owojuyigbe OS, Larbie C, Firempong CK, Komlaga G, Emikpe BO, Oyagbemi AA. Hura crepitans stem bark extract: A potential remedy to sub-acute liver damage. J Ethnopharmacol 2021;284:114768. [PMID: 34688802 DOI: 10.1016/j.jep.2021.114768] [Reference Citation Analysis]
65 Melaram R. Environmental Risk Factors Implicated in Liver Disease: A Mini-Review. Front Public Health 2021;9:683719. [PMID: 34249849 DOI: 10.3389/fpubh.2021.683719] [Reference Citation Analysis]
66 Panwar A, Das P, Tan LP. 3D Hepatic Organoid-Based Advancements in LIVER Tissue Engineering. Bioengineering (Basel) 2021;8:185. [PMID: 34821751 DOI: 10.3390/bioengineering8110185] [Reference Citation Analysis]
67 Nazarie Ignat SR, Gharbia S, Hermenean A, Dinescu S, Costache M. Regenerative Potential of Mesenchymal Stem Cells' (MSCs) Secretome for Liver Fibrosis Therapies. Int J Mol Sci 2021;22:13292. [PMID: 34948088 DOI: 10.3390/ijms222413292] [Reference Citation Analysis]
68 Arechederra M, Recalde M, Gárate-Rascón M, Fernández-Barrena MG, Ávila MA, Berasain C. Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease. Cancers (Basel) 2021;13:1265. [PMID: 33809263 DOI: 10.3390/cancers13061265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Zhong HJ, Sun HH, Xue LF, McGowan EM, Chen Y. Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis. World J Gastroenterol 2019; 25(3): 378-387 [PMID: 30686905 DOI: 10.3748/wjg.v25.i3.378] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
70 Gu W, Hortlik H, Erasmus HP, Schaaf L, Zeleke Y, Uschner FE, Ferstl P, Schulz M, Peiffer KH, Queck A, Sauerbruch T, Brol MJ, Rohde G, Sanchez C, Moreau R, Arroyo V, Zeuzem S, Welsch C, Trebicka J. Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg Health Eur 2022;12:100240. [PMID: 34901909 DOI: 10.1016/j.lanepe.2021.100240] [Reference Citation Analysis]
71 Liu Y, Zhang D, Liu G, Chen Q, Lu Z. Ameliorative effect of dieckol-enriched extraction from Laminaria japonica on hepatic steatosis induced by a high-fat diet via β-oxidation pathway in ICR mice. Journal of Functional Foods 2019;58:44-55. [DOI: 10.1016/j.jff.2019.04.051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
72 Barnhart DA, Kamali I, Nyirahabihirwe F, Mugabo C, Gakuru JP, Uwase M, Nizeyumuremyi E, Musafiri T, Gatete JD, Makuza JD, Kateera F, Hedt-Gauthier B, Ndahimana JD. Knowledge among patients with Hepatitis C initiating on direct-acting antiviral treatment in rural Rwanda: A prospective cohort study. Glob Health Action 2021;14:1953250. [PMID: 34347569 DOI: 10.1080/16549716.2021.1953250] [Reference Citation Analysis]
73 Majumdar A, Tsochatzis EA. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. Metabolism 2020;111:154291. [DOI: 10.1016/j.metabol.2020.154291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
74 Buechler C, Aslanidis C. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma.Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865:158658. [PMID: 32058031 DOI: 10.1016/j.bbalip.2020.158658] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
75 Feng Z, Xiang J, Liu H, Li J, Xu X, Sun G, Zheng R, Zhang S, Liu J, Yang S, Xu Q, Wen X, Yuan H, Sun H, Dai L. Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c02002] [Reference Citation Analysis]
76 Wang X, Wang L, Dong R, Huang K, Wang C, Gu J, Luo H, Liu K, Wu J, Sun H, Meng Q. Luteolin ameliorates LPS-induced acute liver injury by inhibiting TXNIP-NLRP3 inflammasome in mice. Phytomedicine 2021;87:153586. [PMID: 34044253 DOI: 10.1016/j.phymed.2021.153586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Ezhilarasan D. Advantages and challenges in nanomedicines for chronic liver diseases: A hepatologist's perspectives. Eur J Pharmacol 2021;893:173832. [PMID: 33359144 DOI: 10.1016/j.ejphar.2020.173832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Buyco DG, Martin J, Jeon S, Hooks R, Lin C, Carr R. Experimental models of metabolic and alcoholic fatty liver disease. World J Gastroenterol 2021; 27(1): 1-18 [PMID: 33505147 DOI: 10.3748/wjg.v27.i1.1] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Khomich O, Ivanov AV, Bartosch B. Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. Cells 2019;9:E24. [PMID: 31861818 DOI: 10.3390/cells9010024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
80 Melin N, Sánchez-Taltavull D, Fahrner R, Keogh A, Dosch M, Büchi I, Zimmer Y, Medová M, Beldi G, Aebersold DM, Candinas D, Stroka D. Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury. Cell Death Dis 2021;12:366. [PMID: 33824326 DOI: 10.1038/s41419-021-03654-3] [Reference Citation Analysis]
81 Aitharaju V, De Silvestri A, Barr RG. Assessment of chronic liver disease by multiparametric ultrasound: results from a private practice outpatient facility. Abdom Radiol (NY) 2021. [PMID: 34304291 DOI: 10.1007/s00261-021-03225-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Reference Citation Analysis]
83 Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet 2021;398:1359-76. [PMID: 34543610 DOI: 10.1016/S0140-6736(21)01374-X] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
84 Gamboa CM, Wang Y, Xu H, Kalemba K, Wondisford FE, Sabaawy HE. Optimized 3D Culture of Hepatic Cells for Liver Organoid Metabolic Assays. Cells 2021;10:3280. [DOI: 10.3390/cells10123280] [Reference Citation Analysis]
85 Zhang B, Lapenta K, Wang Q, Nam JH, Chung D, Robert ME, Nathanson MH, Yang X. Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis. J Biol Chem 2021;297:100887. [PMID: 34146542 DOI: 10.1016/j.jbc.2021.100887] [Reference Citation Analysis]
86 Åberg F, Färkkilä M, Männistö V. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies. Alcohol Clin Exp Res 2020;44:384-403. [DOI: 10.1111/acer.14271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
87 Younossi ZM, Stepanova M, Younossi Y, Golabi P, Mishra A, Rafiq N, Henry L. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut 2020;69:564-8. [DOI: 10.1136/gutjnl-2019-318813] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 27.7] [Reference Citation Analysis]
88 Nithyananthan S, Sushmaa D, Myrthong I, Valluru L, Guha S, Hassan Mir I, Behera J, Thirunavukkarasu C. Curcuma longa and Trigonella foenum graecum-enriched nutrient mixture from germinated Macrotyloma uniflorum and Vigna radiate ameliorate nonalcoholic fatty liver diseases in rats. J Food Biochem 2020;44:e13159. [PMID: 32017151 DOI: 10.1111/jfbc.13159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 de Vries RJ, Pendexter CA, Cronin SEJ, Marques B, Hafiz EOA, Muzikansky A, van Gulik TM, Markmann JF, Stott SL, Yeh H, Toner M, Uygun K, Tessier SN. Cell release during perfusion reflects cold ischemic injury in rat livers. Sci Rep 2020;10:1102. [PMID: 31980677 DOI: 10.1038/s41598-020-57589-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
90 Wang P, Nie F, Dong T, Yang D, Liu T, Wang G. Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver. Diagnostics 2021;11:2250. [DOI: 10.3390/diagnostics11122250] [Reference Citation Analysis]
91 García-compeán D, Villarreal-pérez JZ, Cavazos MEDLO, Lavalle-gonzalez FJ, Borjas-almaguer OD, Del Cueto-aguilera AN, González-gonzález JA, Treviño-garza C, Huerta-pérez L, Maldonado-garza HJ. Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? Annals of Hepatology 2020;19:258-64. [DOI: 10.1016/j.aohep.2020.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Zheng W, Jiang F, Shan J, Wang Y, Jia Y, Guo Q, Lou J, Zhao Y. Levels of serum IgG subclasses in patients with liver disease: A retrospective study. Exp Ther Med 2021;21:45. [PMID: 33273974 DOI: 10.3892/etm.2020.9476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Chembazhi UV, Bangru S, Hernaez M, Kalsotra A. Cellular plasticity balances the metabolic and proliferation dynamics of a regenerating liver. Genome Res 2021;31:576-91. [PMID: 33649154 DOI: 10.1101/gr.267013.120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
94 Hu S, Russell JO, Liu S, Cao C, McGaughey J, Rai R, Kosar K, Tao J, Hurley E, Poddar M, Singh S, Bell A, Shin D, Raeman R, Singhi AD, Nejak-Bowen K, Ko S, Monga SP. β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction. Elife 2021;10:e71310. [PMID: 34609282 DOI: 10.7554/eLife.71310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Li B, Liu J, Xin X, Zhang L, Zhou J, Xia C, Zhu W, Yu H. MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression. Int J Med Sci 2021;18:615-25. [PMID: 33437196 DOI: 10.7150/ijms.51589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Cai S, Fan J, Ye J, Rao X, Li Y. Phthalates exposure is associated with non-alcoholic fatty liver disease among US adults. Ecotoxicol Environ Saf 2021;224:112665. [PMID: 34438269 DOI: 10.1016/j.ecoenv.2021.112665] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Yan Y, Zeng J, Xing L, Li C. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation. Biomedicines 2021;9:1014. [PMID: 34440218 DOI: 10.3390/biomedicines9081014] [Reference Citation Analysis]
98 Shi M, Deng Y, Yu H, Xu L, Shi C, Chen J, Li G, Du Y, Wang YG. Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway. Mediators Inflamm 2019;2019:7634761. [PMID: 31611735 DOI: 10.1155/2019/7634761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Schwartz G, Darling JO, Mindo M, Damicis L. Management of Adverse Events Associated with Cabozantinib Treatment in Patients with Advanced Hepatocellular Carcinoma. Target Oncol 2020;15:549-65. [PMID: 32770441 DOI: 10.1007/s11523-020-00736-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
100 Costa E Silva PP, Codes L, Rios FF, Esteve CP, Valverde Filho MT, Lima DOC, de Almeida Filho GF, Morais MCA, Lima BC, Chagas PBO, Boa-Sorte N, Bittencourt PL. Comparison of General and Liver-Specific Prognostic Scores in Their Ability to Predict Mortality in Cirrhotic Patients Admitted to the Intensive Care Unit. Can J Gastroenterol Hepatol 2021;2021:9953106. [PMID: 34608435 DOI: 10.1155/2021/9953106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Huang D, Gibeley SB, Xu C, Xiao Y, Celik O, Ginsberg HN, Leong KW. Engineering liver microtissues for disease modeling and regenerative medicine. Adv Funct Mater 2020;30:1909553. [PMID: 33390875 DOI: 10.1002/adfm.201909553] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
102 Piotrowska-Kempisty H, Nowicki M, Jodynis-Liebert J, Kurpik M, Ewertowska M, Adamska T, Oszmiański J, Kujawska M. Assessment of Hepatoprotective Effect of Chokeberry Juice in Rats Treated Chronically with Carbon Tetrachloride. Molecules 2020;25:E1268. [PMID: 32168847 DOI: 10.3390/molecules25061268] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
103 Olafsson S, Rögnvaldsson S, Bergmann OM, Jonasson JG, Benitez Hernandez U, Björnsson ES. A nationwide population-based prospective study of cirrhosis in Iceland. JHEP Rep 2021;3:100282. [PMID: 34041467 DOI: 10.1016/j.jhepr.2021.100282] [Reference Citation Analysis]
104 Kedarisetty CK, Kumar A, Sarin SK. Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis. Semin Liver Dis 2021;41:67-78. [PMID: 33764486 DOI: 10.1055/s-0040-1719177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
105 Alemany-Pagès M, Moura-Ramos M, Araújo S, Macedo MP, Ribeiro RT, do Ó D, Ramalho-Santos J, Azul AM. Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance? BMC Public Health 2020;20:1142. [PMID: 32690054 DOI: 10.1186/s12889-020-09249-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
106 Gorospe F, Istanboulian L, Puts M, Wong D, Lee E, Dale C. Identifying and mapping biopsychosocial factors associated with pain in adults with advanced liver disease: protocol for a scoping review. BMJ Open 2019;9:e033064. [PMID: 31719094 DOI: 10.1136/bmjopen-2019-033064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Akbari S, Arslan N, Senturk S, Erdal E. Next-Generation Liver Medicine Using Organoid Models. Front Cell Dev Biol 2019;7:345. [PMID: 31921856 DOI: 10.3389/fcell.2019.00345] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
108 Chen S, Pürerfellner H, Meyer C, Sommer P, Galindo Kiuchi M, Martinek M, Futyma P, Zanchi S, Zhu L, Schratter A, Wang J, Acou WJ, Liu S, Ling Z, Yin Y, Ouyang F, Chun JKR, Schmidt B. Anticoagulation in atrial fibrillation and liver disease: a pooled-analysis of > 20000 patients. Eur Heart J Cardiovasc Pharmacother 2021:pvab032. [PMID: 33871577 DOI: 10.1093/ehjcvp/pvab032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Ma L, Khatib S, Craig AJ, Wang XW. Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution. Semin Liver Dis 2021;41:321-30. [PMID: 34130336 DOI: 10.1055/s-0041-1729970] [Reference Citation Analysis]
110 Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations. EPMA J 2020;11:505-15. [PMID: 32839667 DOI: 10.1007/s13167-020-00221-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
111 Denk H, Stumptner C, Abuja PM, Zatloukal K. Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma. Expert Opin Ther Targets 2019;23:393-406. [PMID: 30987486 DOI: 10.1080/14728222.2019.1601703] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
112 Zhai M, Long J, Liu S, Liu C, Li L, Yang L, Li Y, Shu B. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Aging (Albany NY) 2021;13:279-300. [PMID: 33436531 DOI: 10.18632/aging.104127] [Reference Citation Analysis]
113 Lyu N, Kong Y, Pan T, Mu L, Sun X, Li S, Deng H, Lai J, Zhao M. Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma. International Journal of Hyperthermia 2019;36:1002-10. [DOI: 10.1080/02656736.2019.1663279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
114 Pickova D, Ostry V, Toman J, Malir F. Presence of Mycotoxins in Milk Thistle (Silybum marianum) Food Supplements: A Review. Toxins (Basel) 2020;12:E782. [PMID: 33302488 DOI: 10.3390/toxins12120782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Chan YT, Wang N, Tan HY, Li S, Feng Y. Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era? Front Pharmacol 2020;11:548. [PMID: 32425789 DOI: 10.3389/fphar.2020.00548] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
116 Wang Q, Zhang F, Lei Y, Liu P, Liu C, Tao Y. microRNA-322/424 promotes liver fibrosis by regulating angiogenesis through targeting CUL2/HIF-1α pathway. Life Sci 2021;266:118819. [PMID: 33333053 DOI: 10.1016/j.lfs.2020.118819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
117 Li Y, Han Q, Zhao H, Guo Q, Zhang J. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Front Pharmacol 2020;11:597520. [PMID: 33343368 DOI: 10.3389/fphar.2020.597520] [Reference Citation Analysis]
118 Wong S, Chan W. Epidemiology of non-alcoholic fatty liver disease in Asia. Indian J Gastroenterol 2020;39:1-8. [DOI: 10.1007/s12664-020-01018-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
119 Wang M, Liu H, Zhang X, Zhao W, Li D, Xu C, Wu Z, Xie F, Li X. Lack of Mof reduces acute liver injury by enhancing transcriptional activation of Igf1. J Cell Physiol 2021;236:6559-70. [PMID: 33634483 DOI: 10.1002/jcp.30332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Lee SY, Kim D, Lee SH, Sung JH. Microtechnology-based in vitro models: Mimicking liver function and pathophysiology. APL Bioeng 2021;5:041505. [PMID: 34703969 DOI: 10.1063/5.0061896] [Reference Citation Analysis]
121 Waqar W, Asghar S, Manzoor S. Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules. PLoS One 2021;16:e0256739. [PMID: 34469466 DOI: 10.1371/journal.pone.0256739] [Reference Citation Analysis]
122 Weersink RA, Burger DM, Hayward KL, Taxis K, Drenth JP, Borgsteede SD. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations. Expert Opinion on Drug Metabolism & Toxicology 2020;16:45-57. [DOI: 10.1080/17425255.2020.1702022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
123 Jang W, Song JS, Kim T, Yoon K. Intraindividual comparison of MRI-derived liver surface nodularity score at 1.5 T and 3 T. Abdom Radiol. [DOI: 10.1007/s00261-022-03415-6] [Reference Citation Analysis]
124 Hu Z, Li Y, Yang Y, Yu W, Xie W, Song G, Qian Y, Song Z. Serum lipids mediate the relationship of multiple polyaromatic hydrocarbons on non-alcoholic fatty liver disease: A population-based study. Sci Total Environ 2021;780:146563. [PMID: 34030288 DOI: 10.1016/j.scitotenv.2021.146563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Ghaziani TT, Kwo PY. How clinicians may use tests of hepatic function now and in the future. Transl Res 2021;233:1-4. [PMID: 33826945 DOI: 10.1016/j.trsl.2021.03.014] [Reference Citation Analysis]
126 Reuter B, Bajaj JS. Microbiome: Emerging Concepts in Patients with Chronic Liver Disease.Clin Liver Dis. 2020;24:493-520. [PMID: 32620285 DOI: 10.1016/j.cld.2020.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
127 Pham TTT, Ho DT, Nguyen T. Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population. WJH 2020;12:210-9. [DOI: 10.4254/wjh.v12.i5.210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Nithyananthan S, Keerthana P, Umadevi S, Guha S, Mir IH, Behera J, Thirunavukkarasu C. Nutrient mixture from germinated legumes: Enhanced medicinal value with herbs-attenuated liver cirrhosis. J Food Biochem 2020;44:e13085. [PMID: 31646659 DOI: 10.1111/jfbc.13085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
129 Egerman RS. New Antiviral Agents for Treatment of Hepatitis C. Clin Obstet Gynecol 2019;62:823-34. [PMID: 31094712 DOI: 10.1097/GRF.0000000000000457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Pi H, Liu M, Xi Y, Chen M, Tian L, Xie J, Chen M, Wang Z, Yang M, Yu Z, Zhou Z, Gao F. Long-term exercise prevents hepatic steatosis: a novel role of FABP1 in regulation of autophagy-lysosomal machinery. FASEB J 2019;33:11870-83. [PMID: 31366243 DOI: 10.1096/fj.201900812R] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
131 Hjorthøj C, Madsen T, Starzer M, Erlangsen A, Nordentoft M. Mortality in substance-induced psychosis: a register-based national cohort study. Addiction 2021. [PMID: 34105214 DOI: 10.1111/add.15598] [Reference Citation Analysis]
132 Rastogi P, Kandasubramanian B. Review of alginate-based hydrogel bioprinting for application in tissue engineering. Biofabrication 2019;11:042001. [PMID: 31315105 DOI: 10.1088/1758-5090/ab331e] [Cited by in Crossref: 98] [Cited by in F6Publishing: 73] [Article Influence: 32.7] [Reference Citation Analysis]
133 Hu C, Zhao L, Zhang L, Bao Q, Li L. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020;11:377. [PMID: 32883343 DOI: 10.1186/s13287-020-01895-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
134 Alvarez CS, Hernández E, Escobar K, Villagrán CI, Kroker-Lobos MF, Rivera-Andrade A, Smith JW, Egner PA, Lazo M, Freedman ND, Guallar E, Dean M, Graubard BI, Groopman JD, Ramírez-Zea M, McGlynn KA. Aflatoxin B1 exposure and liver cirrhosis in Guatemala: a case-control study. BMJ Open Gastroenterol 2020;7:e000380. [PMID: 32641287 DOI: 10.1136/bmjgast-2020-000380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
135 Siqueira MR, Pace FHL, Limongi TM, Henrique DMN, Mira PAC, Oliveira TMD, Oliveira CC, Aguiar AS, Malaguti C. Factors associated with the perceived benefits and barriers to physical activity in liver cirrhosis. Rev Assoc Med Bras (1992) 2021;67:271-6. [PMID: 34406252 DOI: 10.1590/1806-9282.67.02.20200692] [Reference Citation Analysis]
136 Wan SZ, Nie Y, Zhang Y, Liu C, Zhu X. Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department. Dis Markers 2020;2020:5193028. [PMID: 32148566 DOI: 10.1155/2020/5193028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
137 Szafranska K, Kruse LD, Holte CF, McCourt P, Zapotoczny B. The wHole Story About Fenestrations in LSEC. Front Physiol 2021;12:735573. [PMID: 34588998 DOI: 10.3389/fphys.2021.735573] [Reference Citation Analysis]
138 Li Q, Li JF, Mao XR. Application of artificial intelligence in liver diseases: From diagnosis to treatment. Artif Intell Gastroenterol 2021; 2(5): 133-140 [DOI: 10.35712/aig.v2.i5.133] [Reference Citation Analysis]
139 Huang D, Zhang X, Fu X, Zu Y, Sun W, Zhao Y. Liver spheroids on chips as emerging platforms for drug screening. Engineered Regeneration 2021;2:246-56. [DOI: 10.1016/j.engreg.2021.10.003] [Reference Citation Analysis]
140 Lu Y, Li X, Liu H, Xue J, Zeng Z, Dong X, Zhang T, Wu G, Yang K, Xu S. β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma. Oncogene 2021;40:1269-83. [PMID: 33420362 DOI: 10.1038/s41388-020-01596-2] [Reference Citation Analysis]
141 Han X, Cui Z, Song J, Piao H, Lian L, Hou L, Wang G, Zheng S, Dong X, Nan J, Wu Y. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner. Chemico-Biological Interactions 2019;311:108794. [DOI: 10.1016/j.cbi.2019.108794] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
142 Wang C, Ma C, Gong L, Dai S, Li Y. Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. Eur J Pharmacol 2021;912:174604. [PMID: 34743980 DOI: 10.1016/j.ejphar.2021.174604] [Reference Citation Analysis]
143 Nunes Dos Santos K, Florentino RM, França A, Lima Filho ACM, Santos MLD, Missiaggia D, Fonseca MC, Brasil Costa I, Vidigal PVT, Nathanson MH, Lemos FO, Leite MF. Polymorphism in the Promoter Region of NFE2L2 Gene Is a Genetic Marker of Susceptibility to Cirrhosis Associated with Alcohol Abuse. Int J Mol Sci 2019;20:E3589. [PMID: 31340446 DOI: 10.3390/ijms20143589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
144 Baig MT, Ghufran H, Mehmood A, Azam M, Humayun S, Riazuddin S. Vitamin E pretreated Wharton's jelly-derived mesenchymal stem cells attenuate CCl4-induced hepatocyte injury in vitro and liver fibrosis in vivo. Biochem Pharmacol 2021;186:114480. [PMID: 33617844 DOI: 10.1016/j.bcp.2021.114480] [Reference Citation Analysis]
145 Yasuda K, Kotaka M, Toyohara T, Sueta SI, Katakai Y, Ageyama N, Uemoto S, Osafune K. A nonhuman primate model of liver fibrosis towards cell therapy for liver cirrhosis. Biochem Biophys Res Commun 2020;526:661-9. [PMID: 32248968 DOI: 10.1016/j.bbrc.2020.03.148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
146 Khan S, Khan RS, Newsome PN. Cell Therapy for Liver Disease: From Promise to Reality. Semin Liver Dis 2020;40:411-26. [PMID: 33764490 DOI: 10.1055/s-0040-1717096] [Reference Citation Analysis]
147 Salehi B, Machin L, Monzote L, Sharifi-Rad J, Ezzat SM, Salem MA, Merghany RM, El Mahdy NM, Kılıç CS, Sytar O, Sharifi-Rad M, Sharopov F, Martins N, Martorell M, Cho WC. Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health. ACS Omega 2020;5:11849-72. [PMID: 32478277 DOI: 10.1021/acsomega.0c01818] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
148 Heinrich L, Booijink R, Khurana A, Weiskirchen R, Bansal R. Lipoxygenases in chronic liver diseases: current insights and future perspectives. Trends Pharmacol Sci 2021:S0165-6147(21)00246-7. [PMID: 34961619 DOI: 10.1016/j.tips.2021.12.001] [Reference Citation Analysis]
149 Fujiyama S, Akuta N, Sezaki H, Kobayashi M, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kumada H. Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study. BMC Gastroenterol 2021;21:189. [PMID: 33892649 DOI: 10.1186/s12876-021-01770-0] [Reference Citation Analysis]
150 Amanatidou AI, Dedoussis GV. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. Comput Biol Med 2021;131:104243. [PMID: 33550014 DOI: 10.1016/j.compbiomed.2021.104243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases.Transl Gastroenterol Hepatol. 2020;5:16. [PMID: 32258520 DOI: 10.21037/tgh.2019.09.08] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 30.5] [Reference Citation Analysis]
152 Zhang Y, Bi M, Chen Z, Dai M, Zhou G, Hu Y, Yang H, Guan W. Hydrogen gas alleviates acute alcohol-induced liver injury by inhibiting JNK activation. Exp Ther Med 2021;21:453. [PMID: 33767761 DOI: 10.3892/etm.2021.9884] [Reference Citation Analysis]
153 Matsuda M, Seki E. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis. Semin Liver Dis 2020;40:307-20. [PMID: 32242330 DOI: 10.1055/s-0040-1708876] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
154 Ibrahim KA, Eleyan M, Khwanes SA, Mohamed RA, Abd El-Rahman HA. Quercetin ameliorates the hepatic apoptosis of foetal rats induced by in utero exposure to fenitrothion via the transcriptional regulation of paraoxonase-1 and apoptosis-related genes. Biomarkers 2021;26:152-62. [PMID: 33439051 DOI: 10.1080/1354750X.2021.1875505] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Zhang M, Li Q, Zhou C, Zhao Y, Li R, Zhang Y. Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-κB and MAPK signaling. Int Immunopharmacol 2020;80:106137. [PMID: 31931366 DOI: 10.1016/j.intimp.2019.106137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
156 Ai J, Wang J, Liu D, Xiang H, Guo Y, Lv J, Zhang Q, Li J, Zhang X, Li Q, Liang J, Guo X, Feng Y, Liu L, Zhang X, Qin W, Wang X, Rao W, Zhang Q, Tian Q, Zhang Y, Xie F, Jiang S, Yan Y, Qiu Y, Wu H, Hou Z, Zhang N, Zhang A, Ji J, Yang J, Huang J, Zhao Z, Gu Y, Bian L, Zhang Z, Zou S, Ji H, Ge G, Du X, Hou A, Zhu Y, Cong Q, Xu J, Zu H, Wang Y, Yan Z, Yan X, BianBa Y, Ci Q, Zhang L, Yang S, Gao X, Zhong L, He S, Liu C, Huang Y, Liu Y, Xu D, Zhu Q, Xu X, Lv M, Zhang W, Qi X. Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver diseases (CHESS-NMCID 2101): A multicenter study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01346-X. [PMID: 34942370 DOI: 10.1016/j.cgh.2021.12.022] [Reference Citation Analysis]
157 Markova AA, Deterding K, Port K, Bantel H, Manns MP, Cornberg M, Wedemeyer H. Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort. Eur J Gastroenterol Hepatol 2021;32:223-9. [PMID: 32282399 DOI: 10.1097/MEG.0000000000001719] [Reference Citation Analysis]
158 Zhang T, Hickner B, Cotton R, Nguyen Galvan NT, Vierling JM, O'Mahony C, Goss JA, Rana A. Donor Gamma-Glutamyl Transferase Is Associated With Liver Allograft Discard and Failure. Prog Transplant 2021;31:101-7. [PMID: 33729047 DOI: 10.1177/15269248211002800] [Reference Citation Analysis]
159 Schnegelberger RD, Lang AL, Arteel GE, Beier JI. Environmental toxicant-induced maladaptive mitochondrial changes: A potential unifying mechanism in fatty liver disease? Acta Pharmaceutica Sinica B 2021;11:3756-67. [DOI: 10.1016/j.apsb.2021.09.002] [Reference Citation Analysis]
160 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Reference Citation Analysis]
161 Wang GK, Zhang N, Wang Y, Liu JS, Wang G, Zhou ZY, Lu CC, Yang JS. The hepatoprotective activities of Kalimeris indica ethanol extract against liver injury in vivo. Food Sci Nutr 2019;7:3797-807. [PMID: 31763029 DOI: 10.1002/fsn3.1241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
162 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
163 Petrescu AD, DeMorrow S. Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury. Cells 2021;10:1846. [PMID: 34440614 DOI: 10.3390/cells10081846] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Xu SJ, Ye LP, Wang W, Chen YH, Dong J, Mao XL, Li SW. Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases. Stem Cells Int 2021;2021:5513309. [PMID: 34824587 DOI: 10.1155/2021/5513309] [Reference Citation Analysis]
165 Li L, Xu L, Wen T, Wu H, Wang W, Yang J, Chen Z, Wei Y, Xu M, Li B, Zhang M. Poor Prognoses of Young Hepatocellular Carcinoma Patients with Microvascular Invasion: A Propensity Score Matching Cohort Study. Gastroenterol Res Pract 2020;2020:4691425. [PMID: 32148477 DOI: 10.1155/2020/4691425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Arumugam MK, Paal MC, Donohue TM Jr, Ganesan M, Osna NA, Kharbanda KK. Beneficial Effects of Betaine: A Comprehensive Review. Biology (Basel) 2021;10:456. [PMID: 34067313 DOI: 10.3390/biology10060456] [Reference Citation Analysis]
167 Garg SK, Goyal H, Obaitan I, Shah PA, Sarvepalli S, Jophlin LL, Singh D, Asrani S, Kamath PS, Leise MD. Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database. Ann Transl Med 2021;9:1052. [PMID: 34422964 DOI: 10.21037/atm-20-1762] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
168 Kumar M, Toprakhisar B, Van Haele M, Antoranz A, Boon R, Chesnais F, De Smedt J, Tricot T, Idoype TI, Canella M, Tilliole P, De Boeck J, Bajaj M, Ranga A, Bosisio FM, Roskams T, van Grunsven LA, Verfaillie CM. A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model. Biomaterials 2021;276:121006. [PMID: 34304139 DOI: 10.1016/j.biomaterials.2021.121006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Ahmad Raus R, Wan Nawawi WMF, Nasaruddin RR. Alginate and alginate composites for biomedical applications. Asian J Pharm Sci 2021;16:280-306. [PMID: 34276819 DOI: 10.1016/j.ajps.2020.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
170 Pak JE, Kim KH, Shin SD, Song KJ, Hong KJ, Ro YS, Park JH. Association between chronic liver disease and clinical outcomes in out-of-hospital cardiac arrest. Resuscitation 2021;158:1-7. [PMID: 33189806 DOI: 10.1016/j.resuscitation.2020.10.040] [Reference Citation Analysis]
171 Kataoka S, Umemura A, Okuda K, Taketani H, Seko Y, Nishikawa T, Yamaguchi K, Moriguchi M, Kanbara Y, Arbiser JL, Shima T, Okanoue T, Itoh Y. Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells. Int J Mol Sci 2021;22:13354. [PMID: 34948151 DOI: 10.3390/ijms222413354] [Reference Citation Analysis]
172 Wang F, Tang L, Liang B, Jin C, Gao L, Li Y, Li Z, Shao J, Zhang Z, Tan S, Zhang F, Zheng S. Yi-Qi-Jian-Pi Formula Suppresses RIPK1/RIPK3-Complex-Dependent Necroptosis of Hepatocytes Through ROS Signaling and Attenuates Liver Injury in Vivo and in Vitro. Front Pharmacol 2021;12:658811. [PMID: 33967802 DOI: 10.3389/fphar.2021.658811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, Pose E, Brenner EJ, Cargill T, Catana MA, Dhanasekaran R, Eshraghian A, García-Juárez I, Gill US, Jones PD, Kennedy J, Marshall A, Matthews C, Mells G, Mercer C, Perumalswami PV, Avitabile E, Qi X, Su F, Ufere NN, Wong YJ, Zheng MH, Barnes E, Barritt AS 4th, Webb GJ. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol 2021;74:567-77. [PMID: 33035628 DOI: 10.1016/j.jhep.2020.09.024] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 34.5] [Reference Citation Analysis]
174 Bertol FS, Araujo B, Jorge BB, Rinaldi N, De Carli LA, Tovo CV. Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study. World J Gastrointest Surg 2020; 12(6): 269-276 [PMID: 32774765 DOI: 10.4240/wjgs.v12.i6.269] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Laitakari A, Tapio J, Mäkelä KA, Herzig KH, Dengler F, Gylling H, Walkinshaw G, Myllyharju J, Dimova EY, Serpi R, Koivunen P. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD. J Mol Med (Berl) 2020;98:719-31. [PMID: 32296880 DOI: 10.1007/s00109-020-01903-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
176 Cui B, Lin L, Wang B, Liu W, Sun C. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer? Pharmacol Res 2021;175:106022. [PMID: 34883213 DOI: 10.1016/j.phrs.2021.106022] [Reference Citation Analysis]
177 Polidoro MA, Ferrari E, Marzorati S, Lleo A, Rasponi M. Experimental liver models: From cell culture techniques to microfluidic organs-on-chip. Liver Int 2021;41:1744-61. [PMID: 33966344 DOI: 10.1111/liv.14942] [Reference Citation Analysis]
178 Devaraj E, Roy A, Royapuram Veeraragavan G, Magesh A, Varikalam Sleeba A, Arivarasu L, Marimuthu Parasuraman B. β-Sitosterol attenuates carbon tetrachloride-induced oxidative stress and chronic liver injury in rats. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1067-75. [PMID: 31930431 DOI: 10.1007/s00210-020-01810-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
179 Minbashi M, Kordbacheh AA, Ghobadi A, Tuchin VV. Optimization of power used in liver cancer microwave therapy by injection of Magnetic Nanoparticles (MNPs). Computers in Biology and Medicine 2020;120:103741. [DOI: 10.1016/j.compbiomed.2020.103741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 Shen C, Huang X, Geng C, Li T, Wang J, Tang S, Su L, Gao Z, Zhang X, Chen J. Cytotoxic sesquiterpenoids against hepatic stellate cell line LX2 from Artemisia lavandulaefolia. Bioorganic Chemistry 2020;103:104107. [DOI: 10.1016/j.bioorg.2020.104107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
181 Patel AM, Liu YS, Davies SP, Brown RM, Kelly DA, Scheel-Toellner D, Reynolds GM, Stamataki Z. The Role of B Cells in Adult and Paediatric Liver Injury. Front Immunol 2021;12:729143. [PMID: 34630404 DOI: 10.3389/fimmu.2021.729143] [Reference Citation Analysis]
182 Marini TJ, Oppenheimer DC, Baran TM, Rubens DJ, Dozier A, Garra B, Egoavil MS, Quinn RA, Kan J, Ortega RL, Zhao YT, Tamayo L, Carlotto C, Castaneda B. Testing telediagnostic right upper quadrant abdominal ultrasound in Peru: A new horizon in expanding access to imaging in rural and underserved areas. PLoS One 2021;16:e0255919. [PMID: 34379679 DOI: 10.1371/journal.pone.0255919] [Reference Citation Analysis]
183 Aishwarya V, Solaipriya S, Sivaramakrishnan V. Role of ellagic acid for the prevention and treatment of liver diseases. Phytother Res 2021;35:2925-44. [PMID: 33368795 DOI: 10.1002/ptr.7001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Davies SP, Terry LV, Wilkinson AL, Stamataki Z. Cell-in-Cell Structures in the Liver: A Tale of Four E's. Front Immunol 2020;11:650. [PMID: 32528462 DOI: 10.3389/fimmu.2020.00650] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
185 Li R, Ong Q, Wong CC, Chu ESH, Sung JJY, Yang X, Yu J. O-GlcNAcylation inhibits hepatic stellate cell activation. J Gastroenterol Hepatol 2021. [PMID: 34547820 DOI: 10.1111/jgh.15690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Li C, Tan YH, Sun J, Deng FM, Liu YL. PAX6 contributes to the activation and proliferation of hepatic stellate cells via activating Hedgehog/GLI1 pathway. Biochem Biophys Res Commun 2020;526:314-20. [PMID: 32209258 DOI: 10.1016/j.bbrc.2020.03.086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
187 Chen T, Zhou K, Sun T, Sang C, Jia W, Xie G. Altered bile acid glycine : taurine ratio in the progression of chronic liver disease. J Gastroenterol Hepatol 2021. [PMID: 34655465 DOI: 10.1111/jgh.15709] [Reference Citation Analysis]
188 Fan X, Lin L, Cui B, Zhao T, Mao L, Song Y, Wang X, Feng H, Qingxiang Y, Zhang J, Jiang K, Cao X, Wang B, Sun C. Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe. Pharmacol Res 2020;159:104945. [PMID: 32454225 DOI: 10.1016/j.phrs.2020.104945] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
189 Ergün C, Parmaksiz M, Vurat MT, Elçin AE, Elçin YM. Decellularized liver ECM-based 3D scaffolds: Compositional, physical, chemical, rheological, thermal, mechanical, and in vitro biological evaluations. Int J Biol Macromol 2021:S0141-8130(21)02716-1. [PMID: 34971643 DOI: 10.1016/j.ijbiomac.2021.12.086] [Reference Citation Analysis]
190 Ge S, Yang W, Chen H, Yuan Q, Liu S, Zhao Y, Zhang J. MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs. Int J Mol Sci 2021;22:12413. [PMID: 34830293 DOI: 10.3390/ijms222212413] [Reference Citation Analysis]
191 Hou Y, Hsu S, Lee K. Decellularized liver matrix as substrates for rescue of acute hepatocytes toxicity. J Biomed Mater Res 2020;108:1592-602. [DOI: 10.1002/jbm.b.34506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
192 Rattan P, Minacapelli CD, Rustgi V. The Microbiome and Hepatocellular Carcinoma. Liver Transpl. 2020;26:1316-1327. [PMID: 32564483 DOI: 10.1002/lt.25828] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
193 Mousavi SM, Mokhtari P, Asbaghi O, Rigi S, Persad E, Jayedi A, Rezvani H, Mahamat-Saleh Y, Sadeghi O. Does saffron supplementation have favorable effects on liver function indicators? A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2021;:1-13. [PMID: 33724127 DOI: 10.1080/10408398.2021.1900059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Lyu N, Wang X, Li JB, Lai JF, Chen QF, Li SL, Deng HJ, He M, Mu LW, Zhao M. Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1). J Clin Oncol 2021;:JCO2101963. [PMID: 34905388 DOI: 10.1200/JCO.21.01963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
195 Valery PC, McPhail S, Stuart KA, Hartel G, Clark PJ, O'Beirne J, Skoien R, Rahman T, Moser C, Powell EE. Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis. Intern Med J 2021;51:691-8. [PMID: 32096890 DOI: 10.1111/imj.14809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Rey I, Effendi-Ys R. Association Between Serum IL-6, IL-10, IL-12, and IL-23 Levels and Severity of Liver Cirrhosis. Med Arch 2021;75:199-203. [PMID: 34483450 DOI: 10.5455/medarh.2021.75.199-203] [Reference Citation Analysis]
197 Bruschi FV, Tardelli M, Herac M, Claudel T, Trauner M. Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH. Liver Int 2020;40:1098-110. [PMID: 32043752 DOI: 10.1111/liv.14402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
198 Anjorin AA, Abioye AI, Asowata OE, Soipe A, Kazeem MI, Adesanya IO, Raji MA, Adesanya M, Oke FA, Lawal FJ, Kasali BA, Omotayo MO. Comorbidities and the COVID-19 pandemic dynamics in Africa. Trop Med Int Health 2021;26:2-13. [PMID: 33012053 DOI: 10.1111/tmi.13504] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
199 Kehar M, Griffiths R, Flemming JA. Increasing Incidence of Cirrhosis Over the Past 2 Decades Among Children in Ontario, Canada. Am J Gastroenterol 2021. [PMID: 34797224 DOI: 10.14309/ajg.0000000000001564] [Reference Citation Analysis]
200 Pascual S, Miralles C, Bernabé JM, Irurzun J, Planells M. Surveillance and diagnosis of hepatocellular carcinoma: A systematic review. World J Clin Cases 2019; 7(16): 2269-2286 [PMID: 31531321 DOI: 10.12998/wjcc.v7.i16.2269] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
201 Wu S, Meng X, Jiang X, Wu Y, Zhai S, Wang X, Liu Y, Zhang J, Zhao X, Zhou Y, Bu W, Yao Z. Harnessing X-Ray Energy-Dependent Attenuation of Bismuth-Based Nanoprobes for Accurate Diagnosis of Liver Fibrosis. Adv Sci (Weinh) 2021;8:e2002548. [PMID: 34105274 DOI: 10.1002/advs.202002548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Buonomo E, Mei S, Guinn S, Leo I, Peluso M, Nolan M, Schildberg F, Zhao L, Lian C, Xu S, Misdraji J, Kharchenko P, Sharpe A. Liver Stromal Cells Restrict Macrophage Maturation and Stromal IL-6 Limits the Differentiation of Cirrhosis-linked Macrophages. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2021.12.036] [Reference Citation Analysis]
203 Mccrary MW, Bousalis D, Mobini S, Song YH, Schmidt CE. Decellularized tissues as platforms for in vitro modeling of healthy and diseased tissues. Acta Biomaterialia 2020;111:1-19. [DOI: 10.1016/j.actbio.2020.05.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
204 Chiabotto G, Pasquino C, Camussi G, Bruno S. Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis. Front Cell Dev Biol 2020;8:594794. [PMID: 33425900 DOI: 10.3389/fcell.2020.594794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
205 Yeo YH, Hwang J, Jeong D, Dang N, Kam LY, Henry L, Park H, Cheung R, Nguyen MH. Surveillance of patients with cirrhosis remains suboptimal in the United States. J Hepatol 2021:S0168-8278(21)00307-X. [PMID: 33965477 DOI: 10.1016/j.jhep.2021.04.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Lucantoni F, Martínez-Cerezuela A, Gruevska A, Moragrega ÁB, Víctor VM, Esplugues JV, Blas-García A, Apostolova N. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet? J Pathol 2021;254:216-28. [PMID: 33834482 DOI: 10.1002/path.5678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
207 Ji D, Zhang D, Yang T, Mu J, Zhao P, Xu J, Li C, Cheng G, Wang Y, Chen Z, Qin E, Lau G. Effect of COVID-19 on patients with compensated chronic liver diseases. Hepatol Int. 2020;14:701-710. [PMID: 32734407 DOI: 10.1007/s12072-020-10058-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
208 Tafaleng EN, Mukherjee A, Bell A, Morita K, Guzman-Lepe J, Haep N, Florentino RM, Diaz-Aragon R, Frau C, Ostrowska A, Schultz JR, Martini PGV, Soto-Gutierrez A, Fox IJ. Hepatocyte Nuclear Factor 4 alpha 2 Messenger RNA Reprograms Liver-Enriched Transcription Factors and Functional Proteins in End-Stage Cirrhotic Human Hepatocytes. Hepatol Commun 2021;5:1911-26. [PMID: 34558820 DOI: 10.1002/hep4.1763] [Reference Citation Analysis]
209 Klemm P, Huschke S, Rodewald M, Ehteshamzad N, Behnke M, Wang X, Cinar G, Nischang I, Hoeppener S, Weber C, Press AT, Höppener C, Meyer T, Deckert V, Schmitt M, Popp J, Bauer M, Schubert S. Characterization of a library of vitamin A-functionalized polymethacrylate-based nanoparticles for siRNA delivery. Polym Chem 2021;12:911-25. [DOI: 10.1039/d0py01626h] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
210 Ogino N, Nagaoka K, Tomizuka K, Matsuura-Harada Y, Eitoku M, Suganuma N, Ogino K. Compromised glutathione synthesis results in high susceptibility to acetaminophen hepatotoxicity in acatalasemic mice. Food Chem Toxicol 2021;156:112509. [PMID: 34390818 DOI: 10.1016/j.fct.2021.112509] [Reference Citation Analysis]
211 Zhang J, Liu Q, He J, Li Y. Novel Therapeutic Targets in Liver Fibrosis. Front Mol Biosci 2021;8:766855. [PMID: 34805276 DOI: 10.3389/fmolb.2021.766855] [Reference Citation Analysis]
212 Matsuda M, Seki E. The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix. Food Chem Toxicol 2020;143:111556. [PMID: 32640349 DOI: 10.1016/j.fct.2020.111556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
213 Aboulghate M, Elaghoury A, Elebrashy I, Elkafrawy N, Elshishiney G, Abul-Magd E, Bassiouny E, Toaima D, Elezbawy B, Fasseeh A, Abaza S, Vokó Z. The Burden of Obesity in Egypt. Front Public Health 2021;9:718978. [PMID: 34513789 DOI: 10.3389/fpubh.2021.718978] [Reference Citation Analysis]
214 Plaza-Díaz J, Solís-Urra P, Rodríguez-Rodríguez F, Olivares-Arancibia J, Navarro-Oliveros M, Abadía-Molina F, Álvarez-Mercado AI. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. Int J Mol Sci 2020;21:E8351. [PMID: 33171747 DOI: 10.3390/ijms21218351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
215 Zhang L, Pu K, Liu X, Bae SDW, Nguyen R, Bai S, Li Y, Qiao L. The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review. Front Med (Lausanne) 2021;8:644594. [PMID: 34277651 DOI: 10.3389/fmed.2021.644594] [Reference Citation Analysis]
216 Bi C, Xiao G, Liu C, Yan J, Chen J, Si W, Zhang J, Liu Z. Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer. Front Cell Dev Biol 2021;9:702414. [PMID: 34957088 DOI: 10.3389/fcell.2021.702414] [Reference Citation Analysis]
217 Fan Y, Ding W, Zhang C, Fu L, Xu D, Chen X. Obeticholic acid prevents carbon tetrachloride-induced liver fibrosis through interaction between farnesoid X receptor and Smad3. International Immunopharmacology 2019;77:105911. [DOI: 10.1016/j.intimp.2019.105911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
218 Korta Martiartu N, Nambiar S, Nascimento Kirchner I, Paverd C, Cester D, Frauenfelder T, Ruby L, Rominger MB. Sources of Variability in Shear Wave Speed and Dispersion Quantification with Ultrasound Elastography: A Phantom Study. Ultrasound Med Biol 2021;47:3529-42. [PMID: 34548187 DOI: 10.1016/j.ultrasmedbio.2021.08.013] [Reference Citation Analysis]
219 Bai R, An R, Han K, Xue M, Zhang S, Shen X, Zheng S. Prognosis of liver transplantation: Does postoperative ileus matter? BMC Gastroenterol 2021;21:444. [PMID: 34823485 DOI: 10.1186/s12876-021-02026-7] [Reference Citation Analysis]
220 Choudhury N, Quraishi SB, Atiqullah A, Khan MSI, Al Mahtab M, Akbar SM. High Prevalence of Wilson's Diseases with Low Prevalence of Kayser-Fleischer Rings among Patients with Cryptogenic Chronic Liver Diseases in Bangladesh. Euroasian J Hepatogastroenterol 2019;9:67-70. [PMID: 32117693 DOI: 10.5005/jp-journals-10018-1299] [Reference Citation Analysis]
221 Taouli B, Alves FC. Imaging biomarkers of diffuse liver disease: current status. Abdom Radiol (NY) 2020;45:3381-5. [PMID: 32583139 DOI: 10.1007/s00261-020-02619-y] [Reference Citation Analysis]
222 Ezhilararasan D, Lakshmi T, Raut B, S VK. Novel Nano-Based Drug Delivery Systems Targeting Hepatic Stellate Cells in the Fibrotic Liver. Journal of Nanomaterials 2021;2021:1-9. [DOI: 10.1155/2021/4674046] [Reference Citation Analysis]
223 Lu S, Zhang J, Lin S, Zheng D, Shen Y, Qin J, Li Y, Wang S. Recent advances in the development of in vitro liver models for hepatotoxicity testing. Bio-des Manuf 2021;4:717-34. [DOI: 10.1007/s42242-021-00142-7] [Reference Citation Analysis]
224 Cheemerla S, Balakrishnan M. Global Epidemiology of Chronic Liver Disease. Clin Liver Dis (Hoboken) 2021;17:365-70. [PMID: 34136143 DOI: 10.1002/cld.1061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
225 Chen S, Che S, Li S, Ruan Z. The combined impact of decabromodiphenyl ether and high fat exposure on non-alcoholic fatty liver disease in vivo and in vitro. Toxicology 2021;464:153015. [PMID: 34757160 DOI: 10.1016/j.tox.2021.153015] [Reference Citation Analysis]
226 Andreoni M, Sticchi L, Nozza S, Sarmati L, Gori A, Tavio M; Society for Infectious and Tropical Diseases (SIMIT). Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations. Hum Vaccin Immunother 2021;:1-18. [PMID: 34524945 DOI: 10.1080/21645515.2021.1971473] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
227 Zhang Y, Liu H, Jia W, Qi J, Zhang W, Zhang W, Liang G, Zhang Y, Chen AH. Myeloid Differentiation Protein 2 Mediates Angiotensin II-Induced Liver Inflammation and Fibrosis in Mice. Molecules 2019;25:E25. [PMID: 31861702 DOI: 10.3390/molecules25010025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
228 Moraes KCM, Montagne J. Drosophila melanogaster: A Powerful Tiny Animal Model for the Study of Metabolic Hepatic Diseases. Front Physiol 2021;12:728407. [PMID: 34603083 DOI: 10.3389/fphys.2021.728407] [Reference Citation Analysis]
229 Chen DY, Lin CH, Chen HH, Tang KT. Association of tumor necrosis factor-α inhibitors and liver cirrhosis in patients with rheumatoid arthritis: A nationwide population-based nested case-control study. Int J Rheum Dis 2022. [PMID: 34994523 DOI: 10.1111/1756-185X.14272] [Reference Citation Analysis]
230 Castellanos-Fernández MI, Borges-González SA, Stepanova M, Infante-Velázquez ME, Ruenes-Domech C, González-Suero SM, Dorta-Guridi Z, Arus-Soler ER, Racila A, Younossi ZM. Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience. Ann Hepatol 2021;22:100277. [PMID: 33130334 DOI: 10.1016/j.aohep.2020.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
231 Santos RS, Chaves-Filho AB, Silva LAS, Garcia CAB, Silva ARST, Dolabella SS, da Costa SSL, Miyamoto S, Matos HR. Bioactive compounds and hepatoprotective effect of Hancornia speciosa gomes fruit juice on acetaminophen-induced hepatotoxicity in vivo. Nat Prod Res 2021;:1-5. [PMID: 33749461 DOI: 10.1080/14786419.2021.1902324] [Reference Citation Analysis]
232 Dai W, Chen C, Feng H, Li G, Peng W, Liu X, Yang J, Hu X. Protection of Ficus pandurata Hance against acute alcohol-induced liver damage in mice via suppressing oxidative stress, inflammation, and apoptosis. J Ethnopharmacol 2021;275:114140. [PMID: 33915134 DOI: 10.1016/j.jep.2021.114140] [Reference Citation Analysis]
233 Yang J, Li J, Ye G, Luo Y. Comparison of Visual Transient Elastography and Shear Wave Elastography in Evaluating Liver Fibrosis in Patients with Chronic Liver Disease. Int J Gen Med 2021;14:3553-61. [PMID: 34295181 DOI: 10.2147/IJGM.S319101] [Reference Citation Analysis]
234 Zhang Z, Tang H, Chen P, Xie H, Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther 2019;4:41. [PMID: 31637019 DOI: 10.1038/s41392-019-0074-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
235 Gonzalez-Villarreal CA, Quiroz-Reyes AG, Islas JF, Garza-Treviño EN. Colorectal Cancer Stem Cells in the Progression to Liver Metastasis. Front Oncol 2020;10:1511. [PMID: 32974184 DOI: 10.3389/fonc.2020.01511] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
236 Parafati M, Bae SH, Kirby RJ, Fitzek M, Iyer P, Engkvist O, Smith DM, Malany S. Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation. Int J Mol Sci 2020;21:E9557. [PMID: 33334026 DOI: 10.3390/ijms21249557] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
237 Qazi Arisar FA, Kamran M, Nadeem R, Jafri W. Impact of Severity of Chronic Liver Disease on Health-Related Economics. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.97933] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
238 Rustgi VK, Li Y, John T, Catalano C, Elsaid MI. Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real-World Claims Analysis. Hepatol Commun. 2020;4:1404-1418. [PMID: 33024912 DOI: 10.1002/hep4.1573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
239 Watanabe Y, Tsuchiya A, Terai S. The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future. Clin Mol Hepatol 2021;27:70-80. [PMID: 33317249 DOI: 10.3350/cmh.2020.0194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
240 Gao Y, Callanan A. Influence of surface topography on PCL electrospun scaffolds for liver tissue engineering. J Mater Chem B 2021;9:8081-93. [PMID: 34491259 DOI: 10.1039/d1tb00789k] [Reference Citation Analysis]
241 Wang Y, Hu J, Xiang D, Peng X, You Q, Mao Y, Hua D, Yin J. Targeted nanosystem combined with chemo-photothermal therapy for hepatocellular carcinoma treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2020;596:124711. [DOI: 10.1016/j.colsurfa.2020.124711] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
242 Wright T, Wang Y, Bedford MT. The Role of the PRMT5-SND1 Axis in Hepatocellular Carcinoma. Epigenomes 2021;5:2. [PMID: 33768972 DOI: 10.3390/epigenomes5010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
243 Fang C, Zhou Q, Liu Q, Jia W, Xu Y. Crosstalk between gut microbiota and host lipid metabolism in a mouse model of alcoholic liver injury by chronic baijiu or ethanol feeding. Food Funct 2021. [PMID: 34927188 DOI: 10.1039/d1fo02892h] [Reference Citation Analysis]
244 Stanfield D, Lucey MR. The Heightened Risk of Fatty Liver Disorders in the Time of COVID-19. Mayo Clin Proc 2020;95:2580-1. [PMID: 33276827 DOI: 10.1016/j.mayocp.2020.10.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
245 Nitsch J, Sack J, Halle MW, Moltz JH, Wall A, Rutherford AE, Kikinis R, Meine H. MRI-based radiomic feature analysis of end-stage liver disease for severity stratification. Int J Comput Assist Radiol Surg 2021;16:457-66. [PMID: 33646521 DOI: 10.1007/s11548-020-02295-9] [Reference Citation Analysis]
246 Im WH, Song JS, Jang W. Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques. Abdom Radiol (NY) 2021. [PMID: 34228199 DOI: 10.1007/s00261-021-03181-x] [Reference Citation Analysis]
247 Wang L, Zhu M, Cao L, Yao M, Lu Y, Wen X, Zhang Y, Ning J, Long H, Zhu Y, Hu G, Dang S, Fu Q, Chen L, Zhang X, Zhao J, Gao Z, Nan Y, Lu F. Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study. J Clin Transl Hepatol 2019;7:313-21. [PMID: 31915600 DOI: 10.14218/JCTH.2019.00040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
248 Elleuch N, Moalla M, Mahmoud S, Hammami A, Jaziri H, Ameur WB, Dahmani W, Slama AB, Brahem A, Ajmi S, Ksiaa M, Jmaa A. Spectrum of acute hepatitis and its clinical outcome in a central region in Tunisia. Pan Afr Med J 2021;40:53. [PMID: 34795833 DOI: 10.11604/pamj.2021.40.53.25725] [Reference Citation Analysis]
249 Labour MN, Le Guilcher C, Aid-Launais R, El Samad N, Lanouar S, Simon-Yarza T, Letourneur D. Development of 3D Hepatic Constructs Within Polysaccharide-Based Scaffolds with Tunable Properties. Int J Mol Sci 2020;21:E3644. [PMID: 32455711 DOI: 10.3390/ijms21103644] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
250 Chokshi S, Mehta G. Editorial: biomarkers for alcohol-related liver fibrosis-almost there? Aliment Pharmacol Ther 2021;54:1492-3. [PMID: 34741330 DOI: 10.1111/apt.16633] [Reference Citation Analysis]
251 Xu Q. Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications. Front Bioeng Biotechnol 2021;9:730008. [PMID: 34631680 DOI: 10.3389/fbioe.2021.730008] [Reference Citation Analysis]
252 Zhu X, Zhang B, He Y, Bao J. Liver Organoids: Formation Strategies and Biomedical Applications. Tissue Eng Regen Med 2021;18:573-85. [PMID: 34132985 DOI: 10.1007/s13770-021-00357-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Kharat A, Vanpully NS, Jeeson JC. Simplified Guide to MR Elastography in Early Detection of Hepatic Fibrosis with Case Reports: The New Norm in Assessing Liver Health. Indian J Radiol Imaging 2021;31:644-52. [PMID: 34790310 DOI: 10.1055/s-0041-1735929] [Reference Citation Analysis]
254 Wongtrakul W, Charoenngnam N, Ungprasert P. Use of proton pump inhibitors is associated with a higher risk of pneumonia in cirrhotic patients: a systematic review and meta-analysis. Ann Gastroenterol 2020;33:277-84. [PMID: 32382231 DOI: 10.20524/aog.2020.0483] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
255 Suresh D, Srinivas AN, Kumar DP. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. Front Oncol 2020;10:601710. [PMID: 33330100 DOI: 10.3389/fonc.2020.601710] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
256 Golabi P, Rhea L, Henry L, Younossi ZM. Hepatocellular carcinoma and non-alcoholic fatty liver disease. Hepatol Int. 2019;13:688-694. [PMID: 31701393 DOI: 10.1007/s12072-019-09995-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
257 Elzouki AN, Lubbad R, Elzouki I, Elhaddad A, Ibrahim A. Frequency of hepatitis B and C in health care providers at three referral hospitals in Libya. Pan Afr Med J 2020;37:214. [PMID: 33520053 DOI: 10.11604/pamj.2020.37.214.23997] [Reference Citation Analysis]
258 Xiong Y, Hu J, Xuan C, Tian J, Tan K, Chen Z, Luo Y, Du X, Cheng J, Zhang L, Cao W. Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl4-induced liver fibrosis in rats. Chin Med 2021;16:142. [PMID: 34952623 DOI: 10.1186/s13020-021-00552-w] [Reference Citation Analysis]
259 Cheng JH, Yip CW, Jiang YK, Zhou LH, Que CX, Luo Y, Wang X, Zhao HZ, Zhu LP. Clinical Predictors Impacting Cryptococcal Dissemination and Poor Outcome in Patients With Cirrhosis. Open Forum Infect Dis 2021;8:ofab296. [PMID: 34250196 DOI: 10.1093/ofid/ofab296] [Reference Citation Analysis]
260 Okina Y, Sato-Matsubara M, Matsubara T, Daikoku A, Longato L, Rombouts K, Thanh Thuy LT, Ichikawa H, Minamiyama Y, Kadota M, Fujii H, Enomoto M, Ikeda K, Yoshizato K, Pinzani M, Kawada N. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis. J Hepatol 2020;73:882-95. [PMID: 32330605 DOI: 10.1016/j.jhep.2020.03.051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
261 Jeng KS, Lu SJ, Wang CH, Chang CF. Liver Fibrosis and Inflammation under the Control of ERK2. Int J Mol Sci 2020;21:E3796. [PMID: 32471201 DOI: 10.3390/ijms21113796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
262 Boursier J, Anty R, Carette C, Cariou B, Castera L, Caussy C, Fontaine H, Garioud A, Gourdy P, Guerci B, Guillaume M, Michot N, Minello A, Ouizeman DJ, Serfaty L, Bonnet F, Vergès B, Petit JM; AFEF and SFD. Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement. Diabetes Metab 2021;47:101272. [PMID: 34363981 DOI: 10.1016/j.diabet.2021.101272] [Reference Citation Analysis]
263 Park JH, Seo N, Chung YE, Kim SU, Park YN, Choi JY, Park MS, Kim MJ. Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography. Eur Radiol 2021;31:4813-23. [PMID: 33439321 DOI: 10.1007/s00330-020-07600-3] [Reference Citation Analysis]
264 Herrera Vielma F, Valenzuela R, Videla LA, Zúñiga-Hernández J. N-3 Polyunsaturated Fatty Acids and Their Lipid Mediators as A Potential Immune-Nutritional Intervention: A Molecular and Clinical View in Hepatic Disease and Other Non-Communicable Illnesses. Nutrients 2021;13:3384. [PMID: 34684386 DOI: 10.3390/nu13103384] [Reference Citation Analysis]
265 Bottaro M, Abid NU, El-Azizi I, Hallett J, Koranteng A, Formentin C, Montagnese S, Mani AR. Skin temperature variability is an independent predictor of survival in patients with cirrhosis. Physiol Rep 2020;8:e14452. [PMID: 32562383 DOI: 10.14814/phy2.14452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
266 Hirode G, Saab S, Wong RJ. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw Open 2020;3:e201997. [PMID: 32239220 DOI: 10.1001/jamanetworkopen.2020.1997] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
267 Shen C, Huang XY, Geng CA, Li TZ, Tang S, Su LH, Gao Z, Zhang XM, Hu J, Chen JJ. Artemlavanins A and B from Artemisia lavandulaefolia and Their Cytotoxicity Against Hepatic Stellate Cell Line LX2. Nat Prod Bioprospect 2020;10:243-50. [PMID: 32583278 DOI: 10.1007/s13659-020-00254-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
268 Gillman R, Lopes Floro K, Wankell M, Hebbard L. The role of DNA damage and repair in liver cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188493. [PMID: 33316376 DOI: 10.1016/j.bbcan.2020.188493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
269 Wang X, Copmans D, de Witte PAM. Using Zebrafish as a Disease Model to Study Fibrotic Disease. Int J Mol Sci 2021;22:6404. [PMID: 34203824 DOI: 10.3390/ijms22126404] [Reference Citation Analysis]
270 Mo C, Xie S, Zeng T, Lai Y, Huang S, Zhou C, Yan W, Huang S, Gao L, Lv Z. Ginsenoside-Rg1 acts as an IDO1 inhibitor, protects against liver fibrosis via alleviating IDO1-mediated the inhibition of DCs maturation. Phytomedicine 2021;84:153524. [PMID: 33667840 DOI: 10.1016/j.phymed.2021.153524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
271 Zhang H, Ma Y, Cheng X, Wu D, Huang X, Chen B, Ren Y, Jiang W, Tang X, Bai T, Chen Y, Zhao Y, Zhang C, Xiao X, Liu J, Deng Y, Ye T, Chen L, Liu HM, Friedman SL, Chen L, Ding BS, Cao Z. Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis. Sci Transl Med 2021;13:eabd1206. [PMID: 34613814 DOI: 10.1126/scitranslmed.abd1206] [Reference Citation Analysis]
272 Tauseef A, Zafar M, Rashid B, Thirumalareddy J, Chalfant V, Farooque U, Mirza M. Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital. Cureus 2020;12:e11019. [PMID: 33214947 DOI: 10.7759/cureus.11019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
273 Macpherson I, Nobes JH, Dow E, Furrie E, Miller MH, Robinson EM, Dillon JF. Intelligent Liver Function Testing: Working Smarter to Improve Patient Outcomes in Liver Disease. The Journal of Applied Laboratory Medicine 2020;5:1090-100. [DOI: 10.1093/jalm/jfaa109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
274 Fan Y, Yin X. Potential therapeutic targets and biological mechanisms of Centella asiatica on hepatic fibrosis: a study of network pharmacology. Ann Transl Med 2021;9:932. [PMID: 34350247 DOI: 10.21037/atm-21-2253] [Reference Citation Analysis]
275 Yan R, Chu J, Zhou Y, Shan W, Hu Y, Lin M, Zhao Y, Sun R, Wang Z, Lv L, Wang L, Yao J, Zhang N. Ubiquitin-specific protease 22 ameliorates chronic alcohol-associated liver disease by regulating BRD4. Pharmacol Res 2021;168:105594. [PMID: 33826947 DOI: 10.1016/j.phrs.2021.105594] [Reference Citation Analysis]
276 Vergis N, Patel V, Bogdanowicz K, Czyzewska-Khan J, Fiorentino F, Day E, Cross M, Foster N, Lord E, Goldin R, Forrest E, Thursz M. IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis. Trials 2021;22:792. [PMID: 34763711 DOI: 10.1186/s13063-021-05719-2] [Reference Citation Analysis]
277 Mun SJ, Hong YH, Ahn HS, Ryu JS, Chung KS, Son MJ. Long-Term Expansion of Functional Human Pluripotent Stem Cell-Derived Hepatic Organoids. Int J Stem Cells 2020;13:279-86. [PMID: 32323516 DOI: 10.15283/ijsc20060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
278 Li S, Saviano A, Erstad DJ, Hoshida Y, Fuchs BC, Baumert T, Tanabe KK. Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges. J Clin Med 2020;9:E3817. [PMID: 33255794 DOI: 10.3390/jcm9123817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
279 Tesfaye BT, Feyissa TM, Workneh AB, Gudina EK, Yizengaw MA. Chronic Liver Disease in Ethiopia with a Particular Focus on the Etiological Spectrums: A Systematic Review and Meta-Analysis of Observational Studies. Can J Gastroenterol Hepatol 2021;2021:8740157. [PMID: 34858892 DOI: 10.1155/2021/8740157] [Reference Citation Analysis]
280 Li LJ, Wu XY, Tan SW, Xie ZJ, Pan XM, Pan SW, Bai WR, Li HJ, Liu HL, Jiang J, Wu B. Lnc-TCL6 is a potential biomarker for early diagnosis and grade in liver-cirrhosis patients. Gastroenterol Rep (Oxf). 2019;7:434-443. [PMID: 31857905 DOI: 10.1093/gastro/goz050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
281 Rusyn I, Arzuaga X, Cattley RC, Corton JC, Ferguson SS, Godoy P, Guyton KZ, Kaplowitz N, Khetani SR, Roberts RA, Roth RA, Smith MT. Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity. Hepatology 2021. [PMID: 34105804 DOI: 10.1002/hep.31999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Chiabotto G, Ceccotti E, Tapparo M, Camussi G, Bruno S. Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype. Front Cell Dev Biol 2021;9:777462. [PMID: 34796180 DOI: 10.3389/fcell.2021.777462] [Reference Citation Analysis]
283 Jin C, Wu P, Yang Y, He Z, Zhu H, Li Z. A novel fluorescent probe for the detection of peroxynitrite and its application in acute liver injury model. Redox Biol 2021;46:102068. [PMID: 34273655 DOI: 10.1016/j.redox.2021.102068] [Reference Citation Analysis]
284 Zhong HJ, Zhuang YP, Zhang YT, Xu SP, Hong MF, He XX. Distinguishing between the complications of Wilson disease-related cirrhosis and HBV-related cirrhosis. Curr Med Res Opin 2021;:1-7. [PMID: 34665066 DOI: 10.1080/03007995.2021.1993160] [Reference Citation Analysis]
285 Xu XL, Jiang LS, Wu CS, Pan LY, Lou ZQ, Peng CT, Dong Y, Ruan B. The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? J Formos Med Assoc 2021:S0929-6646(21)00344-2. [PMID: 34325952 DOI: 10.1016/j.jfma.2021.07.013] [Reference Citation Analysis]
286 Liu J, Yuan Y, Gong X, Zhang L, Zhou Q, Wu S, Zhang X, Hu J, Kuang G, Yin X, Wan J, Yuan Y. Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice. Int Immunopharmacol 2020;80:106208. [PMID: 31955065 DOI: 10.1016/j.intimp.2020.106208] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
287 Müller M, Bird TG, Nault JC. The landscape of gene mutations in cirrhosis and hepatocellular carcinoma. J Hepatol 2020;72:990-1002. [PMID: 32044402 DOI: 10.1016/j.jhep.2020.01.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
288 Zhao Y, Xing H, Wang X, Ou W, Zhao H, Li B, Li Y, Duan Y, Zhuang L, Li W, Cheng D, Quan M, Zhang Y, Ji S. Management of Diabetes Mellitus in Patients with Chronic Liver Diseases. J Diabetes Res 2019;2019:6430486. [PMID: 31915709 DOI: 10.1155/2019/6430486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
289 Bajaj JS, Duarte-Rojo A, Xie JJ, Acharya C, Wade JB, Robles C, Thacker LR, Flud C, Fagan A, Garcia-Saenz-de-Sicilia M, White MB, Kelly M, Nguyen V, Gavis EA, Vargas HE. Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis. Clin Gastroenterol Hepatol 2020;18:3008-3016.e2. [PMID: 32205222 DOI: 10.1016/j.cgh.2020.03.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
290 Hu S, Xiong H, Kang X, Wang S, Zhang T, Yuan Q, Tian D. Preparation and functional evaluation of monoclonal antibodies targeting Hepatitis B Virus Polymerase. Virulence 2021;12:188-94. [PMID: 33356842 DOI: 10.1080/21505594.2020.1869391] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
291 Zaim O, Diouf A, El Bari N, Lagdali N, Benelbarhdadi I, Ajana FZ, Llobet E, Bouchikhi B. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue. Anal Chim Acta 2021;1184:339028. [PMID: 34625262 DOI: 10.1016/j.aca.2021.339028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Ma H, Hei A, Zhou J, He E, Skog S, Li J. Serum thymidine kinase 1 protein concentration for predicting early progression and monitoring the response to TACE in hepatocellular carcinomas: a network meta-analysis. Future Sci OA 2021;7:FSO717. [PMID: 34258026 DOI: 10.2144/fsoa-2021-0016] [Reference Citation Analysis]
293 Ng E, Le AK, Nguyen MH, Wang SX. Early Multiplexed Detection of Cirrhosis using Giant Magnetoresistive Biosensors with Protein Biomarkers. ACS Sens 2020;5:3049-57. [PMID: 32896123 DOI: 10.1021/acssensors.0c00232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Pomacu MM, Trașcă MD, Pădureanu V, Bugă AM, Andrei AM, Stănciulescu EC, Baniță IM, Rădulescu D, Pisoschi CG. Interrelation of inflammation and oxidative stress in liver cirrhosis. Exp Ther Med 2021;21:602. [PMID: 33936259 DOI: 10.3892/etm.2021.10034] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Miller BM, Oderberg IM, Goessling W. Hepatic Nervous System in Development, Regeneration, and Disease. Hepatology 2021. [PMID: 34256416 DOI: 10.1002/hep.32055] [Reference Citation Analysis]
296 Kaufmann B, Reca A, Kim AD, Feldstein AE. Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic Implications. Semin Liver Dis 2021;41:150-62. [PMID: 34107544 DOI: 10.1055/s-0041-1723031] [Reference Citation Analysis]
297 Goyes D, Danford CJ, Nsubuga JP, Bonder A. Waitlist mortality and transplant free survival in Hispanic patients listed for liver transplant using the UNOS database. Ann Hepatol 2021;23:100304. [PMID: 33444852 DOI: 10.1016/j.aohep.2021.100304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
298 Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD. Hepatology. 2020;72:1605-1616. [PMID: 32043613 DOI: 10.1002/hep.31173] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 34.5] [Reference Citation Analysis]
299 Zhang Y, Huang C, Nie Y, Liu Q, Xiao N, Liu L, Zhu X. Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis. Front Med (Lausanne) 2021;8:698502. [PMID: 34336902 DOI: 10.3389/fmed.2021.698502] [Reference Citation Analysis]
300 Wang J, Ren H, Liu Y, Sun L, Zhang Z, Zhao Y, Shi X. Bioinspired Artificial Liver System with hiPSC-Derived Hepatocytes for Acute Liver Failure Treatment. Adv Healthc Mater 2021;:e2101580. [PMID: 34599859 DOI: 10.1002/adhm.202101580] [Reference Citation Analysis]
301 Han X, Wu Y, Yang Q, Cao G. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacol Ther 2021;222:107791. [PMID: 33321113 DOI: 10.1016/j.pharmthera.2020.107791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
302 Lister INE, Ginting CN, Girsang E, Nataya ED, Azizah AM, Widowati W. Hepatoprotective properties of red betel (Piper crocatum Ruiz and Pav) leaves extract towards H2O2-induced HepG2 cells via anti-inflammatory, antinecrotic, antioxidant potency. Saudi Pharm J 2020;28:1182-9. [PMID: 33132711 DOI: 10.1016/j.jsps.2020.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 24.5] [Reference Citation Analysis]
304 Lee YR, Kang MK, Song JE, Kim HJ, Kweon YO, Tak WY, Jang SY, Park JG, Lee C, Hwang JS, Jang BK, Suh JI, Chung WJ, Kim BS, Park SY. Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea. Clin Mol Hepatol. 2020;26:562-576. [PMID: 33053932 DOI: 10.3350/cmh.2020.0126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
305 Xiang L, Shao Y, Chen Y. Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases. J Drug Target 2021;:1-14. [PMID: 33788656 DOI: 10.1080/1061186X.2021.1909051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Virzì A, Gonzalez-Motos V, Tripon S, Baumert TF, Lupberger J. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. J Clin Med 2021;10:977. [PMID: 33801181 DOI: 10.3390/jcm10050977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
307 Trivedi HD, Niezen S, Jiang ZG, Tapper EB. Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis. Dig Dis Sci 2021. [PMID: 34417922 DOI: 10.1007/s10620-021-07228-3] [Reference Citation Analysis]
308 Kwon HC, Sohn H, Kim DH, Shin DM, Jeong CH, Chang YH, Yune JH, Kim YJ, Kim DW, Kim SH, Han SG. In Vitro and In Vivo Study on the Toxic Effects of Propiconazole Fungicide in the Pathogenesis of Liver Fibrosis. J Agric Food Chem 2021;69:7399-408. [PMID: 34170130 DOI: 10.1021/acs.jafc.1c01086] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
309 Eshraghian A, Taghavi A, Nikeghbalian S, Malek-Hosseini SA. Reduced rate of hospital admissions for liver-related morbidities during the initial COVID-19 outbreak. Lancet Gastroenterol Hepatol 2020;5:803-4. [PMID: 32615070 DOI: 10.1016/S2468-1253(20)30207-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
310 Thiele M, Johansen S, Gudmann NS, Madsen B, Kjaergaard M, Nielsen MJ, Leeming DJ, Jacobsen S, Bendtsen F, Møller S, Detlefsen S, Karsdal M, Krag A; GALAXY Consortium. Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation. Aliment Pharmacol Ther 2021;54:1070-80. [PMID: 34428307 DOI: 10.1111/apt.16567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
311 Mousavi SM, Jayedi A, Bagheri A, Zargarzadeh N, Wong A, Persad E, Akhgarjand C, Koohdani F. What is the influence of cinnamon supplementation on liver enzymes? A systematic review and meta-analysis of randomized controlled trials. Phytother Res 2021. [PMID: 34212447 DOI: 10.1002/ptr.7200] [Reference Citation Analysis]
312 Arias-Loste MT, Iruzubieta P, Crespo J. Paediatric non-alcoholic fatty liver disease: a more complex disease than in the adulthood? Hepatobiliary Surg Nutr 2019;8:270-3. [PMID: 31245411 DOI: 10.21037/hbsn.2018.12.16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
313 Zhang H, Liang H, Wu S, Zhang Y, Yu Z. MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2). Environ Toxicol Pharmacol 2021;82:103559. [PMID: 33290872 DOI: 10.1016/j.etap.2020.103559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
314 Zhu Y, Liu R, Shen Z, Cai G. Combination of luteolin and lycopene effectively protect against the “two-hit” in NAFLD through Sirt1/AMPK signal pathway. Life Sciences 2020;256:117990. [DOI: 10.1016/j.lfs.2020.117990] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
315 Elsaid MI, John T, Li Y, Pentakota SR, Rustgi VK. The Health Care Burden of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:263-75. [DOI: 10.1016/j.cld.2020.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
316 [DOI: 10.1101/2020.12.26.20248491] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
317 Dwyer BJ, Macmillan MT, Brennan PN, Forbes SJ. Cell therapy for advanced liver diseases: Repair or rebuild. J Hepatol 2021;74:185-99. [PMID: 32976865 DOI: 10.1016/j.jhep.2020.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
318 Yang L, Liu Y, Sun Y, Huang C, Li J, Wang Y. New advances of DNA/RNA methylation modification in liver fibrosis. Cell Signal 2021;:110224. [PMID: 34954394 DOI: 10.1016/j.cellsig.2021.110224] [Reference Citation Analysis]
319 Li R, Mao Z, Ye X, Zuo T. Human Gut Microbiome and Liver Diseases: From Correlation to Causation. Microorganisms 2021;9:1017. [PMID: 34066850 DOI: 10.3390/microorganisms9051017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
320 Mohammed SAA, Khan RA, El-Readi MZ, Emwas AH, Sioud S, Poulson BG, Jaremko M, Eldeeb HM, Al-Omar MS, Mohammed HA. Suaeda vermiculata Aqueous-Ethanolic Extract-Based Mitigation of CCl4-Induced Hepatotoxicity in Rats, and HepG-2 and HepG-2/ADR Cell-Lines-Based Cytotoxicity Evaluations. Plants (Basel) 2020;9:E1291. [PMID: 33003604 DOI: 10.3390/plants9101291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
321 He Y, Hwang S, Ahmed YA, Feng D, Li N, Ribeiro M, Lafdil F, Kisseleva T, Szabo G, Gao B. Immunopathobiology and therapeutic targets related to cytokines in liver diseases. Cell Mol Immunol 2021;18:18-37. [PMID: 33203939 DOI: 10.1038/s41423-020-00580-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
322 Kurosawa T, Goto M, Kaji N, Aikiyo S, Mihara T, Ikemoto-Uezumi M, Toyoda M, Kanazawa N, Nakazawa T, Hori M, Uezumi A. Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα. Cell Death Dis 2021;12:11. [PMID: 33414474 DOI: 10.1038/s41419-020-03353-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
323 Choi JH, Loarca L, De Hoyos-Vega JM, Dadgar N, Loutherback K, Shah VH, Stybayeva G, Revzin A. Microfluidic confinement enhances phenotype and function of hepatocyte spheroids. Am J Physiol Cell Physiol 2020;319:C552-60. [PMID: 32697600 DOI: 10.1152/ajpcell.00094.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
324 He YF, Chen JW, An CZ, Hou XL, Zhong ZT, Li CQ, Chen W, Liu B, Zhao YD. Labeling of liver cells with CdSe/ZnS quantum dot-based fluorescence probe below freezing point. Spectrochim Acta A Mol Biomol Spectrosc 2021;263:120203. [PMID: 34325172 DOI: 10.1016/j.saa.2021.120203] [Reference Citation Analysis]
325 Panjawatanan P, Wijarnpreecha K, Kim D. Skeletal muscle mass and sarcopenia in nonalcoholic fatty liver disease. Transl Gastroenterol Hepatol 2019;4:77. [PMID: 31872141 DOI: 10.21037/tgh.2019.11.03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
326 Bhattacharya D, Basta B, Mato JM, Craig A, Fernández-Ramos D, Lopitz-Otsoa F, Tsvirkun D, Hayardeny L, Chandar V, Schwartz RE, Villanueva A, Friedman SL. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis. JHEP Rep 2021;3:100237. [PMID: 34151243 DOI: 10.1016/j.jhepr.2021.100237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
327 Torres S, Abdullah Z, Brol MJ, Hellerbrand C, Fernandez M, Fiorotto R, Klein S, Königshofer P, Liedtke C, Lotersztajn S, Nevzorova YA, Schierwagen R, Reiberger T, Uschner FE, Tacke F, Weiskirchen R, Trebicka J. Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview. Int J Mol Sci 2020;21:E2027. [PMID: 32188134 DOI: 10.3390/ijms21062027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
328 Le Magueresse-Battistoni B. Endocrine disrupting chemicals and metabolic disorders in the liver: What if we also looked at the female side? Chemosphere 2021;268:129212. [PMID: 33359838 DOI: 10.1016/j.chemosphere.2020.129212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
329 Huang CH, Tseng HJ, Amodio P, Chen YL, Wang SF, Chang SH, Hsieh SY, Lin CY. Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Improve Cirrhosis Outcome Prediction: A Modified Seven-Stage Model as a Clinical Alternative to MELD. J Pers Med 2020;10:E186. [PMID: 33105871 DOI: 10.3390/jpm10040186] [Reference Citation Analysis]
330 Tang KT, Dufour JF, Chen PH, Hernaez R, Hutfless S. Antitumour necrosis factor-α agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort. BMJ Open Gastroenterol 2020;7:e000349. [PMID: 32377366 DOI: 10.1136/bmjgast-2019-000349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
331 Bajaj JS, Khoruts A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. Journal of Hepatology 2020;72:1003-27. [DOI: 10.1016/j.jhep.2020.01.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
332 Qie C, Liu Y, Ma P, Wu H. Genetic association between mannose-binding lectin polymorphisms and viral hepatitis: a meta-analysis. Pathog Dis 2019;77:ftz035. [PMID: 31381758 DOI: 10.1093/femspd/ftz035] [Reference Citation Analysis]
333 Strickland JD, Copple BL. Modulation of macrophage phenotype to treat liver fibrosis-Current approaches and future possibilities. Adv Pharmacol 2021;91:213-28. [PMID: 34099109 DOI: 10.1016/bs.apha.2021.03.001] [Reference Citation Analysis]
334 Choi HH, Rodgers SK, Khurana A, Nelson LW, Kamaya A. Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma Surveillance. Magn Reson Imaging Clin N Am 2021;29:279-90. [PMID: 34243917 DOI: 10.1016/j.mric.2021.05.005] [Reference Citation Analysis]
335 Silva JM, Silva MJ, Calinas F, Nogueira PJ. Burden of Liver Cirrhosis in Portugal between 2010 and 2017. GE Port J Gastroenterol 2021;28:153-61. [PMID: 34056037 DOI: 10.1159/000510729] [Reference Citation Analysis]
336 Dengu F, Abbas SH, Ebeling G, Nasralla D. Normothermic Machine Perfusion (NMP) of the Liver as a Platform for Therapeutic Interventions during Ex-Vivo Liver Preservation: A Review. J Clin Med. 2020;9. [PMID: 32272760 DOI: 10.3390/jcm9041046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
337 Hu D, Huang S, Ding Y, Zhao X, Zhang W, Chen H, Wang J. Specnuezhenide reduces carbon tetrachloride-induced liver injury in mice through inhibition of oxidative stress and hepatocyte apoptosis. J Pharm Pharmacol 2021:rgab164. [PMID: 34923584 DOI: 10.1093/jpp/rgab164] [Reference Citation Analysis]
338 Aravalli RN. Generating liver using blastocyst complementation: Opportunities and challenges. Xenotransplantation 2021;28:e12668. [PMID: 33372360 DOI: 10.1111/xen.12668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
339 Nawroth JC, Petropolis DB, Manatakis DV, Maulana TI, Burchett G, Schlünder K, Witt A, Shukla A, Kodella K, Ronxhi J, Kulkarni G, Hamilton G, Seki E, Lu S, Karalis KC. Modeling alcohol-associated liver disease in a human Liver-Chip. Cell Rep 2021;36:109393. [PMID: 34289365 DOI: 10.1016/j.celrep.2021.109393] [Reference Citation Analysis]
340 Qiao JB, Fan QQ, Zhang CL, Lee J, Byun J, Xing L, Gao XD, Oh YK, Jiang HL. Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fibrosis. J Control Release 2020;321:629-40. [PMID: 32135224 DOI: 10.1016/j.jconrel.2020.02.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
341 Vorobioff JD, Contreras F, Tanno F, Hernández L, Bessone F, Colombato L, Adi J, Fassio E, Felgueres M, Fernández G, Gaite L, Gibelli D, Darrichon HG, Lafage M, Lombardo D, López S, Mateo A, Mendizábal M, Pecoraro J, Ruf A, Ruiz P, Severini J, Stieben T, Sixto M, Zárate F, Barraza SB, Sierra ID, Pacheco VR, Roblero JP, Rojas JO, González PR, Rodríguez DSM, Sierralta A, Manchego AU, Valdes E, Yaquich P, Wolff R, Valdivia FB, Gallegos RC, Galloso R, Marcelo JS, Montes P, Tenorio L, Veramendi I, Alava E, Armijos X, Benalcazar G, Carrera E, Pazmiño GF, Díaz EM, Garassini M, Marrero RP, Infante M, Suárez DP, Gutiérrez JC, Reyes CMV, Serrano YM, Hernández RH, Martínez OM, González TP, Andara MT, Hernández MS, Gerona S, García I, Tijera F, López EP, Torres K, Garzón M. A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management. Ann Hepatol 2020;19:396-403. [PMID: 32418749 DOI: 10.1016/j.aohep.2020.03.007] [Reference Citation Analysis]
342 Wang D, Yang X, Long J, Lin J, Mao J, Xie F, Wang Y, Wang Y, Xun Z, Bai Y, Yang X, Guan M, Pan J, Seery S, Sang X, Zhao H. The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study. Front Oncol 2021;11:646979. [PMID: 33912461 DOI: 10.3389/fonc.2021.646979] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
343 Meneses A, Santabárbara JM, Romero JA, Aliaga R, Maceira AM, Moratal D. Determination of Non-Invasive Biomarkers for the Assessment of Fibrosis, Steatosis and Hepatic Iron Overload by MR Image Analysis. A Pilot Study. Diagnostics (Basel) 2021;11:1178. [PMID: 34209547 DOI: 10.3390/diagnostics11071178] [Reference Citation Analysis]
344 Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad RE, Asadirad A, Joharchi K, Tokhanbigli S, Hashemi SM, Łos MJ, Aghdaei HA, Zali MR, Ghavami S. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis. Eur J Pharmacol 2020;882:173263. [PMID: 32535098 DOI: 10.1016/j.ejphar.2020.173263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
345 Chandra PK, Soker S, Atala A. Tissue engineering: current status and future perspectives. Principles of Tissue Engineering. Elsevier; 2020. pp. 1-35. [DOI: 10.1016/b978-0-12-818422-6.00004-6] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
346 Luo S, Xiao S, Ai Y, Wang B, Wang Y. Changes in the hepatic differentiation potential of human mesenchymal stem cells aged in vitro. Ann Transl Med 2021;9:1628. [PMID: 34926672 DOI: 10.21037/atm-21-4918] [Reference Citation Analysis]
347 Lorée H, Bastard C, Miette V, Sandrin L. Vibration-Guided Transient Elastography: A Novel Fibroscan® Examination with Improved Guidance for Liver Stiffness Measurement. Ultrasound Med Biol 2020;46:2193-206. [PMID: 32536508 DOI: 10.1016/j.ultrasmedbio.2020.04.010] [Reference Citation Analysis]
348 Zhou M, Deng Y, Liu M, Liao L, Dai X, Guo C, Zhao X, He L, Peng C, Li Y. The pharmacological activity of berberine, a review for liver protection. Eur J Pharmacol 2021;890:173655. [PMID: 33068590 DOI: 10.1016/j.ejphar.2020.173655] [Reference Citation Analysis]
349 Penman SL, Kiy RT, Jensen RL, Beoku-Betts C, Alfirevic A, Back D, Khoo SH, Owen A, Pirmohamed M, Park BK, Meng X, Goldring CE, Chadwick AE. Safety perspectives on presently considered drugs for the treatment of COVID-19. Br J Pharmacol 2020;177:4353-74. [PMID: 32681537 DOI: 10.1111/bph.15204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
350 Andersson ER, Lohse AW. Advances in genetic, epigenetic and environmental aspects of rare liver diseases. Eur J Med Genet 2021;:104411. [PMID: 34942406 DOI: 10.1016/j.ejmg.2021.104411] [Reference Citation Analysis]
351 Liu N, Feng J, Lv Y, Liu Q, Deng J, Xia Y, Guo C, Zhou Y. Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study. Exp Ther Med 2019;18:4058-66. [PMID: 31611941 DOI: 10.3892/etm.2019.8011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
352 Daniels SJ, Leeming DJ, Detlefsen S, Bruun MF, Hjuler ST, Henriksen K, Hein P, Krag A, Karsdal MA, Nielsen MJ, Brockbank S, Cruwys S. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2020;318:G410-8. [PMID: 31905026 DOI: 10.1152/ajpgi.00066.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
353 Chan BKY, Elmasry M, Forootan SS, Russomanno G, Bunday TM, Zhang F, Brillant N, Starkey Lewis PJ, Aird R, Ricci E, Andrews TD, Sison-Young RL, Schofield AL, Fang Y, Lister A, Sharkey JW, Poptani H, Kitteringham NR, Forbes SJ, Malik HZ, Fenwick SW, Park BK, Goldring CE, Copple IM. Pharmacological Activation of Nrf2 Enhances Functional Liver Regeneration. Hepatology 2021;74:973-86. [PMID: 33872408 DOI: 10.1002/hep.31859] [Reference Citation Analysis]
354 Xu G, Li F, Mao Y. Portal pressure monitoring-state-of-the-art and future perspective. Ann Transl Med. 2019;7:583. [PMID: 31807564 DOI: 10.21037/atm.2019.09.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
355 Elkilany A, Fehrenbach U, Auer TA, Müller T, Schöning W, Hamm B, Geisel D. A radiomics-based model to classify the etiology of liver cirrhosis using gadoxetic acid-enhanced MRI. Sci Rep 2021;11:10778. [PMID: 34031487 DOI: 10.1038/s41598-021-90257-9] [Reference Citation Analysis]
356 de Gregorio E, Colell A, Morales A, Marí M. Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease. Int J Mol Sci 2020;21:E3858. [PMID: 32485811 DOI: 10.3390/ijms21113858] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
357 Yan W, Shen Y, Huang J, Lu L, Zhang Q. MCC950 Ameliorates Acute Liver Injury Through Modulating Macrophage Polarization and Myeloid-Derived Suppressor Cells Function. Front Med (Lausanne) 2021;8:752223. [PMID: 34869447 DOI: 10.3389/fmed.2021.752223] [Reference Citation Analysis]
358 Singh SP, Panigrahi S, Mishra D, Khatua CR. Alcohol-associated liver disease, not hepatitis B, is the major cause of cirrhosis in Asia. J Hepatol 2019;70:1031-2. [PMID: 30782425 DOI: 10.1016/j.jhep.2019.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
359 Du Z, Liu M, Wang Z, Lin Z, Feng Y, Tian D, Xia L. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ. Cell Prolif 2021;54:e13072. [PMID: 34031939 DOI: 10.1111/cpr.13072] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
360 Li W, Deng R, Liu S, Wang K, Sun J. Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non-viral risk factors. Liver Int 2020;40:2316-25. [PMID: 32666675 DOI: 10.1111/liv.14607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
361 Sharma M, Pondugala PK, Jaggaihgari S, Mitnala S, Krishna VV, Jaishetwar G, Naik P, Kumar P, Kulkarni A, Gupta R, Singh JR, Darisetty S, Sekharan A, Reddy DN, Rao GV, Syeda F, Jagtap N, Rao PN. Safety Assessment of Autologous Stem Cell Combination Therapy in Patients With Decompensated Liver Cirrhosis: A Pilot Study. Journal of Clinical and Experimental Hepatology 2022;12:80-8. [DOI: 10.1016/j.jceh.2021.03.010] [Reference Citation Analysis]
362 Gomez-Escobar E, Burlaud-Gaillard J, Visdeloup C, Silva ARE, Coutant P, Roingeard P, Beaumont E. Incorporation of apolipoprotein E into HBV-HCV subviral envelope particles to improve the hepatitis vaccine strategy. Sci Rep 2021;11:21856. [PMID: 34750487 DOI: 10.1038/s41598-021-01428-7] [Reference Citation Analysis]
363 Logge WB, Morley KC, Haber PS. GABAB Receptors and Alcohol Use Disorders: Clinical Studies. Curr Top Behav Neurosci 2021. [PMID: 33580440 DOI: 10.1007/7854_2020_182] [Reference Citation Analysis]
364 Zou D, Wang H, Liu X, Xu ZP, Roberts MS, Zhao CX. Artificial cells for the treatment of liver diseases. Acta Biomater 2021;130:98-114. [PMID: 34126265 DOI: 10.1016/j.actbio.2021.06.012] [Reference Citation Analysis]
365 Qu H, Liu S, Cheng C, Zhao H, Gao X, Wang Z, Yi J. Hepatoprotection of pine nut polysaccharide via NRF2/ARE/MKP1/JNK signaling pathways against carbon tetrachloride-induced liver injury in mice. Food Chem Toxicol 2020;142:111490. [PMID: 32540477 DOI: 10.1016/j.fct.2020.111490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
366 Offerdahl K, Huber M, Long W, Bottenus N, Nelson R, Trahey G. Occult Regions of Suppressed Coherence in Liver B-Mode Images. Ultrasound Med Biol 2022;48:47-58. [PMID: 34702640 DOI: 10.1016/j.ultrasmedbio.2021.09.007] [Reference Citation Analysis]
367 Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, Kamath PS, Mangaonkar AA, Simonetto DA. Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population. Hepatol Commun 2021. [PMID: 34558851 DOI: 10.1002/hep4.1803] [Reference Citation Analysis]
368 Kurniawan DW, Storm G, Prakash J, Bansal R. Role of spleen tyrosine kinase in liver diseases. World J Gastroenterol 2020; 26(10): 1005-1019 [PMID: 32205992 DOI: 10.3748/wjg.v26.i10.1005] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
369 Hashemi N, Viveiros K, Redd WD, Zhou JC, McCarty TR, Bazarbashi AN, Hathorn KE, Wong D, Njie C, Shen L, Chan WW. Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience. Liver Int. 2020;40:2515-2521. [PMID: 32585065 DOI: 10.1111/liv.14583] [Cited by in Crossref: 38] [Cited by in F6Publishing: 49] [Article Influence: 19.0] [Reference Citation Analysis]
370 Pradhan RR, Kafle Bhandari B, Pathak R, Poudyal S, Anees S, Sharma S, Khadga P. The Assessment of Health-Related Quality of Life in Patients With Chronic Liver Disease: A Single-Center Study. Cureus 2020;12:e10727. [PMID: 33145133 DOI: 10.7759/cureus.10727] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
371 Spring A, Saran JS, McCarthy S, McCluskey SA. Anesthesia for the Patient with Severe Liver Failure. Adv Anesth 2020;38:251-67. [PMID: 34106838 DOI: 10.1016/j.aan.2020.09.002] [Reference Citation Analysis]
372 Yaqub F, Latief N, Butt H, Naseer N, Riazuddin S. Alpha lipoic acid priming enhances the hepatoprotective effect of adipose derived stem cells in CCl4 induced hepatic injury in-vitro. Eur J Pharmacol 2021;906:174201. [PMID: 34118221 DOI: 10.1016/j.ejphar.2021.174201] [Reference Citation Analysis]
373 Zhang S, Yang X, Wang W. Associations of genetic polymorphisms in CTLA-4 and IL-18 with chronic liver diseases: Evidence from a meta-analysis. Genomics 2020;112:1889-96. [PMID: 31698031 DOI: 10.1016/j.ygeno.2019.11.001] [Reference Citation Analysis]
374 Wang XP, Wang Y, Ma H, Wang H, Yang DW, Zhao XY, Jin EH, Yang ZH. Assessment of liver fibrosis with liver and spleen magnetic resonance elastography, serum markers in chronic liver disease. Quant Imaging Med Surg 2020;10:1208-22. [PMID: 32550131 DOI: 10.21037/qims-19-849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
375 Szeląg-Pieniek S, Oswald S, Post M, Łapczuk-Romańska J, Droździk M, Kurzawski M. Hepatic drug-metabolizing enzymes and drug transporters in Wilson's disease patients with liver failure. Pharmacol Rep 2021. [PMID: 34117631 DOI: 10.1007/s43440-021-00290-8] [Reference Citation Analysis]
376 Singal AK, Arora S, Wong RJ, Satapathy SK, Shah VH, Kuo YF, Kamath PS. Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States. Am J Gastroenterol. 2020;115:88-95. [PMID: 31651447 DOI: 10.14309/ajg.0000000000000411] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
377 Baweja S, Bihari C, Negi P, Thangariyal S, Kumari A, Lal D, Maheshwari D, Singh Maras J, Nautiyal N, Kumar G, Kumar A, Trehanpati N, Mehta G, Kumar Chaudhary A, Maiwall R, Kumar Sarin S. Circulating extracellular vesicles induce monocyte dysfunction and are associated with sepsis and high mortality in cirrhosis. Liver Int 2021;41:1614-28. [PMID: 33713381 DOI: 10.1111/liv.14875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
378 Innes H, Nischalke HD, Guha IN, Weiss KH, Irving W, Gotthardt D, Barnes E, Fischer J, Ansari MA, Rosendahl J, Lin SK, Marot A, Pedergnana V, Casper M, Benselin J, Lammert F, McLauchlan J, Lutz PL, Hamill V, Mueller S, Morling JR, Semmler G, Eyer F, von Felden J, Link A, Vogel A, Marquardt JU, Sulk S, Trebicka J, Valenti L, Datz C, Reiberger T, Schafmayer C, Berg T, Deltenre P, Hampe J, Stickel F, Buch S. The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis. Hepatol Commun 2021. [PMID: 34958182 DOI: 10.1002/hep4.1886] [Reference Citation Analysis]
379 Olgasi C, Cucci A, Follenzi A. iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine. Int J Mol Sci 2020;21:E6215. [PMID: 32867371 DOI: 10.3390/ijms21176215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
380 Kagadis GC, Drazinos P, Gatos I, Tsantis S, Papadimitroulas P, Spiliopoulos S, Karnabatidis D, Theotokas I, Zoumpoulis P, Hazle JD. Deep learning networks on chronic liver disease assessment with fine-tuning of shear wave elastography image sequences. Phys Med Biol 2020;65:215027. [PMID: 32998480 DOI: 10.1088/1361-6560/abae06] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
381 Wang C, Ma C, Gong L, Guo Y, Fu K, Zhang Y, Zhou H, Li Y. Macrophage Polarization and Its Role in Liver Disease. Front Immunol 2021;12:803037. [PMID: 34970275 DOI: 10.3389/fimmu.2021.803037] [Reference Citation Analysis]
382 Ezhilarasan D. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms. Toxicology 2021;458:152840. [PMID: 34175381 DOI: 10.1016/j.tox.2021.152840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
383 Bangru S, Kalsotra A. Cellular and molecular basis of liver regeneration. Semin Cell Dev Biol 2020;100:74-87. [PMID: 31980376 DOI: 10.1016/j.semcdb.2019.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
384 Zhao J, Wang ZY, Li J, Yu HW, Meng QH. Influence of diabetes mellitus on energy metabolism in patients with alcoholic liver cirrhosis. Eur J Gastroenterol Hepatol 2020;32:110-5. [PMID: 31567641 DOI: 10.1097/MEG.0000000000001560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
385 Acharya C, Bajaj JS. Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease. Gastroenterology 2021;160:556-72. [PMID: 33253686 DOI: 10.1053/j.gastro.2020.10.056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
386 Maninet S, Aungsuroch Y, Jitpanya C. A causal model of functional status among persons with liver cirrhosis from four public hospitals in Thailand. JHR 2021;ahead-of-print. [DOI: 10.1108/jhr-11-2020-0558] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
387 Mohseni R, Alavian SM, Sadeghabadi ZA, Heiat M. Therapeutic effects of Chlorella vulgaris on carbon tetrachloride induced liver fibrosis by targeting Hippo signaling pathway and AMPK/FOXO1 axis. Mol Biol Rep 2021;48:117-26. [PMID: 33296068 DOI: 10.1007/s11033-020-05978-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
388 Ballantine A, Martin D, Thakrar SV. The coagulopathy of liver disease: a shift in thinking. Br J Hosp Med (Lond) 2021;82:1-9. [PMID: 34191571 DOI: 10.12968/hmed.2021.0111] [Reference Citation Analysis]
389 Tennakoon L, Baiu I, Concepcion W, Melcher ML, Spain DA, Knowlton LM. Understanding Health Care Utilization and Mortality After Emergency General Surgery in Patients With Underlying Liver Disease. Am Surg 2020;86:665-74. [PMID: 32683972 DOI: 10.1177/0003134820923304] [Reference Citation Analysis]
390 Cao Y, Ji C, Lu L. Mesenchymal stem cell therapy for liver fibrosis/cirrhosis. Ann Transl Med 2020;8:562. [PMID: 32775363 DOI: 10.21037/atm.2020.02.119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
391 Paik JM, Golabi P, Younossi Y, Saleh N, Nhyira A, Younossi ZM. The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017. Hepatol Commun 2021;5:749-59. [PMID: 34027266 DOI: 10.1002/hep4.1673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
392 Maraolo AE, Scotto R, Zappulo E, Pinchera B, Schiano Moriello N, Nappa S, Buonomo AR, Gentile I. Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials. Expert Rev Anti Infect Ther 2020;18:191-202. [PMID: 32011191 DOI: 10.1080/14787210.2020.1725473] [Reference Citation Analysis]
393 Clugston RD. Carotenoids and fatty liver disease: Current knowledge and research gaps. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158597. [PMID: 31904420 DOI: 10.1016/j.bbalip.2019.158597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
394 Xiang H, Zheng Z, Huang L, Qiu T, Luo Y, Jiang H. In vivo liver thermoacoustic imaging and demonstration based on localization wire. Med Phys 2021;48:1608-15. [PMID: 33492686 DOI: 10.1002/mp.14736] [Reference Citation Analysis]
395 Li Y, Ma J, Li B, Zhu X, Wang J. Cirrhosis of Wilson's disease: High and low cutoff using acoustic radiation force impulse (ARFI) -Comparison and combination with serum fibrosis index. Clin Hemorheol Microcirc 2021. [PMID: 34334385 DOI: 10.3233/CH-211219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Hansen L, Chang MF, Hiatt S, Dieckmann NF, Lyons KS, Lee CS. Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis. Dig Dis Sci 2021. [PMID: 34448980 DOI: 10.1007/s10620-021-07216-7] [Reference Citation Analysis]
397 Peng X, Yang Y, Tang L, Wan J, Dai J, Li L, Huang J, Shen Y, Lin L, Gong X, Zhang L. Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathway. Biomed Pharmacother 2020;125:110020. [PMID: 32106375 DOI: 10.1016/j.biopha.2020.110020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
398 Kartasheva-Ebertz DM, Pol S, Lagaye S. Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis. Front Immunol 2021;12:691073. [PMID: 34211477 DOI: 10.3389/fimmu.2021.691073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
399 Wang T, Yan M, Tang D, Dong Y, Zhu L, Du Q, Sun D, Xing J, Dong Y. Using Child-Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model-based Analysis. Pharmacotherapy 2021;41:172-83. [PMID: 33064889 DOI: 10.1002/phar.2474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
400 Ramachandran P, Matchett KP, Dobie R, Wilson-Kanamori JR, Henderson NC. Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis. Nat Rev Gastroenterol Hepatol 2020;17:457-72. [PMID: 32483353 DOI: 10.1038/s41575-020-0304-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
401 Lee CH, Kim IH. Direct Hyperbilirubinemia as a Predictor of Mortality in Patients with Liver Cirrhosis. Gut Liver 2021;15:490-1. [PMID: 34261817 DOI: 10.5009/gnl210296] [Reference Citation Analysis]
402 Zhang Y, Sun F, Li X, Liu Q, Chen Z, Guo Y. Identification of Molecular Subgroups in Liver Cirrhosis by Gene Expression Profiles. Hepat Mon 2022;21. [DOI: 10.5812/hepatmon.118535] [Reference Citation Analysis]
403 Yu XF, Zhou ZL, Lu XD, Long SQ. Hepatoprotective effect of naringenin in rats with alcoholic liver disease. Shijie Huaren Xiaohua Zazhi 2021; 29(23): 1334-1340 [DOI: 10.11569/wcjd.v29.i23.1334] [Reference Citation Analysis]
404 Li S, Huang P, Jeyarajan AJ, Ma C, Zhu K, Zhu C, Jiang N, Li M, Shao T, Han M, Tan L, Lin W. Assessment of Non-invasive Markers for the Prediction of Esophageal Variceal Hemorrhage. Front Med (Lausanne) 2021;8:770836. [PMID: 34926512 DOI: 10.3389/fmed.2021.770836] [Reference Citation Analysis]
405 Claveria-Cabello A, Colyn L, Uriarte I, Latasa MU, Arechederra M, Herranz JM, Alvarez L, Urman JM, Martinez-Chantar ML, Banales JM, Sangro B, Rombouts K, Oyarzabal J, Marin JJG, Berasain C, Avila MA, Fernandez-Barrena MG. Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis. Cancers (Basel) 2020;12:E3748. [PMID: 33322158 DOI: 10.3390/cancers12123748] [Reference Citation Analysis]
406 Shan L, Jiang T, Ci L, Liu Z, Lv X, Li J. Purine signaling regulating HSCs inflammatory cytokines secretion, activation, and proliferation plays a critical role in alcoholic liver disease. Mol Cell Biochem 2020;466:91-102. [PMID: 31989367 DOI: 10.1007/s11010-020-03691-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
407 Alqahtani SA, Broering DC, Alghamdi SA, Bzeizi KI, Alhusseini N, Alabbad SI, Albenmousa A, Alfaris N, Abaalkhail F, Al-Hamoudi WK. Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease. BMC Gastroenterol 2021;21:245. [PMID: 34074270 DOI: 10.1186/s12876-021-01828-z] [Reference Citation Analysis]
408 Chen Y, Tang D, Wu H, Wu Y, Yuan T, Zhang H, Jiao Y, Yu W, Yan H. Assessment of long-term functional maintenance of primary human hepatocytes to predict drug-induced hepatoxicity in vitro. Arch Toxicol 2021;95:2431-42. [PMID: 33852043 DOI: 10.1007/s00204-021-03050-y] [Reference Citation Analysis]
409 Zimmermann M, Reichert AS. Rapid metabolic and bioenergetic adaptations of astrocytes under hyperammonemia - a novel perspective on hepatic encephalopathy. Biol Chem 2021;402:1103-13. [PMID: 34331848 DOI: 10.1515/hsz-2021-0172] [Reference Citation Analysis]
410 Kurniawan DW, Booijink R, Pater L, Wols I, Vrynas A, Storm G, Prakash J, Bansal R. Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo. J Control Release 2020;328:640-52. [PMID: 32979454 DOI: 10.1016/j.jconrel.2020.09.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
411 Blencowe M, Karunanayake T, Wier J, Hsu N, Yang X. Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease. Genes (Basel). 2019;10. [PMID: 31771247 DOI: 10.3390/genes10120966] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
412 Beyoğlu D, Idle JR. Metabolomic insights into the mode of action of natural products in the treatment of liver disease. Biochemical Pharmacology 2020;180:114171. [DOI: 10.1016/j.bcp.2020.114171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
413 Podrug K, Sporea I, Lupusoru R, Pastrovic F, Mustapic S, Bâldea V, Bozin T, Bokun T, Salkic N, Șirli R, Popescu A, Puljiz Z, Grgurevic I. Diagnostic Performance of 2-D Shear-Wave Elastography with Propagation Maps and Attenuation Imaging in Patients with Non-Alcoholic Fatty Liver Disease. Ultrasound Med Biol 2021;47:2128-37. [PMID: 33985827 DOI: 10.1016/j.ultrasmedbio.2021.03.025] [Reference Citation Analysis]
414 Wei S, Yu X. Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Complement Ther Med 2021;57:102635. [PMID: 33271299 DOI: 10.1016/j.ctim.2020.102635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
415 Mekuria AN, Routledge MN, Gong YY, Sisay M. Aflatoxins as a risk factor for liver cirrhosis: a systematic review and meta-analysis. BMC Pharmacol Toxicol 2020;21:39. [PMID: 32487162 DOI: 10.1186/s40360-020-00420-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
416 Ashour AA, Atta MA, Sadek KW, Obaid KR, Ashour MA, Ashour A, Danjuma MI, Doi SA, ElZouki AN. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update. Eur J Gastroenterol Hepatol 2021;33:479-86. [PMID: 32976190 DOI: 10.1097/MEG.0000000000001932] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
417 Quan Y, Yang J, Qin T, Hu Y. Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysis. World J Surg Oncol 2019;17:216. [PMID: 31830994 DOI: 10.1186/s12957-019-1748-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
418 Agarwal T, Subramanian B, Maiti TK. Liver Tissue Engineering: Challenges and Opportunities. ACS Biomater Sci Eng 2019;5:4167-82. [PMID: 33417776 DOI: 10.1021/acsbiomaterials.9b00745] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 6.7] [Reference Citation Analysis]
419 Castera L. Screening for liver fibrosis in primary care: Focus on subjects above 40 and with metabolic risk factors. United European Gastroenterol J 2021. [PMID: 34228905 DOI: 10.1002/ueg2.12120] [Reference Citation Analysis]
420 Ozel AB, Cilingir-Kaya OT, Sener G, Ozbeyli D, Sen A, Sacan O, Yanardag R, Yarat A. Investigation of possible neuroprotective effects of some plant extracts on brain in bile duct ligated rats. J Food Biochem 2021;:e13835. [PMID: 34173678 DOI: 10.1111/jfbc.13835] [Reference Citation Analysis]
421 Elbanna KY, Mansoori B, Mileto A, Rogalla P, S. Guimarães L. Dual-energy CT in diffuse liver disease: is there a role? Abdom Radiol 2020;45:3413-24. [DOI: 10.1007/s00261-020-02702-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
422 Neupane R, Taweesedt PT, Anjum H, Surani S. Current state of medical tourism involving liver transplantation-the risk of infections and potential complications . World J Hepatol 2021; 13(7): 717-722 [PMID: 34367493 DOI: 10.4254/wjh.v13.i7.717] [Reference Citation Analysis]
423 Bandopadhyay M, Bharadwaj M. Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker. Gut Pathog. 2020;12:23. [PMID: 32346400 DOI: 10.1186/s13099-020-00353-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
424 Zhao X, Gong L, Wang C, Liu M, Hu N, Dai X, Peng C, Li Y. Quercetin mitigates ethanol-induced hepatic steatosis in zebrafish via P2X7R-mediated PI3K/ Keap1/Nrf2 signaling pathway. J Ethnopharmacol 2021;268:113569. [PMID: 33186701 DOI: 10.1016/j.jep.2020.113569] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
425 Mastrodicasa D, Willemink MJ, Duran C, Pizzi AD, Hinostroza V, Molvin L, Khalaf M, Jeffrey RB, Patel BN. Non-invasive assessment of cirrhosis using multiphasic dual-energy CT iodine maps: correlation with model for end-stage liver disease score. Abdom Radiol (NY) 2021;46:1931-40. [PMID: 33211150 DOI: 10.1007/s00261-020-02857-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
426 Skinner C, Thompson AJ, Thursz MR, Marchesi JR, Vergis N. Intestinal permeability and bacterial translocation in patients with liver disease, focusing on alcoholic aetiology: methods of assessment and therapeutic intervention. Therap Adv Gastroenterol 2020;13:1756284820942616. [PMID: 33149761 DOI: 10.1177/1756284820942616] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
427 Neo S, Makiishi E, Fujimoto A, Hisasue M. Human placental hydrolysate promotes the long-term culture of hepatocyte-like cells derived from canine bone marrow. J Vet Med Sci 2021;82:1821-7. [PMID: 33132358 DOI: 10.1292/jvms.20-0320] [Reference Citation Analysis]
428 Rathore C, Upadhyay N, Kaundal R, Dwivedi RP, Rahatekar S, John A, Dua K, Tambuwala MM, Jain S, Chaudari D, Negi P. Enhanced oral bioavailability and hepatoprotective activity of thymoquinone in the form of phospholipidic nano-constructs. Expert Opin Drug Deliv 2020;17:237-53. [PMID: 32003249 DOI: 10.1080/17425247.2020.1716728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
429 Chen B, Rao X, Wang X, Luo Z, Wang J, Sheng S, Liu Y, Zhang N, Jin S, Chen H, Sun C, Xu T, Du Y. cGAS-STING Signaling Pathway and Liver Disease: From Basic Research to Clinical Practice. Front Pharmacol 2021;12:719644. [PMID: 34483930 DOI: 10.3389/fphar.2021.719644] [Reference Citation Analysis]
430 Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650-2666. [PMID: 31401364 DOI: 10.1016/j.cgh.2019.07.060] [Cited by in Crossref: 102] [Cited by in F6Publishing: 110] [Article Influence: 34.0] [Reference Citation Analysis]
431 Gatos I, Drazinos P, Yarmenitis S, Theotokas I, Zoumpoulis PS. Comparison of Sound Touch Elastography, Shear Wave Elastography and Vibration-Controlled Transient Elastography in Chronic Liver Disease Assessment using Liver Biopsy as the “Reference Standard”. Ultrasound in Medicine & Biology 2020;46:959-71. [DOI: 10.1016/j.ultrasmedbio.2019.12.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
432 Rus G, Faris IH, Torres J, Callejas A, Melchor J. Why Are Viscosity and Nonlinearity Bound to Make an Impact in Clinical Elastographic Diagnosis? Sensors (Basel) 2020;20:E2379. [PMID: 32331295 DOI: 10.3390/s20082379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
433 Gidener T, Yin M, Dierkhising RA, Allen AM, Ehman RL, Venkatesh SK. Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study. Hepatology 2021. [PMID: 34510513 DOI: 10.1002/hep.32151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
434 Álvares-da-Silva MR, Oliveira CP, Fagan A, Longo L, Thoen RU, Yoshimura Zitelli PM, Tanaka Ferreira RM, Mcgeorge S, Shamsaddini A, Farias AQ, Sikaroodi M, Gillevet PM, Bajaj JS. Interaction of Microbiome, Diet, and Hospitalizations Between Brazilian and American Patients With Cirrhosis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00355-4. [PMID: 33813071 DOI: 10.1016/j.cgh.2021.03.045] [Reference Citation Analysis]
435 Yang H, Arif M, Yuan M, Li X, Shong K, Türkez H, Nielsen J, Uhlén M, Borén J, Zhang C, Mardinoglu A. A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease. iScience 2021;24:103222. [PMID: 34712920 DOI: 10.1016/j.isci.2021.103222] [Reference Citation Analysis]
436 Jeon S, Carr R. Alcohol effects on hepatic lipid metabolism. J Lipid Res. 2020;61:470-479. [PMID: 32029510 DOI: 10.1194/jlr.r119000547] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
437 Emma MR, Augello G, Cusimano A, Azzolina A, Montalto G, McCubrey JA, Cervello M. GSK-3 in liver diseases: Friend or foe? Biochim Biophys Acta Mol Cell Res 2020;1867:118743. [PMID: 32417256 DOI: 10.1016/j.bbamcr.2020.118743] [Reference Citation Analysis]
438 Wang J, Cheng Q, Fang J, Ding H, Liu H, Fang X, Chen C, Zhang W. A Preliminary Study on the Effect of Hydrogen Gas on Alleviating Early CCl4-Induced Chronic Liver Injury in Rats. Antioxidants (Basel) 2021;10:1933. [PMID: 34943036 DOI: 10.3390/antiox10121933] [Reference Citation Analysis]
439 Ezhilarasan D. Deciphering the toxicological role of Porphyromonas gingivalis derived endotoxins in liver diseases. Environ Toxicol Pharmacol 2021;88:103755. [PMID: 34662732 DOI: 10.1016/j.etap.2021.103755] [Reference Citation Analysis]
440 Yu HH, Qiu YX, Li B, Peng CY, Zeng R, Wang W. Kadsura heteroclita stem ethanol extract protects against carbon tetrachloride-induced liver injury in mice via suppression of oxidative stress, inflammation, and apoptosis. J Ethnopharmacol. 2021;267:113496. [PMID: 33091494 DOI: 10.1016/j.jep.2020.113496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
441 Paik JM, Golabi P, Younossi Y, Srishord M, Mishra A, Younossi ZM. The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017. Hepatol Commun 2020;4:1769-80. [PMID: 33305148 DOI: 10.1002/hep4.1599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
442 Alshammari GM, Al-Qahtani WH, AlFaris NA, Alzahrani NS, Alkhateeb MA, Yahya MA. Quercetin prevents cadmium chloride-induced hepatic steatosis and fibrosis by downregulating the transcription of miR-21. Biofactors 2021;47:489-505. [PMID: 33733575 DOI: 10.1002/biof.1724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
443 Wang T, Wang L, Zhang Y, Sun J, Xie Y, Yuan Y, Gu J, Bian J, Liu Z, Zou H. Puerarin Restores Autophagosome-Lysosome Fusion to Alleviate Cadmium-Induced Autophagy Blockade via Restoring the Expression of Rab7 in Hepatocytes. Front Pharmacol 2021;12:632825. [PMID: 33935722 DOI: 10.3389/fphar.2021.632825] [Reference Citation Analysis]
444 Härmälä S, Parisinos CA, Shallcross L, O'Brien A, Hayward A. Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis. BMJ Open 2019;9:e031070. [PMID: 31494620 DOI: 10.1136/bmjopen-2019-031070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
445 Bestion E, Jilkova ZM, Mège JL, Novello M, Kurma K, Pour STA, Lalmanach G, Vanderlynden L, Fizanne L, Bassissi F, Rachid M, Tracz J, Boursier J, Courcambeck J, Serdjebi C, Ansaldi C, Decaens T, Halfon P, Brun S. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. Ther Adv Chronic Dis 2020;11:2040622320942042. [PMID: 32728410 DOI: 10.1177/2040622320942042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
446 Martínez-Castillo M, Rosique-Oramas D, Medina-Avila Z, Pérez-Hernández JL, Higuera-De la Tijera F, Santana-Vargas D, Montalvo-Jave EE, Sanchez-Avila F, Torre A, Kershenobich D, Gutierrez-Reyes G. Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression. Mol Cell Biochem 2020;469:65-75. [PMID: 32301061 DOI: 10.1007/s11010-020-03728-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
447 Park SH, Plank LD, Suk KT, Park YE, Lee J, Choi JH, Heo NY, Park J, Kim TO, Moon YS, Kim HK, Jang HJ, Park HY, Kim DJ. Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017. Clin Mol Hepatol 2020;26:209-15. [PMID: 31679316 DOI: 10.3350/cmh.2019.0065] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
448 Wu G, Wu D, Lo J, Wang Y, Wu J, Lu S, Xu H, Zhao X, He Y, Li J, Demirci U, Wang S. A bioartificial liver support system integrated with a DLM/GelMA-based bioengineered whole liver for prevention of hepatic encephalopathy via enhanced ammonia reduction. Biomater Sci 2020;8:2814-24. [PMID: 32307491 DOI: 10.1039/c9bm01879d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
449 Nie Y, Liu LX, Chen T, Zhang Y, Zhu X. Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study. Epidemiol Infect 2021;149:e26. [PMID: 33397544 DOI: 10.1017/S0950268820003143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
450 Qu H, Gao X, Cheng C, Zhao H, Wang Z, Yi J. Hepatoprotection mechanism against alcohol-induced liver injury in vivo and structural characterization of Pinus koraiensis pine nut polysaccharide. Int J Biol Macromol 2020;154:1007-21. [PMID: 32209373 DOI: 10.1016/j.ijbiomac.2020.03.168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
451 Wang Y, Dong F, Sun S, Wang X, Zheng X, Huang Y, Li B, Gao Y, Qian Z, Liu F, Lu X, Liu J, Ren H, Zheng Y, Yan H, Deng G, Qiao L, Zhang Y, Gu W, Xiang X, Zhou Y, Xu B, Hou Y, Zhang Q, Xiong Y, Zou C, Chen J, Huang Z, Jiang X, Qi T, Luo S, Chen Y, Gao N, Liu C, Yuan W, Mei X, Li J, Li T, Zheng R, Zhou X, Zhang W, Li H, Meng Z. Increased INR Values Predict Accelerating Deterioration and High Short-Term Mortality Among Patients Hospitalized With Cirrhosis or Advanced Fibrosis. Front Med (Lausanne) 2021;8:762291. [PMID: 34869468 DOI: 10.3389/fmed.2021.762291] [Reference Citation Analysis]
452 Li Z, Zhao L, Xia Y, Chen J, Hua M, Sun Y. Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis. Molecules 2021;26:6882. [PMID: 34833975 DOI: 10.3390/molecules26226882] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
453 Riebensahm C, Ka D, Sow A, Semmo N, Wandeler G. A closer look at the spectrum of drug-induced liver injury in sub-Saharan Africa. Expert Rev Clin Pharmacol 2019;12:875-83. [PMID: 31269818 DOI: 10.1080/17512433.2019.1638251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
454 Ye X, Wei J, Yue M, Wang Y, Chen H, Zhang Y, Wang Y, Zhang M, Huang P, Yu R. Leveraging Single-Cell RNA-seq Data to Uncover the Association Between Cell Type and Chronic Liver Diseases. Front Genet 2021;12:637322. [PMID: 33763117 DOI: 10.3389/fgene.2021.637322] [Reference Citation Analysis]
455 Golabi P, Paik JM, AlQahtani S, Younossi Y, Tuncer G, Younossi ZM. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019. J Hepatol 2021:S0168-8278(21)00358-5. [PMID: 34081959 DOI: 10.1016/j.jhep.2021.05.022] [Reference Citation Analysis]
456 Yang W, He H, Wang T, Su N, Zhang F, Jiang K, Zhu J, Zhang C, Niu K, Wang L, Yuan X, Liu N, Li L, Wei W, Hu J. Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice. Hepatology 2021. [PMID: 34089528 DOI: 10.1002/hep.31987] [Reference Citation Analysis]
457 Ward LD, Tu HC, Quenneville CB, Tsour S, Flynn-Carroll AO, Parker MM, Deaton AM, Haslett PAJ, Lotta LA, Verweij N, Ferreira MAR, Baras A, Hinkle G, Nioi P; Regeneron Genetics Center., Geisinger-Regeneron DiscovEHR Collaboration. GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms. Nat Commun 2021;12:4571. [PMID: 34315874 DOI: 10.1038/s41467-021-24563-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
458 Marini TJ, Oppenheimer DC, Baran TM, Rubens DJ, Toscano M, Drennan K, Garra B, Miele FR, Garra G, Noone SJ, Tamayo L, Carlotto C, Trujillo L, Waks E, Garra K, Egoavil MS, Berrospi J, Castaneda B. New Ultrasound Telediagnostic System for Low-Resource Areas: Pilot Results From Peru. J Ultrasound Med 2021;40:583-95. [PMID: 32798267 DOI: 10.1002/jum.15420] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
459 Clemente-Sánchez A, Oliveira-Mello A, Bataller R. Moderate Alcoholic Hepatitis. Clin Liver Dis 2021;25:537-55. [PMID: 34229838 DOI: 10.1016/j.cld.2021.03.001] [Reference Citation Analysis]
460 Mori M, Izawa T, Inai Y, Fujiwara S, Aikawa R, Kuwamura M, Yamate J. Dietary Iron Overload Differentially Modulates Chemically-Induced Liver Injury in Rats. Nutrients 2020;12:E2784. [PMID: 32932999 DOI: 10.3390/nu12092784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
461 Guixé-muntet S, Zhu C, Xie W, Gracia-sancho J. Novel therapeutics for portal hypertension and fibrosis in chronic liver disease. Pharmacology & Therapeutics 2020;215:107626. [DOI: 10.1016/j.pharmthera.2020.107626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
462 Aloia L. The influence of tissue spatial geometry and functional organisation on liver regeneration. Semin Cell Dev Biol 2021:S1084-9521(21)00246-9. [PMID: 34563460 DOI: 10.1016/j.semcdb.2021.09.011] [Reference Citation Analysis]
463 Soto R, Díaz LA, Rivas V, Fuentes-López E, Zalaquett M, Bruera MJ, González C, Mezzano G, Benítez C. Frailty and reduced gait speed are independently related to mortality of cirrhotic patients in long-term follow-up. Ann Hepatol 2021;25:100327. [PMID: 33596465 DOI: 10.1016/j.aohep.2021.100327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
464 Ballestri S, Nascimbeni F, Lugari S, Lonardo A, Francica G. A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Rev Gastroenterol Hepatol 2019;13:667-81. [PMID: 31104523 DOI: 10.1080/17474124.2019.1621164] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
465 Simon TG, Patorno E, Schneeweiss S. Glucose-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00724-2. [PMID: 34256144 DOI: 10.1016/j.cgh.2021.07.010] [Reference Citation Analysis]
466 Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ, Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version) . World J Gastroenterol 2020; 26(45): 7088-7103 [PMID: 33362370 DOI: 10.3748/wjg.v26.i45.7088] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
467 Farooqi HMU, Sammantasinghar A, Kausar F, Farooqi MA, Chethikkattuveli Salih AR, Hyun K, Lim J, Khalil AAK, Mumtaz AS, Choi KH. Study of the Anticancer Potential of Plant Extracts Using Liver Tumor Microphysiological System. Life 2022;12:135. [DOI: 10.3390/life12020135] [Reference Citation Analysis]
468 Russell JO, Camargo FD. Hippo signalling in the liver: role in development, regeneration and disease. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35064256 DOI: 10.1038/s41575-021-00571-w] [Reference Citation Analysis]
469 Tonon M, Piano S. Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever. Clin Mol Hepatol 2021;27:94-6. [PMID: 33317236 DOI: 10.3350/cmh.2020.0305] [Reference Citation Analysis]
470 Argemi J, Bataller R. Hepatocyte-stellate cell synapse in alcohol-induced steatosis: another role for endocannabinoids. Nat Rev Gastroenterol Hepatol 2020;17:5-6. [PMID: 31686014 DOI: 10.1038/s41575-019-0233-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
471 Brennan PN, MacMillan M, Manship T, Moroni F, Glover A, Graham C, Semple S, Morris DM, Fraser AR, Pass C, McGowan NWA, Turner ML, Lachlan N, Dillon JF, Campbell JDM, Fallowfield JA, Forbes SJ. Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). BMJ Open 2021;11:e053190. [PMID: 34750149 DOI: 10.1136/bmjopen-2021-053190] [Reference Citation Analysis]
472 Taher M, Toossi MN, Jafarian A, Rasti A, Nayeri ND. Patients' Experiences of Life Challenges After Liver Transplantation: A Qualitative Study. J Patient Exp 2021;8:2374373521996956. [PMID: 34179375 DOI: 10.1177/2374373521996956] [Reference Citation Analysis]
473 Abbasi U, Abbina S, Gill A, Takuechi LE, Kizhakkedathu JN. Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities. ACS Chem Biol 2021;16:945-72. [PMID: 34102834 DOI: 10.1021/acschembio.1c00122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
474 Hofmann J, Hackl V, Esser H, Meszaros AT, Fodor M, Öfner D, Troppmair J, Schneeberger S, Hautz T. Cell-Based Regeneration and Treatment of Liver Diseases. Int J Mol Sci 2021;22:10276. [PMID: 34638617 DOI: 10.3390/ijms221910276] [Reference Citation Analysis]
475 Li Y, Li L, Weng HL, Liebe R, Ding HG. Computed tomography vs liver stiffness measurement and magnetic resonance imaging in evaluating esophageal varices in cirrhotic patients: A systematic review and meta-analysis. World J Gastroenterol 2020; 26(18): 2247-2267 [PMID: 32476790 DOI: 10.3748/wjg.v26.i18.2247] [Reference Citation Analysis]
476 Jo E, Kim H, König A, Yang J, Yoon SK, Windisch MP. Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors. Antiviral Res 2021;196:105195. [PMID: 34736995 DOI: 10.1016/j.antiviral.2021.105195] [Reference Citation Analysis]
477 Chen X, Zhou P, De L, Li B, Su S. The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta-analysis of 24,147 subjects. Mol Genet Genomic Med 2019;7:e824. [PMID: 31309745 DOI: 10.1002/mgg3.824] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
478 Tao J, Krutsenko Y, Moghe A, Singh S, Poddar M, Bell A, Oertel M, Singhi AD, Geller D, Chen X, Lujambio A, Liu S, Monga SP. Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications. Hepatology 2021;74:741-59. [PMID: 33529367 DOI: 10.1002/hep.31730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
479 Wang H, Che J, Cui K, Zhuang W, Li H, Sun J, Chen J, Wang C. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo. Phytomedicine 2021;88:153609. [PMID: 34126414 DOI: 10.1016/j.phymed.2021.153609] [Reference Citation Analysis]
480 Rezzani R, Franco C, Rodella LF. Curcumin as a Therapeutic Strategy in Liver Diseases. Nutrients 2019;11:E2498. [PMID: 31627369 DOI: 10.3390/nu11102498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
481 Shabangu CS, Huang JF, Hsiao HH, Yu ML, Chuang WL, Wang SC. Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases. Int J Mol Sci 2020;21:E3732. [PMID: 32466319 DOI: 10.3390/ijms21103732] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
482 Tong M, Wang F. APOC3rs2854116 , PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD : A meta‐analysis. IUBMB Life 2020;72:1757-64. [DOI: 10.1002/iub.2302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
483 Hsieh MS, Cheng KC, Hsieh ML, Chiang JH, Hsieh VC. Mortality Risk and Decompensation in Hospitalized Patients with Non-Alcoholic Liver Cirrhosis: Implications for Disease Management. Int J Environ Res Public Health 2021;18:E606. [PMID: 33445719 DOI: 10.3390/ijerph18020606] [Reference Citation Analysis]
484 Xu W, Zhu H, Hu B, Cheng Y, Guo Y, Yao W, Qian H. Echinacea in hepatopathy: A review of its phytochemistry, pharmacology, and safety. Phytomedicine 2021;87:153572. [PMID: 34029938 DOI: 10.1016/j.phymed.2021.153572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
485 Laroia ST, Vellore Srinivasan S, Yadav K, Rastogi A, Kumar S, Kumar G, Kumar M. Performance of shear wave elastography: A single centre pilot study of mixed etiology liver disease patients with normal BMI. Australas J Ultrasound Med 2021;24:120-36. [PMID: 34765422 DOI: 10.1002/ajum.12244] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
486 Simón J, Casado-Andrés M, Goikoetxea-Usandizaga N, Serrano-Maciá M, Martínez-Chantar ML. Nutraceutical Properties of Polyphenols against Liver Diseases. Nutrients 2020;12:E3517. [PMID: 33203174 DOI: 10.3390/nu12113517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
487 Stickel F, Lutz P, Buch S, Nischalke HD, Silva I, Rausch V, Fischer J, Weiss KH, Gotthardt D, Rosendahl J, Marot A, Elamly M, Krawczyk M, Casper M, Lammert F, Buckley TWM, McQuillin A, Spengler U, Eyer F, Vogel A, Marhenke S, von Felden J, Wege H, Sharma R, Atkinson S, Franke A, Nehring S, Moser V, Schafmayer C, Spahr L, Lackner C, Stauber RE, Canbay A, Link A, Valenti L, Grove JI, Aithal GP, Marquardt JU, Fateen W, Zopf S, Dufour JF, Trebicka J, Datz C, Deltenre P, Mueller S, Berg T, Hampe J, Morgan MY. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers. Hepatology 2020;72:88-102. [PMID: 31630428 DOI: 10.1002/hep.30996] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 12.5] [Reference Citation Analysis]
488 Böttger R, Pauli G, Chao P, Al Fayez N, Hohenwarter L, Li S. Lipid-based nanoparticle technologies for liver targeting. Advanced Drug Delivery Reviews 2020;154-155:79-101. [DOI: 10.1016/j.addr.2020.06.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
489 Zeng B, Liao B, Zhou D, Bai Y, Chen H, Chen B, Zhu Z. [Inhibitory effect of Xinhui citrus fermentation liquor on liver fibrosis in mice]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:588-92. [PMID: 33963720 DOI: 10.12122/j.issn.1673-4254.2021.04.16] [Reference Citation Analysis]
490 Aghabi YO, Yasin A, Kennedy JI, Davies SP, Butler AE, Stamataki Z. Targeting Enclysis in Liver Autoimmunity, Transplantation, Viral Infection and Cancer. Front Immunol 2021;12:662134. [PMID: 33953725 DOI: 10.3389/fimmu.2021.662134] [Reference Citation Analysis]
491 Zakaria ZA, Kamisan FH, Kek TL, Salleh MZ. Hepatoprotective and antioxidant activities of Dicranopteris linearis leaf extract against paracetamol-induced liver intoxication in rats. Pharm Biol 2020;58:478-89. [PMID: 32476526 DOI: 10.1080/13880209.2020.1764058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
492 Bhushan B, Banerjee S, Paranjpe S, Koral K, Mars WM, Stoops JW, Orr A, Bowen WC, Locker J, Michalopoulos GK. Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast‐Food Diet Model. Hepatology 2019;70:1546-63. [DOI: 10.1002/hep.30696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
493 Spring A, Saran JS, McCarthy S, McCluskey SA. Anesthesia for the Patient with Severe Liver Failure. Anesthesiol Clin 2020;38:35-50. [PMID: 32008656 DOI: 10.1016/j.anclin.2019.10.002] [Reference Citation Analysis]
494 Xi S, Zheng X, Li X, Jiang Y, Wu Y, Gong J, Jie Y, Li Z, Cao J, Sha L, Zhang M, Chong Y. Activated Hepatic Stellate Cells Induce Infiltration and Formation of CD163+ Macrophages via CCL2/CCR2 Pathway. Front Med (Lausanne) 2021;8:627927. [PMID: 33614685 DOI: 10.3389/fmed.2021.627927] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
495 Gantzel RH, Kjær MB, Laursen TL, Kazankov K, George J, Møller HJ, Grønbæk H. Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis. Front Med (Lausanne) 2020;7:615599. [PMID: 33490096 DOI: 10.3389/fmed.2020.615599] [Reference Citation Analysis]
496 Hannan MA, Rahman MA, Sohag AAM, Uddin MJ, Dash R, Sikder MH, Rahman MS, Timalsina B, Munni YA, Sarker PP, Alam M, Mohibbullah M, Haque MN, Jahan I, Hossain MT, Afrin T, Rahman MM, Tahjib-Ul-Arif M, Mitra S, Oktaviani DF, Khan MK, Choi HJ, Moon IS, Kim B. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients 2021;13:1784. [PMID: 34073784 DOI: 10.3390/nu13061784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
497 Costa FO, Cortelli SC, Cortelli JR, Lages EJP, Pereira GHM, Costa AM, Cota LOM. Association between liver cirrhosis and peri-implant diseases: a case-control study on implant- and patient-related risk factors. Clin Oral Investig 2021. [PMID: 34859326 DOI: 10.1007/s00784-021-04324-6] [Reference Citation Analysis]
498 Goudsmit BFJ, Putter H, Tushuizen ME, de Boer J, Vogelaar S, Alwayn IPJ, van Hoek B, Braat AE. Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region. Am J Transplant 2021;21:229-40. [PMID: 32529758 DOI: 10.1111/ajt.16142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
499 Kuroda H, Fujiwara Y, Abe T, Nagasawa T, Oguri T, Noguchi S, Kamiyama N, Takikawa Y. Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis. PLoS One 2021;16:e0249493. [PMID: 33826669 DOI: 10.1371/journal.pone.0249493] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
500 Tan Z, Sun H, Xue T, Gan C, Liu H, Xie Y, Yao Y, Ye T. Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Front Cell Dev Biol 2021;9:730176. [PMID: 34621747 DOI: 10.3389/fcell.2021.730176] [Reference Citation Analysis]
501 Xie Z, Li H, Tan W, Yang L, Ma X, Li W, Wang Q, Shang C, Chen Y. Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study. Front Med 2021;8:787777. [DOI: 10.3389/fmed.2021.787777] [Reference Citation Analysis]
502 Casler K, Chaney A. Cirrhosis: An evidence-based approach. Nursing 2021;51:24-34. [PMID: 33953095 DOI: 10.1097/01.NURSE.0000731828.24893.bb] [Reference Citation Analysis]
503 Xiao W, Huang X, Wang JH, Lin DR, Zhu Y, Chen C, Yang YH, Xiao J, Zhao LQ, Li JO, Cheung CY, Mise Y, Guo ZY, Du YF, Chen BB, Hu JX, Zhang K, Lin XS, Wen W, Liu YZ, Chen WR, Zhong YS, Lin HT. Screening and identifying hepatobiliary diseases through deep learning using ocular images: a prospective, multicentre study. Lancet Digit Health 2021;3:e88-97. [PMID: 33509389 DOI: 10.1016/S2589-7500(20)30288-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
504 Mo C, Xie S, Liu B, Zhong W, Zeng T, Huang S, Lai Y, Deng G, Zhou C, Yan W, Chen Y, Huang S, Gao L, Lv Z. Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis. Cell Death Dis 2021;12:16. [PMID: 33414436 DOI: 10.1038/s41419-020-03277-0] [Reference Citation Analysis]
505 Zeng S, Schnabl B. Roles for the mycobiome in liver disease. Liver Int 2022. [PMID: 34995410 DOI: 10.1111/liv.15160] [Reference Citation Analysis]
506 Skurikhin EG, Zhukova MA, Pan ES, Ermakova NN, Pershina OV, Pakhomova AV, Putrova OD, Sandrikina LA, Krupin VA, Kogai LV, Rebrova TY, Afanas'ev SA, Dygai AM. Age-Related Features of the Response of the Liver and Stem Cells during Modeling of Liver Cirrhosis. Bull Exp Biol Med 2021;171:127-33. [PMID: 34046793 DOI: 10.1007/s10517-021-05184-6] [Reference Citation Analysis]
507 Williams R. Hepatology through the crystal ball. Hepatol Int 2019;13:403-6. [PMID: 31273617 DOI: 10.1007/s12072-019-09959-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
508 Kelty E, Ward SV, Cadby G, McCarthy NS, O'Leary P, Moses EK, Ee HC, Preen DB. Familial and non-familial risk factors associated with incidence of colorectal cancer in young and middle-aged persons in Western Australia. Cancer Epidemiol 2019;62:101591. [PMID: 31494463 DOI: 10.1016/j.canep.2019.101591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
509 Wilkinson AL, Qurashi M, Shetty S. The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver. Front Physiol 2020;11:990. [PMID: 32982772 DOI: 10.3389/fphys.2020.00990] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
510 Vaz J, Eriksson B, Strömberg U, Buchebner D, Midlöv P. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study. BMC Gastroenterol 2020;20:84. [PMID: 32245414 DOI: 10.1186/s12876-020-01239-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
511 Song IA, Jang ES, Oh TK. Validation of Dynamic Aspartate-to-Alanine Aminotransferase Ratio for Predicting Liver Disease Mortality. Hepatol Commun 2021. [PMID: 34713990 DOI: 10.1002/hep4.1844] [Reference Citation Analysis]
512 Rezakhani S, Gjorevski N, Lutolf MP. Extracellular matrix requirements for gastrointestinal organoid cultures. Biomaterials 2021;276:121020. [PMID: 34280822 DOI: 10.1016/j.biomaterials.2021.121020] [Reference Citation Analysis]
513 Alipoor B, Nikouei S, Rezaeinejad F, Malakooti-Dehkordi SN, Sabati Z, Ghasemi H. Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets. J Endocrinol Invest 2021;44:2015-41. [PMID: 33792864 DOI: 10.1007/s40618-021-01559-8] [Reference Citation Analysis]
514 Krepkova LV, Babenko AN, Saybel' OL, Lupanova IA, Kuzina OS, Job KM, Sherwin CM, Enioutina EY. Valuable Hepatoprotective Plants - How Can We Optimize Waste Free Uses of Such Highly Versatile Resources? Front Pharmacol 2021;12:738504. [PMID: 34867345 DOI: 10.3389/fphar.2021.738504] [Reference Citation Analysis]
515 Zhang G, Huang X, Xiu H, Sun Y, Chen J, Cheng G, Song Z, Peng Y, Shen Y, Wang J, Cai Z. Extracellular vesicles: Natural liver-accumulating drug delivery vehicles for the treatment of liver diseases. J Extracell Vesicles 2020;10:e12030. [PMID: 33335695 DOI: 10.1002/jev2.12030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
516 Dolicka D, Sobolewski C, Correia de Sousa M, Gjorgjieva M, Foti M. mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer. Int J Mol Sci 2020;21:E6648. [PMID: 32932781 DOI: 10.3390/ijms21186648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
517 Ahmed O, Xu M, Zhou F, Wein AN, Upadhya GA, Ye L, Wong BW, Lin Y, O'Farrelly C, Chapman WC. NRF2 assessment in discarded liver allografts: A role in allograft function and salvage. Am J Transplant 2021. [PMID: 34379880 DOI: 10.1111/ajt.16789] [Reference Citation Analysis]
518 Sharma R, Porterfield JE, An HT, Jimenez AS, Lee S, Kannan S, Sharma A, Kannan RM. Rationally Designed Galactose Dendrimer for Hepatocyte-Specific Targeting and Intracellular Drug Delivery for the Treatment of Liver Disorders. Biomacromolecules 2021;22:3574-89. [PMID: 34324818 DOI: 10.1021/acs.biomac.1c00649] [Reference Citation Analysis]
519 Genfi AKA, Larbie C, Emikpe BO, Oyagbemi AA, Firempong CK, Adjei CO. Modulation of Oxidative Stress and Inflammatory Cytokines as Therapeutic Mechanisms of Ocimum americanum L Extract in Carbon Tetrachloride and Acetaminophen-Induced Toxicity in Rats. J Evid Based Integr Med 2020;25:2515690X20938002. [PMID: 32967433 DOI: 10.1177/2515690X20938002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
520 Mu LY, Li SQ, Tang LX, Li R. Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis. Clinics (Sao Paulo) 2021;76:e2409. [PMID: 34133478 DOI: 10.6061/clinics/2021/e2409] [Reference Citation Analysis]
521 Valentino G, Zivko C, Weber F, Brülisauer L, Luciani P. Synergy of Phospholipid-Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells. Pharmaceutics 2019;11:E676. [PMID: 31842373 DOI: 10.3390/pharmaceutics11120676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
522 Sang C, Yan H, Chan WK, Zhu X, Sun T, Chang X, Xia M, Sun X, Hu X, Gao X, Jia W, Bian H, Chen T, Xie G. Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. Front Med (Lausanne) 2021;8:637652. [PMID: 33708783 DOI: 10.3389/fmed.2021.637652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
523 You X, Xiao Y, Liu K, Yu Y, Liu Y, Long P, Wang H, Zhou L, Deng Q, Lin Y, Zhang X, He M, Wu T, Yuan Y. Association of plasma antimony concentration with markers of liver function in Chinese adults. Environ Chem 2020;17:304. [DOI: 10.1071/en19195] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
524 Hagström H, Lindfors A, Holmer M, Bengtsson B, Björkström K, Hegmar H, von Seth E. Etiologies and outcomes of cirrhosis in a large contemporary cohort. Scand J Gastroenterol 2021;56:727-32. [PMID: 33872099 DOI: 10.1080/00365521.2021.1912167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
525 Yang L, Li J, Ma L, Xiang H, He D, Lu C, Tang L, Luo Y, Chen S. Noninvasive assessment of liver fibrosis in chronic hepatitis B carriers with sound touch elastography: study of surgical pathology specimens. Expert Rev Med Devices 2020;17:845-53. [PMID: 32686517 DOI: 10.1080/17434440.2020.1798226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
526 Ding Y, Sun Z, Zhang S, Chen Y, Zhou B, Li G, Sun Q, Zhou D, Ge Y, Yan S, Wang W. Down-regulation of Long Non-coding RNA LINC01554 in Hepatocellular Cancer and its Clinical Significance. J Cancer 2020;11:3369-74. [PMID: 32231743 DOI: 10.7150/jca.40512] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
527 Raj D, Sharma V, Upadhyaya A, Kumar N, Joshi R, Acharya V, Kumar D, Patial V. Swertia purpurascens Wall ethanolic extract mitigates hepatic fibrosis and restores hepatic hepcidin levels via inhibition of TGFβ/SMAD/NFκB signaling in rats. J Ethnopharmacol 2021;284:114741. [PMID: 34699946 DOI: 10.1016/j.jep.2021.114741] [Reference Citation Analysis]
528 Boyd A, Newsome P, Lu W. The role of stem cells in liver injury and repair. Expert Review of Gastroenterology & Hepatology 2019;13:623-31. [DOI: 10.1080/17474124.2019.1618186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
529 Zupo R, Castellana F, De Nucci S, De Pergola G, Lozupone M, Bortone I, Castellana M, Sborgia G, Lampignano L, Giannelli G, Panza F, Sardone R. Liver Fibrosis and 8-Year All-Cause Mortality Trajectories in the Aging Cohort of the Salus in Apulia Study. Biomedicines 2021;9:1617. [PMID: 34829846 DOI: 10.3390/biomedicines9111617] [Reference Citation Analysis]
530 Tenório MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF. N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants (Basel) 2021;10:967. [PMID: 34208683 DOI: 10.3390/antiox10060967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
531 Li R, Toan S, Zhou H. Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease. Aging (Albany NY) 2020;12:6467-85. [PMID: 32213662 DOI: 10.18632/aging.102972] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
532 Yang Y, Sun M, Li W, Liu C, Jiang Z, Gu P, Li J, Wang W, You R, Ba Q, Li X, Wang H. Rebalancing TGF-β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis. Clin Transl Med 2021;11:e410. [PMID: 34323416 DOI: 10.1002/ctm2.410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
533 Aravalli RN, Steer CJ. Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism. Genes (Basel) 2020;11:E729. [PMID: 32630053 DOI: 10.3390/genes11070729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
534 Danielsson O, Nissinen MJ, Jula A, Salomaa V, Männistö S, Lundqvist A, Perola M, Åberg F. Waist and hip circumference are independently associated with the risk of liver disease in population-based studies. Liver Int 2021. [PMID: 34510711 DOI: 10.1111/liv.15053] [Reference Citation Analysis]
535 Shankar N, Ramani A, Griffin C, Agbim U, Kim D, Ahmed A, Asrani SK. Extrahepatic causes of death in cirrhosis compared to other chronic conditions in the United States, 1999-2017. Ann Hepatol 2021;26:100565. [PMID: 34728419 DOI: 10.1016/j.aohep.2021.100565] [Reference Citation Analysis]
536 [DOI: 10.1101/2020.09.03.280883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
537 Lebossé F, Zoulim F. [Hepatitis B vaccine and liver cancer]. Bull Cancer 2021;108:90-101. [PMID: 33358507 DOI: 10.1016/j.bulcan.2020.10.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
538 Gillessen A, Schmidt HH. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Adv Ther 2020;37:1279-301. [PMID: 32065376 DOI: 10.1007/s12325-020-01251-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
539 [DOI: 10.1101/2020.07.14.203166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
540 Yuan S, Wei C, Liu G, Zhang L, Li J, Li L, Cai S, Fang L. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway. Cell Prolif 2021;:e13158. [PMID: 34811833 DOI: 10.1111/cpr.13158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
541 Burra P. Management of complex liver diseases. Minerva Gastroenterol (Torino) 2021;67:2-3. [PMID: 33784806 DOI: 10.23736/S2724-5985.20.02803-2] [Reference Citation Analysis]
542 Yang J, Hu F, Guo C, Liang Y, Song H, Cheng K. Discovery of isoliquiritigenin analogues that reverse acute hepatitis by inhibiting macrophage polarization. Bioorg Chem 2021;114:105043. [PMID: 34120019 DOI: 10.1016/j.bioorg.2021.105043] [Reference Citation Analysis]
543 Budi EH, Schaub JR, Decaris M, Turner S, Derynck R. TGF-β as a driver of fibrosis: physiological roles and therapeutic opportunities. J Pathol 2021;254:358-73. [PMID: 33834494 DOI: 10.1002/path.5680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
544 Mohandas S, Vairappan B. Pregnane X receptor activation by its natural ligand Ginkgolide-A improves tight junction proteins expression and attenuates bacterial translocation in cirrhosis. Chem Biol Interact. 2020;315:108891. [PMID: 31697926 DOI: 10.1016/j.cbi.2019.108891] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
545 Zhou F, She W, He L, Zhu J, Gu L. The effect of anthocyanins supplementation on liver enzymes among patients with metabolic disorders: A systematic review and meta-analysis of randomized clinical trials. Phytother Res 2021. [PMID: 34510592 DOI: 10.1002/ptr.7280] [Reference Citation Analysis]
546 Savale L, Guimas M, Ebstein N, Fertin M, Jevnikar M, Renard S, Horeau-Langlard D, Tromeur C, Chabanne C, Prevot G, Chaouat A, Moceri P, Artaud-Macari É, Degano B, Tresorier R, Boissin C, Bouvaist H, Simon AC, Riou M, Favrolt N, Palat S, Bourlier D, Magro P, Cottin V, Bergot E, Lamblin N, Jaïs X, Coilly A, Durand F, Francoz C, Conti F, Hervé P, Simonneau G, Montani D, Duclos-Vallée JC, Samuel D, Humbert M, De Groote P, Sitbon O. Portopulmonary hypertension in the current era of pulmonary hypertension management. J Hepatol 2020;73:130-9. [PMID: 32145258 DOI: 10.1016/j.jhep.2020.02.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
547 Liu S, Qiu J, He G, He W, Liu C, Cai D, Pan H. TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3. Cancer Cell Int 2021;21:63. [PMID: 33472635 DOI: 10.1186/s12935-020-01724-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
548 Ahamad N, Kar A, Mehta S, Dewani M, Ravichandran V, Bhardwaj P, Sharma S, Banerjee R. Immunomodulatory nanosystems for treating inflammatory diseases. Biomaterials 2021;274:120875. [PMID: 34010755 DOI: 10.1016/j.biomaterials.2021.120875] [Reference Citation Analysis]
549 Ming L, Qi B, Hao S, Ji R. Camel milk ameliorates inflammatory mechanisms in an alcohol-induced liver injury mouse model. Sci Rep 2021;11:22811. [PMID: 34819599 DOI: 10.1038/s41598-021-02357-1] [Reference Citation Analysis]
550 Jiang Z, Guo X, Zhang K, Sekaran G, Cao B, Zhao Q, Zhang S, Kirby GM, Zhang X. The Essential Oils and Eucalyptol From Artemisia vulgaris L. Prevent Acetaminophen-Induced Liver Injury by Activating Nrf2-Keap1 and Enhancing APAP Clearance Through Non-Toxic Metabolic Pathway. Front Pharmacol 2019;10:782. [PMID: 31404264 DOI: 10.3389/fphar.2019.00782] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
551 Shi M, Dong B, Yang W, Su S, Zhang H. Preventive and therapeutic role of Tanshinone ⅡA in hepatology. Biomedicine & Pharmacotherapy 2019;112:108676. [DOI: 10.1016/j.biopha.2019.108676] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
552 Li D, Hu Z, He Q, Guo Y, Chong Y, Xu J, Qin L. Lactoferrin Alleviates Acute Alcoholic Liver Injury by Improving Redox-Stress Response Capacity in Female C57BL/6J Mice. J Agric Food Chem 2021;69:14856-67. [PMID: 34873911 DOI: 10.1021/acs.jafc.1c06813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
553 Zeng X, Yuan X, Cai Q, Tang C, Gao J. Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. Cells 2021;10:1945. [PMID: 34440714 DOI: 10.3390/cells10081945] [Reference Citation Analysis]
554 Powell EE, Skoien R, Rahman T, Clark PJ, O'Beirne J, Hartel G, Stuart KA, McPhail SM, Gupta R, Boyd P, Valery PC. Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians. EClinicalMedicine 2019;11:44-53. [PMID: 31317132 DOI: 10.1016/j.eclinm.2019.05.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
555 Lin CY, Adhikary P, Cheng K. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Adv Drug Deliv Rev 2021;174:127-39. [PMID: 33857552 DOI: 10.1016/j.addr.2021.04.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
556 Milton-Laskibar I, Marcos-Zambrano LJ, Gómez-Zorita S, Fernández-Quintela A, Carrillo de Santa Pau E, Martínez JA, Portillo MP. Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset. Nutrients 2021;13:1738. [PMID: 34065444 DOI: 10.3390/nu13051738] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
557 Wang JP, Li TZ, Huang XY, Geng CA, Shen C, Sun JJ, Xue D, Chen JJ. Synthesis and anti-fibrotic effects of santamarin derivatives as cytotoxic agents against hepatic stellate cell line LX2. Bioorg Med Chem Lett 2021;41:127994. [PMID: 33775837 DOI: 10.1016/j.bmcl.2021.127994] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
558 Roberts SB, Hansen BE, Shin S, Abrahamyan L, Lapointe-Shaw L, Janssen HLA, Razak F, Verma AA, Hirschfield GM. Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort. Aliment Pharmacol Ther 2021;54:689-98. [PMID: 34181776 DOI: 10.1111/apt.16488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
559 Bajaj JS, Reddy KR, O'Leary JG, Vargas HE, Lai JC, Kamath PS, Tandon P, Wong F, Subramanian RM, Thuluvath P, Fagan A, White MB, Gavis EA, Sehrawat T, de la Rosa Rodriguez R, Thacker LR, Sikaroodi M, Garcia-Tsao G, Gillevet PM. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis. Gastroenterology 2020;159:1715-1730.e12. [PMID: 32687928 DOI: 10.1053/j.gastro.2020.07.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
560 Simchick G, Zhao R, Hamilton G, Reeder SB, Hernando D. Spectroscopy-based multi-parametric quantification in subjects with liver iron overload at 1.5T and 3T. Magn Reson Med 2022;87:597-613. [PMID: 34554595 DOI: 10.1002/mrm.29021] [Reference Citation Analysis]
561 Nakagawa M, Nawa N, Takeichi E, Shimizu T, Tsuchiya J, Sato A, Miyoshi M, Kawai-kitahata F, Murakawa M, Nitta S, Itsui Y, Azuma S, Kakinuma S, Fujiwara T, Watanabe M, Tanaka Y, Asahina Y; the Ochanomizu Liver Conference Study Group. Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs. J Gastroenterol 2020;55:990-9. [DOI: 10.1007/s00535-020-01715-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
562 Monga SP. Inside-Out or Outside-In: Choosing the Right Model of Hepatocellular Cancer. Gene Expr 2020;20:139-45. [PMID: 32503685 DOI: 10.3727/105221620X15913805462476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
563 Chung GE, Chang Y, Cho Y, Cho EJ, Yoo JJ, Park SH, Han K, Shin DW, Yu SJ, Kim YJ, Yoon JH. The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis. Biomedicines 2021;9:1948. [PMID: 34944764 DOI: 10.3390/biomedicines9121948] [Reference Citation Analysis]
564 Burkholder DA, Moran IJ, DiBattista JV, Lok AS, Parikh ND, Chen VL. Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications. Dig Dis Sci 2021. [PMID: 34674069 DOI: 10.1007/s10620-021-07282-x] [Reference Citation Analysis]
565 Samji NS, Heda R, Kovalic AJ, Satapathy SK. Similarities and Differences Between Nonalcoholic Steatohepatitis and Other Causes of Cirrhosis. Gastroenterology Clinics of North America 2020;49:151-64. [DOI: 10.1016/j.gtc.2019.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
566 Ampuero J, Romero-Gomez M. Stratification of patients in NASH clinical trials: A pitfall for trial success. JHEP Rep 2020;2:100148. [PMID: 32954243 DOI: 10.1016/j.jhepr.2020.100148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
567 Golabi P, Paik JM, Eberly K, de Avila L, Alqahtani SA, Younossi ZM. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C. Ann Hepatol 2021;27:100556. [PMID: 34800721 DOI: 10.1016/j.aohep.2021.100556] [Reference Citation Analysis]
568 Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N. Anti-fibrotic treatments for chronic liver diseases: The present and the future. Clin Mol Hepatol 2021;27:413-24. [PMID: 33317250 DOI: 10.3350/cmh.2020.0187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
569 Abdullah AS, El Sayed IET, El-Torgoman AMA, Alghamdi NA, Ullah S, Wageh S, Kamel MA. Preparation and Characterization of Silymarin-Conjugated Gold Nanoparticles with Enhanced Anti-Fibrotic Therapeutic Effects against Hepatic Fibrosis in Rats: Role of MicroRNAs as Molecular Targets. Biomedicines 2021;9:1767. [PMID: 34944582 DOI: 10.3390/biomedicines9121767] [Reference Citation Analysis]
570 Agarwal A, Rai SK, Lin Y, Patnaik RK, Yeh JA. Ammonia Selectivity Over Acetone by Viscosity Modulation of Silicone Oil Filter for Diagnosing Liver Dysfunction. ECS J Solid State Sci Technol 2020;9:115030. [DOI: 10.1149/2162-8777/abc513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
571 Lu X, Wang Z, Yang L, Yang C, Song M. Risk Factors of Atrial Arrhythmia in Patients With Liver Cirrhosis: A Retrospective Study. Front Cardiovasc Med 2021;8:704073. [PMID: 34291096 DOI: 10.3389/fcvm.2021.704073] [Reference Citation Analysis]
572 Ma C, Zhang L, He T, Cao H, Ren X, Ma C, Yang J, Huang R, Pan G. Single cell Raman spectroscopy to identify different stages of proliferating human hepatocytes for cell therapy. Stem Cell Res Ther 2021;12:555. [PMID: 34717753 DOI: 10.1186/s13287-021-02619-9] [Reference Citation Analysis]
573 Francica G, Borzio M. Status of, and strategies for improving, adherence to HCC screening and surveillance. J Hepatocell Carcinoma 2019;6:131-41. [PMID: 31440486 DOI: 10.2147/JHC.S159269] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
574 Canivet CM, Smati S, Lannes A, Brisseau J, Judon L, Roch ML, Cariou B, Bellanger W, Guerci B, Boursier J. Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners. Clin Res Hepatol Gastroenterol 2021;:101848. [PMID: 34922062 DOI: 10.1016/j.clinre.2021.101848] [Reference Citation Analysis]
575 Zhao X, Zhu Y, Laslett AL, Chan HF. Hepatic Differentiation of Stem Cells in 2D and 3D Biomaterial Systems. Bioengineering (Basel) 2020;7:E47. [PMID: 32466173 DOI: 10.3390/bioengineering7020047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
576 Acun A, Oganesyan R, Uygun K, Yeh H, Yarmush ML, Uygun BE. Liver donor age affects hepatocyte function through age-dependent changes in decellularized liver matrix. Biomaterials 2021;270:120689. [PMID: 33524812 DOI: 10.1016/j.biomaterials.2021.120689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
577 Tapper EB, Asrani SK. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. J Hepatol. 2020;73:441-445. [PMID: 32298769 DOI: 10.1016/j.jhep.2020.04.005] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 35.0] [Reference Citation Analysis]
578 Miyata T, Wu X, Fan X, Huang E, Sanz-Garcia C, Ross CKC, Roychowdhury S, Bellar A, McMullen MR, Dasarathy J, Allende DS, Caballeria J, Sancho-Bru P, McClain CJ, Mitchell M, McCullough AJ, Radaeva S, Barton B, Szabo G, Dasarathy S, Nagy LE. Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans. JCI Insight 2021;6:140180. [PMID: 33616081 DOI: 10.1172/jci.insight.140180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
579 Witzigmann D, Kulkarni JA, Leung J, Chen S, Cullis PR, van der Meel R. Lipid nanoparticle technology for therapeutic gene regulation in the liver. Adv Drug Deliv Rev 2020;159:344-63. [PMID: 32622021 DOI: 10.1016/j.addr.2020.06.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
580 Chao TY, Hsieh CC, Kuo YH, Yu YJ, Wan CH, Hsieh SC. Bracteanolide A abrogates oxidative stress-induced cellular damage and protects against hepatic ischemia and reperfusion injury in rats. Food Sci Nutr 2021;9:4758-69. [PMID: 34531989 DOI: 10.1002/fsn3.2374] [Reference Citation Analysis]
581 Caiazza C, Parisi S, Caiazzo M. Liver Organoids: Updates on Disease Modeling and Biomedical Applications. Biology (Basel) 2021;10:835. [PMID: 34571712 DOI: 10.3390/biology10090835] [Reference Citation Analysis]
582 Cheng K, Chen Y, Wang X, Xu M, Liao W, Duan X, Zhao X, Sun Y, Duan Z, Wang L. Entecavir combined with interferon-α is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B. Cancer 2021. [PMID: 34623636 DOI: 10.1002/cncr.33949] [Reference Citation Analysis]
583 Zivko C, Fuhrmann G, Luciani P. Liver-derived extracellular vesicles: A cell by cell overview to isolation and characterization practices. Biochimica et Biophysica Acta (BBA) - General Subjects 2021;1865:129559. [DOI: 10.1016/j.bbagen.2020.129559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
584 Martinez MA, Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatol Commun 2021. [PMID: 34222744 DOI: 10.1002/hep4.1745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
585 Faris IH, Melchor J, Callejas A, Torres J, Rus G. Viscoelastic Biomarkers of Ex Vivo Liver Samples via Torsional Wave Elastography. Diagnostics (Basel) 2020;10:E111. [PMID: 32092900 DOI: 10.3390/diagnostics10020111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
586 Bakr RO, Shahat EA, Elissawy AE, Fayez AM, Eldahshan OA. Evaluation of the hepatoprotective activity of Pulicaria incisa subspecies candolleana and in silico screening of its isolated phenolics. J Ethnopharmacol 2021;271:113767. [PMID: 33444722 DOI: 10.1016/j.jep.2020.113767] [Reference Citation Analysis]
587 Sarmast N, Ogola GO, Kouznetsova M, Leise MD, Bahirwani R, Maiwall R, Tapper E, Trotter J, Bajaj JS, Thacker LR, Tandon P, Wong F, Reddy KR, O'Leary JG, Masica A, Modrykamien AM, Kamath PS, Asrani SK. Model for End-Stage Liver Disease-Lactate and Prediction of Inpatient Mortality in Patients With Chronic Liver Disease. Hepatology. 2020;72:1747-1757. [PMID: 32083761 DOI: 10.1002/hep.31199] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
588 Kabarra K, Golabi P, Younossi ZM. Nonalcoholic steatohepatitis: global impact and clinical consequences. Endocr Connect 2021;10:R240-7. [PMID: 34486981 DOI: 10.1530/EC-21-0048] [Reference Citation Analysis]
589 Zhang F, Wang K, Hu G, Fu F, Fan R Dr, Li J, Yang L, Liu Y, Feng N, Gu X, Jia M, Chen X, Pei J. Genetic ablation of fas-activated serine/threonine kinase ameliorates alcoholic liver disease through modulating HuR-SIRT1 mRNA complex stability. Free Radic Biol Med 2021;166:201-11. [PMID: 33610658 DOI: 10.1016/j.freeradbiomed.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
590 Xiang H, Wu Z, Wang J, Wu T. Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. J Cancer 2021;12:5929-37. [PMID: 34476007 DOI: 10.7150/jca.57951] [Reference Citation Analysis]
591 Chang HJ, Zúñiga A, Conejero I, Voyvodic PL, Gracy J, Fajardo-Ruiz E, Cohen-Gonsaud M, Cambray G, Pageaux GP, Meszaros M, Meunier L, Bonnet J. Programmable receptors enable bacterial biosensors to detect pathological biomarkers in clinical samples. Nat Commun 2021;12:5216. [PMID: 34471137 DOI: 10.1038/s41467-021-25538-y] [Reference Citation Analysis]
592 Lai J, Jiang S, Shuai L, Zhang Y, Xia R, Chen Q, Bai L. Comparison of the biological and functional characteristics of mesenchymal stem cells from intrahepatic and identical bone marrow. Stem Cell Res 2021;55:102477. [PMID: 34343826 DOI: 10.1016/j.scr.2021.102477] [Reference Citation Analysis]
593 Sang L, Kang K, Sun Y, Li Y, Chang B. FOXO4 ameliorates alcohol-induced chronic liver injury via inhibiting NF-κB and modulating gut microbiota in C57BL/6J mice. Int Immunopharmacol 2021;96:107572. [PMID: 33798806 DOI: 10.1016/j.intimp.2021.107572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
594 El Masri J, El Ayoubi LM, Zreika B, Adhami F, El Masri D, El Hage S, Abou-Jaoudé M. Current state of clinical trials regarding liver transplant rejection. Transpl Immunol 2021;70:101522. [PMID: 34954324 DOI: 10.1016/j.trim.2021.101522] [Reference Citation Analysis]
595 Izzy M, Angirekula M, Abu Dayyeh BK, Bazerbachi F, Watt KD. Bariatric surgery proves long-term benefit in patients with cirrhosis. Gastroenterol Rep (Oxf) 2021;9:252-6. [PMID: 34316375 DOI: 10.1093/gastro/goaa057] [Reference Citation Analysis]
596 Martínez-Uña M, López-Mancheño Y, Diéguez C, Fernández-Rojo MA, Novelle MG. Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases. Int J Mol Sci 2020;21:E9368. [PMID: 33316927 DOI: 10.3390/ijms21249368] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
597 Fontes A, Alemany-Pagès M, Oliveira PJ, Ramalho-Santos J, Zischka H, Azul AM. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease. Int J Mol Sci 2019;20:E3987. [PMID: 31426291 DOI: 10.3390/ijms20163987] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
598 Emara MH, Soliman HH, Elnadry M, Mohamed Said E, Abd-Elsalam S, Elbatae HE, Zaher TI, Ezzeldin S Bazeed S, Abdel-Razik A, Youssef Mohamed S, Elfert A; “Egyptian Ramadan Fasting, Liver Diseases Interest Group”. Ramadan fasting and liver diseases: A review with practice advices and recommendations. Liver Int 2021;41:436-48. [PMID: 33369880 DOI: 10.1111/liv.14775] [Reference Citation Analysis]
599 Rostom DM, Attia N, Khalifa HM, Abou Nazel MW, El Sabaawy EA. The Therapeutic Potential of Extracellular Vesicles Versus Mesenchymal Stem Cells in Liver Damage. Tissue Eng Regen Med. 2020;17:537-552. [PMID: 32506351 DOI: 10.1007/s13770-020-00267-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
600 Dawood RM, Salum GM, El-Meguid MA. The Impact of COVID-19 on Liver Injury: COVID-19 and Liver Injury. Am J Med Sci 2021:S0002-9629(21)00400-6. [PMID: 34752738 DOI: 10.1016/j.amjms.2021.11.001] [Reference Citation Analysis]
601 Aboshanab MHA, El-Nabarawi MA, Teaima MH, El-Nekeety AA, Abdel-Aziem SH, Hassan NS, Abdel-Wahhab MA. Fabrication, characterization and biological evaluation of silymarin nanoparticles against carbon tetrachloride-induced oxidative stress and genotoxicity in rats. Int J Pharm 2020;587:119639. [PMID: 32673772 DOI: 10.1016/j.ijpharm.2020.119639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
602 Li J, Guo C, Wu J. Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent. Drug Des Devel Ther 2020;14:2275-85. [PMID: 32606597 DOI: 10.2147/DDDT.S230749] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
603 Zhu T, Cheng Z, Peng X, Xing D, Zhang M. HIF-1α RNAi Combined with Asparagus Polysaccharide Exerts an Antiangiogenesis Effect on Hepatocellular Carcinoma In Vitro and In Vivo. Evid Based Complement Alternat Med 2021;2021:9987383. [PMID: 34335854 DOI: 10.1155/2021/9987383] [Reference Citation Analysis]
604 Vyas HS, Upadhyay KK, Devkar RV. miRNAs Signatures In Patients With Acute Liver Injury: Clinical Concerns and Correlations. Curr Mol Med 2020;20:325-35. [PMID: 31823701 DOI: 10.2174/1566524020666191211153546] [Reference Citation Analysis]
605 Shwartz A, Goessling W, Yin C. Macrophages in Zebrafish Models of Liver Diseases. Front Immunol 2019;10:2840. [PMID: 31867007 DOI: 10.3389/fimmu.2019.02840] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
606 Li Q, Zhang H, Zou J, Mai H, Su D, Feng X, Feng D. Bisphenol A exposure induces cholesterol synthesis and hepatic steatosis in C57BL/6 mice by down-regulating the DNA methylation levels of SREBP-2. Food and Chemical Toxicology 2019;133:110786. [DOI: 10.1016/j.fct.2019.110786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
607 Vogler J, Böttger R, Al Fayez N, Zhang W, Qin Z, Hohenwarter L, Chao PH, Rouhollahi E, Bilal N, Chen N, Lee B, Chen C, Wilkinson B, Kieffer TJ, Kulkarni JA, Cullis PR, Witzigmann D, Li SD. Altering the intra-liver distribution of phospholipid-free small unilamellar vesicles using temperature-dependent size-tunability. J Control Release 2021;333:151-61. [PMID: 33771624 DOI: 10.1016/j.jconrel.2021.03.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
608 Zhu J, Wang P, Ye H, Shi J, Wang X, Wang K, Duan F, Yang Q, Sun G, Zhang J. Trend of the mortality of major liver diseases and its impact on life expectancy in China from 2006 to 2017. J Public Health (Oxf) 2021:fdaa261. [PMID: 33454770 DOI: 10.1093/pubmed/fdaa261] [Reference Citation Analysis]
609 Bogensperger C, Hofmann J, Messner F, Resch T, Meszaros A, Cardini B, Weissenbacher A, Oberhuber R, Troppmair J, Öfner D, Schneeberger S, Hautz T. Ex Vivo Mesenchymal Stem Cell Therapy to Regenerate Machine Perfused Organs. Int J Mol Sci 2021;22:5233. [PMID: 34063399 DOI: 10.3390/ijms22105233] [Reference Citation Analysis]
610 Thorne AM, Ubbink R, Brüggenwirth IMA, Nijsten MW, Porte RJ, de Meijer VE. Hyperthermia-induced changes in liver physiology and metabolism: a rationale for hyperthermic machine perfusion. Am J Physiol Gastrointest Liver Physiol 2020;319:G43-50. [PMID: 32508156 DOI: 10.1152/ajpgi.00101.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
611 Fu Z, Jiao Y, Li YQ, Ke JJ, Xu YH, Jia BX, Liu B. PES1 In Liver Cancer: A Prognostic Biomarker With Tumorigenic Roles. Cancer Manag Res 2019;11:9641-53. [PMID: 31814761 DOI: 10.2147/CMAR.S226471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
612 Schulze RJ, Ding WX. Lipid droplet dynamics in alcoholic fatty liver disease. Liver Res 2019;3:185-90. [PMID: 33664985 DOI: 10.1016/j.livres.2019.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
613 Yu Y, Qu J, Zhou C, You G. Relationship of genetic polymorphisms in CTLA-4 and IL-18 with viral hepatitis: evidence from a meta-analysis. Epidemiol Infect 2019;147:e313. [PMID: 31801640 DOI: 10.1017/S0950268819001997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
614 Rodríguez MJ, Sabaj M, Tolosa G, Herrera Vielma F, Zúñiga MJ, González DR, Zúñiga-Hernández J. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation. Cells 2021;10:3406. [PMID: 34943914 DOI: 10.3390/cells10123406] [Reference Citation Analysis]
615 Lee S, Kim SS, Chang DR, Kim H, Kim MJ. Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging. Clin Mol Hepatol 2020;26:340-51. [PMID: 32492765 DOI: 10.3350/cmh.2020.0004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
616 Boyer-Diaz Z, Morata P, Aristu-Zabalza P, Gibert-Ramos A, Bosch J, Gracia-Sancho J. Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical. Nutrients 2020;12:E2627. [PMID: 32872239 DOI: 10.3390/nu12092627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
617 Tsuchiya H, Shiota G. Clinical and Biological Implications of Cancer Stem Cells in Hepatocellular Carcinoma. Yonago Acta Med 2021;64:1-11. [PMID: 33642898 DOI: 10.33160/yam.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
618 Haberl EM, Weiss TS, Peschel G, Weigand K, Köhler N, Pauling JK, Wenzel JJ, Höring M, Krautbauer S, Liebisch G, Buechler C. Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma. Int J Mol Sci 2021;22:5297. [PMID: 34069902 DOI: 10.3390/ijms22105297] [Reference Citation Analysis]
619 Singanayagam A, Triantafyllou E. Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting. Front Immunol 2021;12:661182. [PMID: 33868313 DOI: 10.3389/fimmu.2021.661182] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
620 Nayantara PV, Kamath S, Manjunath KN, Rajagopal KV. Computer-aided diagnosis of liver lesions using CT images: A systematic review. Comput Biol Med 2020;127:104035. [PMID: 33099219 DOI: 10.1016/j.compbiomed.2020.104035] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
621 Tao MH, Fulda KG. Association of Magnesium Intake with Liver Fibrosis among Adults in the United States. Nutrients 2021;13:E142. [PMID: 33401667 DOI: 10.3390/nu13010142] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
622 Jiang Y, Qin S, Wei X, Liu X, Guan J, Zhu H, Chang G, Chen Y, Lu H, Qian J, Wang Z, Shen M, Lin X. Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patients. Immunol Lett 2021;232:9-19. [PMID: 33515618 DOI: 10.1016/j.imlet.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
623 Miyatake D, Shibata T, Toyoshima J, Kaneko Y, Oda K, Nishimura T, Katashima M, Sakaki M, Inoue K, Ito T, Uchida N, Furihata K, Urae A. Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function. Clin Pharmacol Drug Dev 2020;9:699-708. [PMID: 31833184 DOI: 10.1002/cpdd.751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
624 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M, Tsubota A. Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis. JGH Open 2021;5:763-9. [PMID: 34263070 DOI: 10.1002/jgh3.12582] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
625 Agarwal T, Borrelli MR, Makvandi P, Ashrafizadeh M, Maiti TK. Paper-Based Cell Culture: Paving the Pathway for Liver Tissue Model Development on a Cellulose Paper Chip. ACS Appl Bio Mater 2020;3:3956-74. [DOI: 10.1021/acsabm.0c00558] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
626 Niriella MA, Kasturiratne A, Beddage TU, Withanage SA, Goonatilleke DC, Abeysinghe CP, De Mel RT, Balapitiya TL, De Silva ST, Dassanayake AS, De Silva AP, Pathmeswaran A, Wickramasinghe AR, Kato N, Silva HJ. Metabolic syndrome, but not non‐alcoholic fatty liver disease, increases 10‐year mortality: A prospective, community‐cohort study. Liver Int 2019;40:101-6. [DOI: 10.1111/liv.14237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
627 Zhong HJ, Xiao P, Lin D, Zhou HM, He XX. Cirrhosis in Wilson Disease is characterized by Impaired Hepatic Synthesis, Leukopenia and Thrombocytopenia. Int J Med Sci 2020;17:1345-50. [PMID: 32624691 DOI: 10.7150/ijms.44338] [Reference Citation Analysis]
628 Han HH, Tian H, Zang Y, Sedgwick AC, Li J, Sessler JL, He XP, James TD. Small-molecule fluorescence-based probes for interrogating major organ diseases. Chem Soc Rev 2021;50:9391-429. [PMID: 34232230 DOI: 10.1039/d0cs01183e] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
629 Xiao X, Hu Q, Deng X, Shi K, Zhang W, Jiang Y, Ma X, Zeng J, Wang X. Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases. Pharmacol Res 2021;175:106005. [PMID: 34843960 DOI: 10.1016/j.phrs.2021.106005] [Reference Citation Analysis]
630 Balkrishna A, Gohel V, Singh R, Joshi M, Varshney Y, Srivastava J, Bhattacharya K, Varshney A. Tri-Herbal Medicine Divya Sarva-Kalp-Kwath (Livogrit) Regulates Fatty Acid-Induced Steatosis in Human HepG2 Cells through Inhibition of Intracellular Triglycerides and Extracellular Glycerol Levels. Molecules 2020;25:E4849. [PMID: 33096687 DOI: 10.3390/molecules25204849] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
631 Ampuero J, Aller R, Gallego-Durán R, Crespo J, Abad J, González-Rodríguez Á, Gómez-Camarero J, Caballería J, Lo Iacono O, Ibañez L, García-Samaniego J, Martín-Mateos R, Francés R, Fernández-Rodríguez C, Diago M, Soriano G, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Estévez P, Hernández-Guerra M, Augustín S, Pareja-Megia MJ, Banales JM, Aspichueta P, Benlloch S, Rosales JM, Salmerón J, Turnes J, Romero-Gómez M; HEPAmet Registry. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects. Liver Int 2021;41:2076-86. [PMID: 33896100 DOI: 10.1111/liv.14898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
632 Ravichandran A, Murekatete B, Moedder D, Meinert C, Bray LJ. Photocrosslinkable liver extracellular matrix hydrogels for the generation of 3D liver microenvironment models. Sci Rep 2021;11:15566. [PMID: 34330947 DOI: 10.1038/s41598-021-94990-z] [Reference Citation Analysis]
633 Cho IY, Chang Y, Sung E, Sohn W, Kang JH, Shin H, Ryu S. Depressive symptoms and risk of liver-related mortality in individuals with hepatitis B virus infection: a cohort study. Sci Rep 2020;10:20812. [PMID: 33257781 DOI: 10.1038/s41598-020-77886-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
634 García-Cordero JM, Martínez-Palma NY, Madrigal-Bujaidar E, Jiménez-Martínez C, Madrigal-Santillán E, Morales-González JA, Paniagua-Pérez R, Álvarez-González I. Phaseolin, a Protein from the Seed of Phaseolus vulgaris, Has Antioxidant, Antigenotoxic, and Chemopreventive Properties. Nutrients 2021;13:1750. [PMID: 34063915 DOI: 10.3390/nu13061750] [Reference Citation Analysis]
635 Pham TTT, Ho DT, Nguyen T. Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population. World J Hepatol 2020; 12(5): 220-229 [PMID: 32547689 DOI: 10.4254/wjh.v12.i5.220] [Reference Citation Analysis]
636 Kim E, Park SH. [Diagnosis and Severity Assessment of Alcohol-Related Liver Disease]. Korean J Gastroenterol 2020;76:60-4. [PMID: 32839367 DOI: 10.4166/kjg.2020.76.2.60] [Reference Citation Analysis]
637 Ahmadi A, Niknahad H, Li H, Mobasheri A, Manthari RK, Azarpira N, Mousavi K, Khalvati B, Zhao Y, Sun J, Zong Y, Ommati MM, Heidari R. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity. Toxicol Lett 2021;349:12-29. [PMID: 34089816 DOI: 10.1016/j.toxlet.2021.05.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
638 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
639 Xin C, Liu S, Qu H, Wang Z. The novel nanocomplexes containing deoxycholic acid-grafted chitosan and oleanolic acid displays the hepatoprotective effect against CCl4-induced liver injury in vivo. Int J Biol Macromol 2021;185:338-49. [PMID: 34171250 DOI: 10.1016/j.ijbiomac.2021.06.109] [Reference Citation Analysis]
640 Chayanupatkul M, Gambarin-Gelwan M, Schiano TD. The presence of non-hepatic malignancy and its implication in pursuing liver transplantation. Clin Transplant 2021. [PMID: 34189778 DOI: 10.1111/ctr.14410] [Reference Citation Analysis]
641 Yang TW, Wang CC, Tsai MC, Wang YT, Tseng MH, Lin CC. Comorbidities and Outcome of Alcoholic and Non-Alcoholic Liver Cirrhosis in Taiwan: A Population-Based Study. Int J Environ Res Public Health 2020;17:E2825. [PMID: 32325957 DOI: 10.3390/ijerph17082825] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
642 Knight H, Harman D, Morling JR, Aithal G, Card T, Guha IN, Bains M. Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation. BMJ Open 2020;10:e041574. [PMID: 33208336 DOI: 10.1136/bmjopen-2020-041574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
643 Du Z, Lin Z, Wang Z, Liu D, Tian D, Xia L. SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway. Lab Invest 2020;100:1042-56. [DOI: 10.1038/s41374-020-0425-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
644 Frigerio J, Tedesco E, Benetti F, Insolia V, Nicotra G, Mezzasalma V, Pagliari S, Labra M, Campone L. Anticholesterolemic Activity of Three Vegetal Extracts (Artichoke, Caigua, and Fenugreek) and Their Unique Blend. Front Pharmacol 2021;12:726199. [PMID: 34887750 DOI: 10.3389/fphar.2021.726199] [Reference Citation Analysis]
645 Liu R, Chen QH, Ren JW, Sun B, Cai XX, Li D, Mao RX, Wu X, Li Y. Ginseng (Panax ginseng Meyer) Oligopeptides Protect Against Binge Drinking-Induced Liver Damage through Inhibiting Oxidative Stress and Inflammation in Rats. Nutrients 2018;10:E1665. [PMID: 30400371 DOI: 10.3390/nu10111665] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
646 Rouf R, Ghosh P, Uzzaman MR, Sarker DK, Zahura FT, Uddin SJ, Muhammad I. Hepatoprotective Plants from Bangladesh: A Biophytochemical Review and Future Prospect. Evid Based Complement Alternat Med 2021;2021:1633231. [PMID: 34504532 DOI: 10.1155/2021/1633231] [Reference Citation Analysis]
647 Cotovio JP, Fernandes TG. Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications. Bioengineering (Basel) 2020;7:E36. [PMID: 32283585 DOI: 10.3390/bioengineering7020036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
648 Zhang C, Zhang C, Wang Q, Li Z, Lin J, Wang H. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types. JAMA Netw Open 2020;3:e202950. [PMID: 32267515 DOI: 10.1001/jamanetworkopen.2020.2950] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
649 Calès P, Bertrais S, Boursier J, Fouchard I, Oberti F; SNIFF 16 group. Non-selective beta-blockers increase overall and liver mortality in alcoholic cirrhosis with MELD ≥ 12 over 5 years of follow-up. Liver Int 2021;41:168-79. [PMID: 32979020 DOI: 10.1111/liv.14674] [Reference Citation Analysis]
650 Alshehri AS, El-Kott AF, El-Kenawy AE, Khalifa HS, AlRamlawy AM. Cadmium chloride induces non-alcoholic fatty liver disease in rats by stimulating miR-34a/SIRT1/FXR/p53 axis. Sci Total Environ 2021;784:147182. [PMID: 34088068 DOI: 10.1016/j.scitotenv.2021.147182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
651 Pan G, Diamanti K, Cavalli M, Lara Gutiérrez A, Komorowski J, Wadelius C. Multifaceted regulation of hepatic lipid metabolism by YY1. Life Sci Alliance 2021;4:e202000928. [PMID: 34099540 DOI: 10.26508/lsa.202000928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
652 So J, Kim A, Lee SH, Shin D. Liver progenitor cell-driven liver regeneration. Exp Mol Med 2020;52:1230-8. [PMID: 32796957 DOI: 10.1038/s12276-020-0483-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
653 Basu E, Mehta M, Zhang C, Zhao C, Rosenblatt R, Tapper EB, Parikh NS. Association of chronic liver disease with cognition and brain volumes in two randomized controlled trial populations. J Neurol Sci 2021;434:120117. [PMID: 34959080 DOI: 10.1016/j.jns.2021.120117] [Reference Citation Analysis]
654 Udayawara Rudresh D, Maradagi T, Stephen NM, Niraikulam A, Nambi Ramudu K, Ponesakki G. Neoxanthin prevents H2O2-induced cytotoxicity in HepG2 cells by activating endogenous antioxidant signals and suppressing apoptosis signals. Mol Biol Rep 2021;48:6923-34. [PMID: 34487292 DOI: 10.1007/s11033-021-06695-1] [Reference Citation Analysis]
655 Ma Q, Yang F, Ma B, Jing W, Liu J, Guo M, Li J, Wang Z, Liu M. Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study. Hepatol Int 2021;15:127-36. [PMID: 33512644 DOI: 10.1007/s12072-020-10132-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
656 Lee C, Kim M, Han J, Yoon M, Jung Y. Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis. Biomedicines 2021;9:1598. [PMID: 34829827 DOI: 10.3390/biomedicines9111598] [Reference Citation Analysis]
657 Yu AT, Berasain C, Bhatia S, Rivera K, Liu B, Rigo F, Pappin DJ, Spector DL. PHAROH lncRNA regulates Myc translation in hepatocellular carcinoma via sequestering TIAR. Elife 2021;10:e68263. [PMID: 34002693 DOI: 10.7554/eLife.68263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
658 Aloia L. Epigenetic Regulation of Cell-Fate Changes That Determine Adult Liver Regeneration After Injury. Front Cell Dev Biol 2021;9:643055. [PMID: 33732709 DOI: 10.3389/fcell.2021.643055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
659 Kostallari E, Wei B, Sicard D, Li J, Cooper SA, Gao J, Dehankar M, Li Y, Cao S, Yin M, Tschumperlin DJ, Shah VH. Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2021. [PMID: 34941452 DOI: 10.1152/ajpgi.00254.2021] [Reference Citation Analysis]
660 Yang H, Xie Y, Li T, Liu S, Zeng S, Wang B. A novel minimally invasive OFM technique with orthotopic transplantation of hUC-MSCs and in vivo monitoring of liver metabolic microenvironment in liver fibrosis treatment. Stem Cell Res Ther 2021;12:534. [PMID: 34627378 DOI: 10.1186/s13287-021-02599-w] [Reference Citation Analysis]
661 Dorji T, Srichan P, Apidechkul T, Sunsern R, Suttana W. Factors associated with different forms of alcohol use behaviors among college students in Bhutan: a cross-sectional study. Subst Abuse Treat Prev Policy 2020;15:70. [PMID: 32928241 DOI: 10.1186/s13011-020-00315-0] [Reference Citation Analysis]
662 Zhang W, Böttger R, Qin Z, Kulkarni JA, Vogler J, Cullis PR, Li S. Phospholipid‐Free Small Unilamellar Vesicles for Drug Targeting to Cells in the Liver. Small 2019;15:1901782. [DOI: 10.1002/smll.201901782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
663 Han JJ, Chen Y, Nan YC, Yang YL. Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report. World J Clin Cases 2021; 9(28): 8492-8497 [PMID: 34754858 DOI: 10.12998/wjcc.v9.i28.8492] [Reference Citation Analysis]
664 Gao Z, Huang XY, Geng CA, Li TZ, Chen JJ. Artemicapillasins A-N, cytotoxic coumaric acid analogues against hepatic stellate cell LX2 from Artemisia capillaris (Yin-Chen). Bioorg Chem 2021;117:105441. [PMID: 34695731 DOI: 10.1016/j.bioorg.2021.105441] [Reference Citation Analysis]
665 Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen V, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin K, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch A, Viveiros K, Chan W, Chascsa D, Kwo P, Dhanasekaran R. Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2020;. [PMID: 32950749 DOI: 10.1016/j.cgh.2020.09.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
666 Paik JM, Golabi P, Biswas R, Alqahtani S, Venkatesan C, Younossi ZM. Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States. Hepatol Commun 2020;4:890-903. [PMID: 32490324 DOI: 10.1002/hep4.1510] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
667 Alsahli MA, Almatroodi SA, Almatroudi A, Khan AA, Anwar S, Almutary AG, Alrumaihi F, Rahmani AH. 6-Gingerol, a Major Ingredient of Ginger Attenuates Diethylnitrosamine-Induced Liver Injury in Rats through the Modulation of Oxidative Stress and Anti-Inflammatory Activity. Mediators Inflamm 2021;2021:6661937. [PMID: 33531877 DOI: 10.1155/2021/6661937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
668 Haep N, Florentino RM, Squires JE, Bell A, Soto-Gutierrez A. The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone. Semin Liver Dis 2021;41:213-24. [PMID: 33992030 DOI: 10.1055/s-0041-1725023] [Reference Citation Analysis]
669 Thong VD, Quynh BTH. Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease. Int J Gen Med 2021;14:1349-55. [PMID: 33889015 DOI: 10.2147/IJGM.S309311] [Reference Citation Analysis]
670 Elkassem AA, Allen BC, Lirette ST, Cox KL, Remer EM, Pickhardt PJ, Lubner MG, Sirlin CB, Dondlinger T, Schmainda M, Jacobus RB, Severino PE, Smith AD. Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients with Hepatitis C. AJR Am J Roentgenol 2021. [PMID: 34935403 DOI: 10.2214/AJR.21.27062] [Reference Citation Analysis]
671 Zhou Z, Qi J, Kim JW, You MJ, Lim CW, Kim B. AK-1, a Sirt2 inhibitor, alleviates carbon tetrachloride-induced hepatotoxicity in vivo and in vitro. Toxicol Mech Methods 2020;30:324-35. [PMID: 32063085 DOI: 10.1080/15376516.2020.1729915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
672 Herrero A, Knetemann E, Mannaerts I. Review: Challenges of In Vitro CAF Modelling in Liver Cancers. Cancers (Basel) 2021;13:5914. [PMID: 34885024 DOI: 10.3390/cancers13235914] [Reference Citation Analysis]
673 Kim SK, Kim YH, Park S, Cho SW. Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling. Acta Biomater 2021:S1742-7061(21)00143-4. [PMID: 33711526 DOI: 10.1016/j.actbio.2021.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
674 Bate TSR, Gadd VL, Forbes SJ, Callanan A. Response differences of HepG2 and Primary Mouse Hepatocytes to morphological changes in electrospun PCL scaffolds. Sci Rep 2021;11:3059. [PMID: 33542251 DOI: 10.1038/s41598-021-81761-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
675 Baghaei K, Mazhari S, Tokhanbigli S, Parsamanesh G, Alavifard H, Schaafsma D, Ghavami S. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis. Drug Discov Today 2021:S1359-6446(21)00562-6. [PMID: 34952225 DOI: 10.1016/j.drudis.2021.12.012] [Reference Citation Analysis]
676 Hade MD, Suire CN, Suo Z. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine. Cells 2021;10:1959. [PMID: 34440728 DOI: 10.3390/cells10081959] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
677 Wauquier F, Boutin-Wittrant L, Viret A, Guilhaudis L, Oulyadi H, Bourafai-Aziez A, Charpentier G, Rousselot G, Cassin E, Descamps S, Roux V, Macian N, Pickering G, Wittrant Y. Metabolic and Anti-Inflammatory Protective Properties of Human Enriched Serum Following Artichoke Leaf Extract Absorption: Results from an Innovative Ex Vivo Clinical Trial. Nutrients 2021;13:2653. [PMID: 34444810 DOI: 10.3390/nu13082653] [Reference Citation Analysis]
678 Hernaez R, Kramer JR, Khan A, Phillips J, McCallister K, Chaffin K, Hernandez AP, Fullington H, Ortiz C, Blackwell JM, Loewen A, Liu Y, Tiro JA, Lee SC, Singal AG. Depression and Anxiety Are Common Among Patients With Cirrhosis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31154-X. [PMID: 32835845 DOI: 10.1016/j.cgh.2020.08.045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
679 Rohit Singh T, Ezhilarasan D. Lagerstroemia speciosa (L.) Pers., ethanolic leaves extract attenuates dapsone-induced liver inflammation in rats. Drug Chem Toxicol 2021;:1-10. [PMID: 34225555 DOI: 10.1080/01480545.2021.1945079] [Reference Citation Analysis]
680 Chen Y, Li R, Hu N, Yu C, Song H, Li Y, Dai Y, Guo Z, Li M, Zheng Y, Guo Z, Qi Y. Baihe Wuyao decoction ameliorates CCl4-induced chronic liver injury and liver fibrosis in mice through blocking TGF-β1/Smad2/3 signaling, anti-inflammation and anti-oxidation effects. Journal of Ethnopharmacology 2020;263:113227. [DOI: 10.1016/j.jep.2020.113227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
681 Salam B, Mubarak F, Waheed Y, Khan N. Complications of Ultrasound-guided Liver Biopsy at a Tertiary Care Hospital in Pakistan: An Audit. Cureus 2019;11:e5811. [PMID: 31737453 DOI: 10.7759/cureus.5811] [Reference Citation Analysis]